Reynolds American Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the quarterly period ended September 30, 2008 |
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 1-32258
Reynolds American Inc.
(Exact name of registrant as specified in its charter)
|
|
|
North Carolina
|
|
20-0546644 |
(State or other jurisdiction of
|
|
(I.R.S. Employer Identification Number) |
incorporation or organization) |
|
|
401 North Main Street
Winston-Salem, NC 27101
(Address of principal executive offices) (Zip Code)
(336) 741-2000
(Registrants telephone number, including area code)
(Former name, former address and former fiscal year, if changed from last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. YES þ NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one)
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
|
|
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). YES o NO þ
Indicate the number of shares outstanding of each of the issuers classes of common stock as
of the latest practicable date: 291,452,662 shares of common stock, par value $.0001 per share, as
of October 10, 2008
PART I Financial Information
Item 1. Financial Statements
REYNOLDS AMERICAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in Millions, Except Per Share Amounts)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months |
|
|
For the Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
Net sales1 |
|
$ |
2,156 |
|
|
$ |
2,174 |
|
|
$ |
6,330 |
|
|
$ |
6,419 |
|
Net sales, related party |
|
|
116 |
|
|
|
123 |
|
|
|
338 |
|
|
|
374 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
2,272 |
|
|
|
2,297 |
|
|
|
6,668 |
|
|
|
6,793 |
|
Costs and expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold1, 2, 3 |
|
|
1,229 |
|
|
|
1,250 |
|
|
|
3,698 |
|
|
|
3,768 |
|
Selling, general and administrative expenses |
|
|
375 |
|
|
|
440 |
|
|
|
1,148 |
|
|
|
1,237 |
|
Amortization expense |
|
|
5 |
|
|
|
5 |
|
|
|
16 |
|
|
|
17 |
|
Restructuring charge |
|
|
91 |
|
|
|
|
|
|
|
91 |
|
|
|
|
|
Trademark impairment charge |
|
|
173 |
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
399 |
|
|
|
602 |
|
|
|
1,542 |
|
|
|
1,771 |
|
Interest and debt expense |
|
|
68 |
|
|
|
81 |
|
|
|
208 |
|
|
|
257 |
|
Interest income |
|
|
(16 |
) |
|
|
(33 |
) |
|
|
(51 |
) |
|
|
(94 |
) |
Gain on termination of joint venture |
|
|
|
|
|
|
|
|
|
|
(328 |
) |
|
|
|
|
Other (income) expense, net |
|
|
13 |
|
|
|
(7 |
) |
|
|
3 |
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes
and extraordinary item |
|
|
334 |
|
|
|
561 |
|
|
|
1,710 |
|
|
|
1,600 |
|
Provision for income taxes |
|
|
123 |
|
|
|
203 |
|
|
|
630 |
|
|
|
590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before extraordinary item |
|
|
211 |
|
|
|
358 |
|
|
|
1,080 |
|
|
|
1,010 |
|
Extraordinary item gain on acquisition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
211 |
|
|
$ |
358 |
|
|
$ |
1,080 |
|
|
$ |
1,011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before extraordinary item |
|
$ |
0.72 |
|
|
$ |
1.22 |
|
|
$ |
3.68 |
|
|
$ |
3.43 |
|
Extraordinary item |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.72 |
|
|
$ |
1.22 |
|
|
$ |
3.68 |
|
|
$ |
3.43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before extraordinary item |
|
$ |
0.72 |
|
|
$ |
1.21 |
|
|
$ |
3.68 |
|
|
$ |
3.43 |
|
Extraordinary item |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
0.72 |
|
|
$ |
1.21 |
|
|
$ |
3.68 |
|
|
$ |
3.43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share |
|
$ |
0.85 |
|
|
$ |
0.85 |
|
|
$ |
2.55 |
|
|
$ |
2.35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Excludes excise taxes of $492 million and $521 million for the three months ended
September 30, 2008 and 2007, respectively, and $1,429 million and $1,544 million for the
nine months ended September 30, 2008 and 2007, respectively. |
|
2 |
|
Includes Master Settlement Agreement and other state settlement agreements,
collectively referred to as the MSA, expense of $695 million and $720 million for the
three months ended September 30, 2008 and 2007, respectively, and $2,079 million and
$2,145 million for the nine months ended September 30, 2008 and 2007, respectively. |
|
3 |
|
Includes federal tobacco quota buyout expenses of $59 million and $61 million for
the three months ended September 30, 2008 and 2007, respectively, and $186 million and
$203 million for the nine months ended September 30, 2008 and 2007, respectively. |
See Notes to Condensed Consolidated Financial Statements (Unaudited)
3
REYNOLDS AMERICAN INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Millions)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended |
|
|
|
September 30, |
|
|
|
2008 |
|
|
2007 |
|
Cash flows from (used in) operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,080 |
|
|
$ |
1,011 |
|
Adjustments to reconcile to net cash flows from
(used in) continuing operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
106 |
|
|
|
106 |
|
Gain on termination of joint venture |
|
|
(328 |
) |
|
|
|
|
Restructuring charge, net of cash payments |
|
|
81 |
|
|
|
(11 |
) |
Trademark impairment charge |
|
|
173 |
|
|
|
|
|
Deferred income tax expense |
|
|
38 |
|
|
|
44 |
|
Loss on extinguishment of debt |
|
|
|
|
|
|
19 |
|
Extraordinary itemgain on acquisition |
|
|
|
|
|
|
(1 |
) |
Other changes, that provided (used) cash: |
|
|
|
|
|
|
|
|
Accounts and other receivables |
|
|
(48 |
) |
|
|
(18 |
) |
Inventories |
|
|
124 |
|
|
|
102 |
|
Related party, net |
|
|
(14 |
) |
|
|
(53 |
) |
Accounts payable |
|
|
(49 |
) |
|
|
(56 |
) |
Accrued liabilities including income
taxes and other working capital |
|
|
(28 |
) |
|
|
363 |
|
Tobacco settlement accruals |
|
|
(283 |
) |
|
|
27 |
|
Pension and postretirement |
|
|
(56 |
) |
|
|
(323 |
) |
Litigation bonds, net |
|
|
5 |
|
|
|
92 |
|
Other, net |
|
|
27 |
|
|
|
(14 |
) |
|
|
|
|
|
|
|
Net cash flows from operating activities |
|
|
828 |
|
|
|
1,288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities: |
|
|
|
|
|
|
|
|
Purchases of short-term investments |
|
|
(56 |
) |
|
|
(3,663 |
) |
Proceeds from sale of short-term investments |
|
|
208 |
|
|
|
4,154 |
|
Proceeds from settlement of long-term investments |
|
|
6 |
|
|
|
|
|
Capital expenditures |
|
|
(95 |
) |
|
|
(95 |
) |
Distributions from equity investees |
|
|
27 |
|
|
|
9 |
|
Proceeds from termination of joint venture |
|
|
164 |
|
|
|
|
|
Other, net |
|
|
10 |
|
|
|
(4 |
) |
|
|
|
|
|
|
|
Net cash flows from investing activities |
|
|
264 |
|
|
|
401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities: |
|
|
|
|
|
|
|
|
Dividends paid on common stock |
|
|
(752 |
) |
|
|
(665 |
) |
Repayment of long-term debt |
|
|
|
|
|
|
(329 |
) |
Proceeds from issuance of long-term debt |
|
|
|
|
|
|
1,547 |
|
Repayment of term loan |
|
|
|
|
|
|
(1,542 |
) |
Deferred debt issuance cost |
|
|
|
|
|
|
(15 |
) |
Excess tax benefit from stock-based compensation |
|
|
2 |
|
|
|
1 |
|
Proceeds from stock options exercised |
|
|
1 |
|
|
|
|
|
Repurchase of common stock |
|
|
(207 |
) |
|
|
(60 |
) |
Other, net |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows used in financing activities |
|
|
(955 |
) |
|
|
(1,063 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of
exchange rate changes on cash and cash equivalents |
|
|
(23 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
114 |
|
|
|
626 |
|
Cash and cash equivalents at beginning of period |
|
|
2,215 |
|
|
|
1,433 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
2,329 |
|
|
$ |
2,059 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid, net of refunds |
|
$ |
624 |
|
|
$ |
106 |
|
Interest paid |
|
$ |
161 |
|
|
$ |
205 |
|
See Notes to Condensed Consolidated Financial Statements (Unaudited)
4
REYNOLDS AMERICAN INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Millions)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2008 |
|
|
2007 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
2,329 |
|
|
$ |
2,215 |
|
Short-term investments |
|
|
52 |
|
|
|
377 |
|
Accounts receivable, net of allowance (2008 $1; 2007 $1) |
|
|
79 |
|
|
|
73 |
|
Accounts receivable, related party |
|
|
67 |
|
|
|
80 |
|
Notes receivable |
|
|
33 |
|
|
|
1 |
|
Other receivables |
|
|
63 |
|
|
|
25 |
|
Inventories |
|
|
1,072 |
|
|
|
1,196 |
|
Deferred income taxes, net |
|
|
852 |
|
|
|
845 |
|
Prepaid expenses and other |
|
|
143 |
|
|
|
180 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
4,690 |
|
|
|
4,992 |
|
Property, plant and equipment, net of accumulated depreciation (2008
$1,558; 2007 $1,517) |
|
|
1,053 |
|
|
|
1,073 |
|
Trademarks, net of accumulated amortization (2008 $529; 2007 $524) |
|
|
3,229 |
|
|
|
3,407 |
|
Goodwill |
|
|
8,174 |
|
|
|
8,174 |
|
Other intangibles, net of accumulated amortization (2008 $84; 2007 $73) |
|
|
191 |
|
|
|
202 |
|
Other assets and deferred charges |
|
|
1,081 |
|
|
|
781 |
|
|
|
|
|
|
|
|
|
|
$ |
18,418 |
|
|
$ |
18,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
169 |
|
|
$ |
218 |
|
Tobacco settlement accruals |
|
|
2,159 |
|
|
|
2,449 |
|
Due to related party |
|
|
2 |
|
|
|
7 |
|
Deferred revenue, related party |
|
|
13 |
|
|
|
35 |
|
Current maturities of long-term debt |
|
|
200 |
|
|
|
|
|
Other current liabilities |
|
|
1,158 |
|
|
|
1,194 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
3,701 |
|
|
|
3,903 |
|
Long-term debt (less current maturities) |
|
|
4,304 |
|
|
|
4,515 |
|
Deferred income taxes, net |
|
|
1,220 |
|
|
|
1,184 |
|
Long-term retirement benefits (less current portion) |
|
|
1,166 |
|
|
|
1,167 |
|
Other noncurrent liabilities |
|
|
439 |
|
|
|
394 |
|
Commitments and contingencies: |
|
|
|
|
|
|
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
Common stock (shares issued: 2008 291,452,779; 2007 295,007,327) |
|
|
|
|
|
|
|
|
Paid-in capital |
|
|
8,459 |
|
|
|
8,653 |
|
Accumulated deficit |
|
|
(541 |
) |
|
|
(873 |
) |
Accumulated other comprehensive loss (defined benefit pension and post-
retirement plans: 2008 $(293)
and 2007 $(306), net of tax) |
|
|
(330 |
) |
|
|
(314 |
) |
|
|
|
|
|
|
|
Total shareholders equity |
|
|
7,588 |
|
|
|
7,466 |
|
|
|
|
|
|
|
|
|
|
$ |
18,418 |
|
|
$ |
18,629 |
|
|
|
|
|
|
|
|
See Notes to Condensed Consolidated Financial Statements (Unaudited)
5
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Business and Summary of Significant Accounting Policies
Overview
The condensed consolidated financial statements (unaudited) include the accounts of Reynolds
American Inc., referred to as RAI, and its wholly owned subsidiaries. RAIs wholly owned
subsidiaries include its operating subsidiaries, R. J. Reynolds Tobacco Company; Santa Fe Natural
Tobacco Company, Inc., referred to as Santa Fe; Lane, Limited, referred to as Lane; R. J. Reynolds
Global Products, Inc., referred to as GPI; and Conwood Company, LLC, Conwood Sales Co., LLC, Scott
Tobacco LLC and Rosswil LLC, collectively referred to as the Conwood companies.
RAI was incorporated as a holding company in the state of North Carolina on January 5, 2004,
and its common stock is listed on the NYSE under the symbol RAI. RAI was created to facilitate
the transactions on July 30, 2004, to combine the U.S. assets, liabilities and operations of
Brown & Williamson Holdings, Inc., formerly known as Brown & Williamson Tobacco Corporation and
referred to as B&W, an indirect, wholly owned subsidiary of British American Tobacco p.l.c.,
referred to as BAT, with R. J. Reynolds Tobacco Company, a wholly owned operating subsidiary of
R.J. Reynolds Tobacco Holdings, Inc., referred to as RJR. These July 30, 2004, transactions
generally are referred to as the B&W business combination.
References to RJR Tobacco prior to July 30, 2004, relate to R. J. Reynolds Tobacco Company, a
New Jersey corporation and a wholly owned subsidiary of RJR. References to RJR Tobacco on and
subsequent to July 30, 2004, relate to the combined U.S. assets, liabilities and operations of B&W
and R. J. Reynolds Tobacco Company, a North Carolina corporation.
RAIs reportable operating segments are RJR Tobacco and Conwood. RJR Tobacco consists of the
primary operations of R. J. Reynolds Tobacco Company. Conwood consists of the Conwood companies and
Lane. RAIs wholly owned operating subsidiaries Santa Fe and GPI, among others, are included in All
Other. The segments were identified based on how RAIs chief operating decision maker allocates
resources and assesses performance.
Basis of Presentation
The accompanying interim condensed consolidated financial statements (unaudited) have been
prepared in accordance with accounting principles generally accepted in the United States of
America, referred to as GAAP, for interim financial information and, in managements opinion,
contain all adjustments, consisting only of normal recurring items, necessary for a fair
presentation of the results for the periods presented. Accordingly, they do not include all of the
information and footnotes required by GAAP for complete financial statements. For interim
reporting purposes, certain costs and expenses are charged to operations in proportion to the
estimated total annual amount expected to be incurred primarily based on sales volumes. The
results for the interim period ended September 30, 2008, are not necessarily indicative of the
results that may be expected for the year ending December 31, 2008.
The equity method is used to account for investments in businesses that RAI does not control,
but has the ability to significantly influence operating and financial policies. The cost method is
used to account for investments in which RAI does not have the ability to significantly influence
operating and financial policies. RAI has no investments in entities greater than 20% for which it
accounts by the cost method, and has no investments in entities greater than 50% for which it
accounts by the equity method. All material intercompany balances have been eliminated.
The condensed consolidated financial statements (unaudited) should be read in conjunction with
the consolidated financial statements and related footnotes, which appear in RAIs Annual Report on
Form 10-K for the year ended December 31, 2007. Certain reclassifications were made to conform
prior years financial statements to the current presentation. All dollar amounts, other than per
share amounts, are presented in millions, except for amounts set forth in note 12 and as otherwise
noted.
Pension and Postretirement
Recognized gains or losses are annual changes in the amount of either the benefit obligation or the
market-related value of plan assets resulting from experience different from that assumed or from
changes in assumptions. The minimum amortization of unrecognized gains or losses, as described in
Statement of Financial Accounting Standards,
6
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
referred to as SFAS, No. 87, Employers Accounting for Pensions, was included in pension
expense, and as described in SFAS No. 106, Employers Accounting for Postretirement Benefits other
than Pensions, was included in the postretirement benefit cost. Prior service costs, which are
changes in benefit obligations due to plan amendments, are amortized on a straight-line basis over
the average remaining service period for active employees. The market-related value of plan assets
recognizes changes in fair value in a systematic and rational manner over five years.
The components of the pension benefits and the postretirement benefits are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Three Months Ended |
|
|
For The Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
|
Postretirement |
|
|
|
|
|
|
|
|
|
|
Postretirement |
|
|
|
Pension Benefits |
|
|
Benefits |
|
|
Pension Benefits |
|
|
Benefits |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
Service cost |
|
$ |
9 |
|
|
$ |
10 |
|
|
$ |
1 |
|
|
$ |
1 |
|
|
$ |
27 |
|
|
$ |
30 |
|
|
$ |
4 |
|
|
$ |
4 |
|
Interest cost |
|
|
80 |
|
|
|
78 |
|
|
|
23 |
|
|
|
22 |
|
|
|
239 |
|
|
|
235 |
|
|
|
68 |
|
|
|
68 |
|
Expected return on plan assets |
|
|
(113 |
) |
|
|
(109 |
) |
|
|
(7 |
) |
|
|
(6 |
) |
|
|
(338 |
) |
|
|
(327 |
) |
|
|
(20 |
) |
|
|
(20 |
) |
Amortization of prior service
cost (credit) |
|
|
5 |
|
|
|
|
|
|
|
4 |
|
|
|
(3 |
) |
|
|
14 |
|
|
|
1 |
|
|
|
12 |
|
|
|
(9 |
) |
Amortization of net loss
(income) |
|
|
1 |
|
|
|
11 |
|
|
|
(3 |
) |
|
|
6 |
|
|
|
4 |
|
|
|
32 |
|
|
|
(9 |
) |
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit
(income) cost |
|
|
(18 |
) |
|
|
(10 |
) |
|
|
18 |
|
|
|
20 |
|
|
|
(54 |
) |
|
|
(29 |
) |
|
|
55 |
|
|
|
60 |
|
Curtailments/special
benefits1 |
|
|
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlements |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefit (income) cost |
|
$ |
(7 |
) |
|
$ |
(10 |
) |
|
$ |
18 |
|
|
$ |
20 |
|
|
$ |
(43 |
) |
|
$ |
(29 |
) |
|
$ |
55 |
|
|
$ |
60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
See note 3 to condensed consolidated financial statements (unaudited) for more
information on the special pension benefits related to a restructuring at RAI and RJR Tobacco. |
Employer Contributions
RAI disclosed in its financial statements for the year ended December 31, 2007, that it
expected to contribute $7 million to its pension plans in 2008. As of September 30, 2008, RAI
expects to contribute $17 million to its pension plans in 2008, of which $10 million was
contributed during the first nine months of 2008.
Due to the adverse changes in the financial markets, RAIs pension assets have been negatively
impacted. Through September 30, 2008, the overall year-to-date rate of return on the investments
for the pension assets was approximately negative 16.3%.
Recently Adopted Accounting Pronouncements
Effective January 1, 2008, RAI adopted SFAS No. 157, Fair Value Measurements, for financial
assets and financial liabilities. SFAS No. 157 does not require any new fair value measurements
but provides a definition of fair value, establishes a framework for measuring fair value and
expands disclosure about fair value measurements. RAI will adopt SFAS No. 157 for nonfinancial
assets and nonfinancial liabilities on January 1, 2009. The adoption of SFAS No. 157 on financial
assets and financial liabilities did not have a material impact on RAIs consolidated results of
operations, financial position or cash flows. RAI is currently assessing the impact of SFAS No.
157 for nonfinancial assets and nonfinancial liabilities on its consolidated results of operations,
financial position and cash flows.
On October 10, 2008, the Financial Accounting Standards Board, referred to as FASB, issued
FASB Staff Position, referred to as FSP, No. FAS 157-3, Determining the Fair Value of a Financial
Asset When the Market for That Asset Is Not Active. FSP FAS 157-3 clarifies the application of
SFAS No. 157, Fair Value Measurements, in a market that is not active and provides an
example to illustrate key considerations in determining the fair value of a financial asset when
the market for that financial asset is not active. FSP FAS 157-3 is effective immediately,
including prior periods for which financial statements have not been issued. RAI has adopted FSP
FAS 157-3 effective with the financial statements ended September 30, 2008. The adoption of FSP FAS
157-3 had no impact on RAIs consolidated results of operations, financial position or cash flows.
7
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Recently Issued Accounting Pronouncements
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and
Hedging Activities-an amendment of FASB Statement No. 133. SFAS No. 161 seeks qualitative
disclosures about the objectives and strategies for using derivatives, quantitative data about the
fair value of and gains and losses on derivative contracts, and details of credit-risk-related
contingent features in hedged positions. SFAS No. 161 also seeks enhanced disclosure around
derivative instruments in financial statements, accounted for under SFAS No. 133, Accounting for
Derivative Instruments and Hedging Activities, and how hedges affect an entitys financial
position, financial performance and cash flows. SFAS No. 161 is effective for RAI as of January 1,
2009. RAI does not expect the adoption of SFAS No. 161 to have a material impact on its results
of operations, financial position or cash flows.
In April 2008, the FASB issued FSP No. FAS 142-3, Determination of the Useful Life of
Intangible Assets. FSP FAS 142-3 amends the factors that should be considered in developing
renewal or extension assumptions used to determine the useful life of a recognized intangible asset
under SFAS No. 142, Goodwill and Other Intangible Assets. The objective of FSP FAS 142-3 is to
improve the consistency between the useful life of a recognized intangible asset under SFAS No. 142
and the period of expected cash flows used to measure the fair value of the asset under SFAS No.
141(R) and GAAP. FSP FAS 142-3 is effective for financial statements issued for years beginning
after December 15, 2008, and interim periods within those years and is applied prospectively to
intangible assets acquired after the effective date. RAI does not expect the adoption of FSP FAS
142-3 to have a material impact on its financial position, results of operations or cash flows.
Note 2Intangible Assets
The changes in the carrying amount of trademarks by segment during the nine months ended
September 30, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco |
|
|
Conwood |
|
|
All Other |
|
|
|
|
|
|
Indefinite |
|
|
Finite |
|
|
Indefinite |
|
|
Finite |
|
|
Indefinite |
|
|
|
|
|
|
Life |
|
|
Life |
|
|
Life |
|
|
Life |
|
|
Life |
|
|
Consolidated |
|
Balance as of January 1, 2008 |
|
$ |
1,826 |
|
|
$ |
41 |
|
|
$ |
1,374 |
|
|
$ |
11 |
|
|
$ |
155 |
|
|
$ |
3,407 |
|
Impairment included in
operating income |
|
|
(173 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(173 |
) |
Amortization expense |
|
|
|
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30, 2008 |
|
$ |
1,653 |
|
|
$ |
36 |
|
|
$ |
1,374 |
|
|
$ |
11 |
|
|
$ |
155 |
|
|
$ |
3,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During the third quarter of 2008, RJR Tobacco made the decision to change its brand portfolio
strategy and reclassified the KOOL brand from a growth brand to a support brand. RJR Tobacco
recorded an impairment charge of $173 million during the third quarter of 2008 as a result of
impairment testing conducted on the KOOL trademark triggered by this
change in brand portfolio strategy. This charge was based on the excess of KOOLs carrying value over its fair value
using the present value of estimated future cash flows assuming a discount rate of 10.5%. The
discount rate was determined by adjusting the enterprise discount rate by an appropriate risk
premium to reflect an asset group risk. The impairment charge is reflected as a decrease in the
carrying value of the KOOL trademark in the condensed consolidated balance sheet (unaudited) as of September
30, 2008, as a trademark impairment charge in the condensed consolidated statement of income
(unaudited) for the three and nine months ended September 30, 2008, and had no impact on cash
flows.
The changes in the carrying amount of other intangibles by segment during the nine months
ended September 30, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco |
|
|
All Other |
|
|
|
|
|
|
Indefinite |
|
|
|
|
|
|
Indefinite |
|
|
|
|
|
|
Life |
|
|
Finite Life |
|
|
Life |
|
|
Consolidated |
|
Balance as of January 1, 2008 |
|
$ |
55 |
|
|
$ |
100 |
|
|
$ |
47 |
|
|
$ |
202 |
|
Amortization expense |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30, 2008 |
|
$ |
55 |
|
|
$ |
89 |
|
|
$ |
47 |
|
|
$ |
191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Indefinite-lived intangibles include acquired trademarks and distribution rights and
agreements. Finite-lived intangible assets as of September 30, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
Gross |
|
|
Amortization |
|
|
Net |
|
Contract manufacturing |
|
$ |
151 |
|
|
$ |
62 |
|
|
$ |
89 |
|
Technology-based |
|
|
3 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other intangibles |
|
|
154 |
|
|
|
65 |
|
|
|
89 |
|
Trademarks |
|
|
95 |
|
|
|
48 |
|
|
|
47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
249 |
|
|
$ |
113 |
|
|
$ |
136 |
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2008, the estimated remaining amortization associated with finite-lived
intangible assets was expected to be expensed as follows:
|
|
|
|
|
|
Year |
|
|
Amount |
|
Remainder of 2008 |
|
|
$ |
6 |
|
2009 |
|
|
|
22 |
|
2010 |
|
|
|
20 |
|
2011 |
|
|
|
20 |
|
2012 |
|
|
|
19 |
|
2013 |
|
|
|
18 |
|
Thereafter |
|
|
|
31 |
|
|
|
|
|
|
|
|
|
$ |
136 |
|
|
|
|
|
|
Note 3Restructuring
In the third quarter of 2008, RAI and RJR Tobacco announced changes in their organizational
structures to streamline non-core business processes and programs in order to allocate additional
resources to strategic growth initiatives. The reorganizations will result in the elimination of
approximately 600 full-time jobs, expected to be substantially completed by December 31, 2009.
Under existing benefit plans, $84 million of severance-related cash benefits and $7 million of
non-cash pension-related benefits comprised a restructuring charge of $91 million. Of this charge,
$81 million was recorded in the RJR Tobacco segment. None of the cash portion of the charge was
paid as of September 30, 2008. Accordingly, in the condensed consolidated balance sheet
(unaudited) as of September 30, 2008, $36 million was included in other current liabilities and $48
million was included in other noncurrent liabilities. The cash benefits are expected to be
substantially paid by December 31, 2010.
The component of the restructuring charge accrued and utilized was as follows:
|
|
|
|
|
|
|
Employee Severance |
|
|
|
and Benefits |
|
Original accrual |
|
$ |
91 |
|
Utilized in 2008 |
|
|
(7 |
) |
|
|
|
|
Balance as of September 30, 2008 |
|
$ |
84 |
|
|
|
|
|
Note 4Termination of Joint Venture
In 2002, R.J. Reynolds Tobacco C.V., an indirect wholly owned subsidiary of RAI and referred
to as RJRTCV, and an affiliate of Gallaher Group Plc, referred to as Gallaher, formed a joint
venture, with each party owning a 50% membership interest. The joint venture, R. J.
Reynolds-Gallaher International Sarl, marketed American-blend cigarettes primarily in Italy, France
and Spain.
On April 18, 2007, an affiliate of Japan Tobacco Inc. acquired Gallaher, and Gallaher
subsequently notified RJRTCV that the acquisition constituted a change of control of Gallaher
within the meaning of the joint venture
9
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
agreement. Pursuant to the terms of the joint venture agreement, RJRTCV elected to terminate the
joint venture prior to its expiration date. The joint venture was terminated on December 31, 2007.
The joint venture agreement provided that upon a termination of the joint venture, the value
of all the trademarks each joint venture member or its affiliate licensed to the joint venture,
other than NATURAL AMERICAN SPIRIT, would be calculated and that the party whose licensed
trademarks were determined to be of greater value would be required to pay the other party an
amount, referred to as the Termination Amount, equal to one-half of the difference between the
values of the parties respective trademarks. On February 20, 2008, following the parties
negotiations regarding the trademarks values, RJRTCV and Gallaher Limited, an affiliate of
Gallaher, entered into a valuation payment settlement agreement, pursuant to which Gallaher Limited
agreed to pay RJRTCV a Termination Amount equal to euros 265 million, or approximately $388 million
using a February 20, 2008, exchange rate of 1.4625. Of this amount, euros 106 million, or 40%, was
paid in April 2008, and the remaining 60% is to be paid in six equal annual installments commencing
April 2009. Of this receivable, $32 million, including imputed interest, and $161 million are
included in notes receivable and other assets and deferred charges, respectively, in RAIs
condensed consolidated balance sheet (unaudited) as of September 30, 2008. Related to the gain on
termination of the joint venture of $328 million, approximately $118 million of deferred tax was
recorded and included in deferred income taxes, net in the noncurrent liability section of the
condensed consolidated balance sheet (unaudited) as of September 30, 2008.
In the first quarter of 2008, an indirect subsidiary of RJR Tobacco sold the AUSTIN trademark,
a brand formerly sold through the joint venture, resulting in a gain of $6 million. GPI continues
to sell NATURAL AMERICAN SPIRIT to the primary markets of the former joint venture in addition to
other international markets.
Note 5Income Per Share
The components of the calculation of income per share were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months |
|
|
For the Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
Income from continuing operations before extraordinary
item |
|
$ |
211 |
|
|
$ |
358 |
|
|
$ |
1,080 |
|
|
$ |
1,010 |
|
Extraordinary item gain on acquisition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
211 |
|
|
$ |
358 |
|
|
$ |
1,080 |
|
|
$ |
1,011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares, in thousands1 |
|
|
291,425 |
|
|
|
294,169 |
|
|
|
293,083 |
|
|
|
294,454 |
|
Effect of dilutive potential shares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options |
|
|
190 |
|
|
|
243 |
|
|
|
209 |
|
|
|
249 |
|
Restricted stock |
|
|
428 |
|
|
|
294 |
|
|
|
427 |
|
|
|
226 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares, in thousands |
|
|
292,043 |
|
|
|
294,706 |
|
|
|
293,719 |
|
|
|
294,929 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Outstanding contingently issuable restricted stock of 0.9 million shares and 0.8
million shares for the three-month periods, and 1.0 million shares and 0.8 million shares for the
nine-month periods, ended September 30, 2008 and 2007, respectively, were excluded from the basic
share calculation, as the related vesting provisions had not been met. |
Note 6Fair Value Measurement
On
January 1, 2008, RAI adopted SFAS No. 157, Fair Value
Measurements, as clarified by FSP FAS 157-3
Determining the Fair Value of a Financial Asset When the Market
for That Asset Is Not Active, for financial assets
and financial liabilities. SFAS No. 157 provides a definition of fair value, establishes a
framework for measuring fair value and expands disclosure about fair value measurements. SFAS No.
157 establishes a fair value hierarchy that distinguishes between market participant assumptions
developed based on market data obtained from sources independent of the reporting entity, and the
reporting entitys own assumptions about market participant assumptions developed based on the best
information available in the circumstances.
SFAS No. 157 defines fair value as the price that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants at the measurement
date, essentially an exit price.
10
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
The levels of the fair value hierarchy established by SFAS No. 157 are:
Level 1: inputs are quoted prices, unadjusted, in active markets for identical assets
or liabilities that the reporting entity has the ability to access at the measurement
date.
Level 2: inputs are other than quoted prices included within Level 1 that are
observable for the asset or liability, either directly or indirectly. A Level 2 input
must be observable for substantially the full term of the asset or liability.
Level 3: inputs are unobservable and reflect the reporting entitys own assumptions
about the assumptions that market participants would use in pricing the asset or
liability.
Financial assets carried at fair value as of September 30, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
Money market funds |
|
$ |
2,023 |
|
|
$ |
|
|
|
$ |
52 |
|
|
$ |
2,075 |
|
Auction rate notes |
|
|
|
|
|
|
|
|
|
|
108 |
|
|
|
108 |
|
Mortgage-backed securities |
|
|
|
|
|
|
|
|
|
|
27 |
|
|
|
27 |
|
Assets held in grantor trusts |
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
16 |
|
Interest rate swaps |
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets at fair value |
|
$ |
2,039 |
|
|
$ |
106 |
|
|
$ |
187 |
|
|
$ |
2,332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The fair value for the interest rate swaps, classified as a Level 2, was derived using the
notional amount of the interest rate swap multiplied by the observable inputs of time to maturity,
interest rates and credit spreads.
The fair value for the money market funds, classified as a Level 3, were based upon expected
future cash flows from accumulated cash in the fund and future maturities of the remaining held
securities. During September 2008, the managers of the Reserve Fund-Primary Fund and Reserve
Fund-International Liquidity Fund, both AAA-rated money market funds, quit accepting purchases into
the funds and did not honor redemption requests that would cause the fund to liquidate outstanding
holdings into a volatile market at a loss. At September 30, 2008, there still had not been any
purchases into or redemptions out of these money market funds. In addition, no valuations had been
issued by either fund. RAI was unable to identify a similar fund that carried identical holdings.
As a result, the observable transactions or pricing were not current. The funds did issue a
detailed listing of the securities that were held and not matured, as well as their face value and
maturity date. This observable data, along with unobservable factors such as discount rate, and
assumptions about fund liquidation of accumulated cash and the collectability of the outstanding
underlying securities were used to determine the fair value of the funds as of September 30, 2008.
The fair values for the auction securities, whose risk is tied to longer term debt or capital
issued by a diverse range of corporations, including but not limited to, manufacturing, financial
and insurance sectors, classified as a Level 3, were based upon calculating the weighted average
present value of future cash payments, given the probability of certain events occurring within the
market. Although RAI considers the market for auction rate notes to be inactive, the models
utilized observable inputs, including LIBOR-based interest rate curves, corporate credit spreads
and corporate
ratings/market valuations. Additionally, unobservable factors incorporated into the models
included default probability assumptions, recovery potential and how these factors changed as
collateral ratings migrated from one level to another.
The fair values for the mortgage-backed securities, classified as a Level 3, were based upon
the calculation of an overall weighted average valuation, derived from the actual, or modeled,
market pricing of the specific collateral, depending on availability. These mortgage-backed
securities have not had any market activity throughout 2008, and therefore, RAI has deemed the
market for these securities to be inactive. However, the underlying collateral continues to
perform favorably, and the security continues to pay interest on time and within terms.
11
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
The changes in the Level 3 investments as of September 30, 2008, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds |
|
|
Auction Rate Notes |
|
|
Mortgage-Backed Securities |
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
Realized |
|
|
Estimated |
|
|
|
|
|
|
Unrealized |
|
|
Estimated |
|
|
|
|
|
|
Unrealized |
|
|
Estimated |
|
|
|
Cost |
|
|
Loss |
|
|
Fair Value |
|
|
Cost |
|
|
Loss |
|
|
Fair Value |
|
|
Cost |
|
|
Loss |
|
|
Fair Value |
|
Balance as of January 1, 2008 |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
145 |
|
|
$ |
(18 |
) |
|
$ |
127 |
|
|
$ |
45 |
|
|
$ |
(1 |
) |
|
$ |
44 |
|
Transfers into Level 3 |
|
|
54 |
|
|
|
|
|
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(19 |
) |
|
|
(19 |
) |
|
|
|
|
|
|
(11 |
) |
|
|
(11 |
) |
Realized losses |
|
|
|
|
|
|
(2 |
) |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6 |
) |
|
|
|
|
|
|
(6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30, 2008 |
|
$ |
54 |
|
|
$ |
(2 |
) |
|
$ |
52 |
|
|
$ |
145 |
|
|
$ |
(37 |
) |
|
$ |
108 |
|
|
$ |
39 |
|
|
$ |
(12 |
) |
|
$ |
27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 7Investments
Short-term investments classified as available-for-sale were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
|
December 31, 2007 |
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
Realized |
|
|
Estimated |
|
|
|
|
|
|
Unrealized |
|
|
Estimated |
|
|
|
Cost |
|
|
Loss |
|
|
Fair Value |
|
|
Cost |
|
|
Loss |
|
|
Fair Value |
|
Reserve Fund Primary Fund |
|
$ |
37 |
|
|
$ |
(1 |
) |
|
$ |
36 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
Reserve Fund International Liquidity Fund |
|
|
17 |
|
|
|
(1 |
) |
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal agency securities and treasury bills and notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
206 |
|
|
|
|
|
|
|
206 |
|
Auction rate notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
145 |
|
|
|
(18 |
) |
|
|
127 |
|
Mortgage-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45 |
|
|
|
(1 |
) |
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
54 |
|
|
$ |
(2 |
) |
|
$ |
52 |
|
|
$ |
396 |
|
|
$ |
(19 |
) |
|
$ |
377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
During the third quarter of 2008, the Reserve Funds, which are money market funds, were
reclassified to short-term investments from cash equivalents due to the liquidity restrictions
issued by the fund managers preventing immediate withdrawals. The Primary Fund is made up of
investments in securities that primarily include bank notes,
certificates of deposit, commercial
paper and floating-rate discount notes. The International Liquidity Fund consists of investments
in securities that include bank notes, certificates of deposit,
commercial paper and floating-rate
discount notes. Included in both the Primary Fund and the International Liquidity Fund were
investments in Lehman Brothers Holdings Inc., referred to as Lehman. On September 15, 2008, Lehman
filed for protection under Chapter 11 of the federal Bankruptcy Code. The value of RAIs pro rata
share of indirect holdings in the Lehman investments has been impaired and recognized as a loss
in other (income) expense, net in the condensed consolidated statement
of income (unaudited) for the three- and nine-month periods ended
September 30, 2008.
No additional impairment was recorded on the Reserve Funds beyond the Lehman impairment as the
Reserve Funds will distribute cash as assets mature or are sold. In addition, RAI has the intent
and the ability to hold the investments in the Reserve Funds until maturity and, at this time, the
Reserve Funds expect maturity at stated face value.
The investments in federal agency securities and treasury bills and notes were liquidated
during the second quarter of 2008 to meet working capital needs.
Auction rate notes are instruments with long-term contractual maturities, but have
historically been highly liquid. Historically, they have repriced at intervals ranging from 7 to
49 days, and therefore, the fair values have approximated carrying values. However, during 2007,
adverse changes in the financial markets caused certain auction rate notes to revalue lower than
their carrying value and become less liquid. The auction rate notes were reclassified to a
long-term investment during the second quarter of 2008 as RAI believes a successful auction is not
likely to occur within the next year. The auction rate notes were included in other assets and
deferred charges in RAIs condensed consolidated balance sheet (unaudited) as of September 30,
2008. The funds associated with the auction rate notes will not be accessible until a successful
auction occurs or a buyer is found.
The mortgage-backed securities were reclassified to a long-term investment as of March 31,
2008, as a result of a restructuring with the original issuer. These securities were included in
other assets and deferred charges in RAIs condensed consolidated balance sheet (unaudited) as of
September 30, 2008. This restructured investment extends the
12
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
life of the security, but is supported by the same underlying collateral that carries the same
economic risks. As of September 30, 2008, RAI received $6 million in principal payments on these
mortgage-backed securities.
RAI intends, and has the ability, to hold the auction rate notes and mortgage-backed
securities for a period of time sufficient to allow for the anticipated recovery in fair value.
These investments will be evaluated on a quarterly basis.
Long-term investments classified as available-for-sale were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2008 |
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
Estimated |
|
|
|
Cost |
|
|
Loss |
|
|
Fair Value |
|
Auction rate notes |
|
$ |
145 |
|
|
$ |
(37 |
) |
|
$ |
108 |
|
Mortgage-backed securities |
|
|
39 |
|
|
|
(12 |
) |
|
|
27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
184 |
|
|
$ |
(49 |
) |
|
$ |
135 |
|
|
|
|
|
|
|
|
|
|
|
There were no long-term investments classified as available-for-sale at December 31, 2007.
RAI reviews impairments associated with the above in accordance with SFAS No. 115, Accounting
for Certain Investments in Debt and Equity Securities, and FSP FAS 115-1 and FAS 124-1, The
Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments, to
determine the classification of the impairment as temporary or other-than-temporary. RAI considers
the auction rate notes and mortgage-backed securities to be temporarily impaired as of September
30, 2008, with the unrealized loss included in accumulated other comprehensive loss in the
condensed consolidated balance sheet (unaudited) as of September 30, 2008. Such unrealized loss did
not reduce net income for the three- or nine-month periods ended September 30, 2008.
Note 8Inventories
The major components of inventories were as follows:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2008 |
|
|
2007 |
|
Leaf tobacco |
|
$ |
841 |
|
|
$ |
967 |
|
Other raw materials |
|
|
51 |
|
|
|
45 |
|
Work in process |
|
|
55 |
|
|
|
48 |
|
Finished products |
|
|
172 |
|
|
|
163 |
|
Other |
|
|
33 |
|
|
|
24 |
|
|
|
|
|
|
|
|
Total |
|
|
1,152 |
|
|
|
1,247 |
|
Less LIFO allowance |
|
|
80 |
|
|
|
51 |
|
|
|
|
|
|
|
|
|
|
$ |
1,072 |
|
|
$ |
1,196 |
|
|
|
|
|
|
|
|
RJR Tobacco will perform its annual LIFO inventory valuation at December 31, 2008, as interim
periods represent an estimate of the expected annual valuation.
Note 9Income Taxes
The provision for income taxes in the third quarter of 2008 was $123 million, or an effective
rate of 36.8%, compared with $203 million, or an effective rate of 36.2%, in the third quarter of
2007. The provision for income taxes for the first nine months of 2008 was $630 million, or an
effective rate of 36.8%, compared with $590 million, or an effective rate of 36.9%, in the first
nine months of 2007. The effective rate for the first nine months of 2008 was favorably impacted
by a lower tax rate related to the gain on the termination of the Reynolds-Gallaher International
Sarl joint venture.
13
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
The effective rate exceeds the federal statutory rate of 35% primarily due to the impact of
state taxes and certain other nondeductible items, offset by the domestic production activities
deduction of the American Jobs Creation Act enacted on October 22, 2004.
The gross accruals for unrecognized income tax benefits, including interest and penalties,
reflected in other noncurrent liabilities were $164 million and $172 million at September 30, 2008,
and December 31, 2007, respectively. RAI accrues interest and penalties related to accruals for
income taxes and reflects these amounts in tax expense. The gross amount of interest accrued at
September 30, 2008, and December 31, 2007, was $50 million and $49 million, respectively. The
gross amount of penalties of $12 million was accrued at each of September 30, 2008, and December
31, 2007.
The gross increases in unrecognized tax benefits related to tax positions were $13 million for
the nine months ended September 30, 2008. Included in this amount were $10 million attributable to
current year tax positions and $3 million attributable to prior-year tax positions.
The gross decreases in unrecognized tax benefits were $22 million for the nine months ended
September 30, 2008. Included in this amount were $3 million attributable to prior-year tax
positions, $14 million attributable to settlements with taxing authorities and $5 million
attributable to statute of limitation expirations.
As of September 30, 2008, $60 million of unrecognized tax benefits and $43 million of interest
and penalties, if recognized, would affect the effective tax rate.
Included in the provision for income taxes for the three months and nine months ended
September 30, 2008, was $2 million and $11 million of additional tax expense including $1 million
and $3 million of interest expense, net of federal benefit, and penalties associated with
unrecognized tax benefits, respectively. Comparable amounts for the three months and nine months
ended September 30, 2007, were $4 million and $12 million of additional tax expense, including $1
million and $5 million of interest expense, net of federal benefit, and penalties, respectively.
RAI and its subsidiaries may be subject to income taxes in the United States, certain foreign
jurisdictions and multiple state jurisdictions. A number of years may elapse before a particular
matter for which RAI has established an
accrual is audited and finally resolved. The number of years with open tax audits varies
depending on the tax jurisdiction. RAIs major taxing jurisdictions and related open tax audits
are discussed below.
The IRS completed its examination and issued an assessment for the years 2002 and 2003. RAI
filed a protest in 2006, and a formal settlement agreement was signed during the first quarter of
2008. Overpayments from prior year audits exceed the settlement agreement amount, and a refund of
$2 million was received in April 2008. Amended state returns will be prepared in 2008 to reflect
these federal adjustments. The additional state income tax associated with these returns is
reflected in the accruals for unrecognized income tax benefits.
RAI has filed a federal consolidated income tax return for the years 2004 through 2007. The
statute of limitations remains open for the years 2005 through 2007. There are no IRS examinations
scheduled at this time for these open years.
In December 2007, North Carolina completed its examination of RJR Tobacco for years 2000
through 2002 and issued a total assessment of $37 million: $21 million related to tax, $8 million
related to interest and $8 million related to penalties. RJR Tobacco filed a protest in January
2008. RJR Tobacco will continue to work with North Carolina to resolve issues identified and
assessed for years 2000 through 2002. A complete resolution is not anticipated within the next 12
months. However, in the event a complete resolution of this audit is reached during the next 12
months, RJR Tobacco could recognize additional expense of up to $13 million, inclusive of tax,
interest, net of federal benefit, and penalties.
It is expected that the amount of unrecognized tax benefits will change in the next 12 months.
Excluding the impact of North Carolinas assessment for years 2000 through 2002, RAI does not
expect the change to have a significant impact on its consolidated results of operations, financial
position or cash flows.
14
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Note 10Borrowing Arrangements
On June 28, 2007, RAI entered into a Fifth Amended and Restated Credit Agreement, which, as
subsequently amended, is referred to as the Credit Facility. The Credit Facility provides for a
five-year, $550 million revolving credit facility, which may be increased to $900 million at the
discretion of the lenders upon the request of RAI. The Credit Facilitys maturity date of June 28,
2012, may be extended, at the discretion of the lenders upon RAIs request, in two separate
one-year increments. Effective March 31, 2008, the Credit Facility was amended by:
|
|
|
adding a further exception to the covenant that restricts the sale of assets, so
as to permit the disposition of real properties and related assets, whether by
donation or sale below fair market value, in an aggregate amount not to exceed $15
million; |
|
|
|
|
modifying the covenant limiting the amount of cash, Marketable Investments and
Investment Equities that a Non-Guarantor Subsidiary, that is not a Domestic
Subsidiary, as such terms are defined in the Credit Facility, may hold; and |
|
|
|
|
modifying certain related definitions. |
On October 5, 2008, Lehman Commercial Paper Inc., a lender in the Credit Facility and referred
to as LCPI, filed for protection under Chapter 11 of the federal Bankruptcy Code. RAI has never
borrowed under the Credit Facility, but given LCPIs bankruptcy filing, there can be no assurance
that LCPI would loan to RAI LCPIs pro rata share of any borrowing requests made by RAI. Subject
to the terms and conditions in the Credit Facility, RAI has the right to replace a lender in
certain circumstances, including upon a lender defaulting in its obligation to make loans. If any
lender were to default in its obligation to make loans, there can be no assurance as to when or
whether RAI could find an acceptable replacement lender. LCPIs commitment under the Credit
Facility is $52 million.
Certain of RAIs subsidiaries, including its material domestic subsidiaries, referred to as
the Guarantors, have guaranteed RAIs obligations under the Credit Facility and under RAIs
outstanding senior notes, referred to as the Notes. Until the credit ratings actions described
below, RAI had pledged substantially all of its assets, including the stock of its direct
subsidiaries, to secure its obligations under the Credit Facility, and the Guarantors had pledged
substantially all of their assets to secure their guarantees of RAIs obligations under the Credit
Facility. Until such credit ratings actions, the Notes and related guarantees had been secured by
any Principal Property, as such term is
defined in the indenture governing the Notes, of RAI and certain of the Guarantors, and the
stock, indebtedness or other obligations of RJR Tobacco.
On May 2, 2008, S&P raised its corporate credit rating for RAI from BB+, a non-investment
grade rating, and a positive outlook, to BBB-, an investment grade rating, and a stable outlook.
On June 20, 2008, Moodys, consistent with its notching practices for an investment grade issuer,
withdrew its corporate credit rating of Ba1, a non-investment grade rating, for RAI, and upgraded
the Notes from Ba1 to Baa3, an investment grade rating. Moodys also revised its outlook for RAI
from positive to stable.
Pursuant to the terms of the loan documents relating to the Credit Facility, Notes and related
guarantees, which terms provide for a release of collateral if RAI obtains investment grade
corporate credit ratings, with not worse than stable outlooks, from each of S&P and Moodys, the
collateral securing the Credit Facility, Notes and related guarantees was released automatically on
June 20, 2008, upon the ratings issued by Moodys on that date. The relevant loan documents do not
provide for a release of the Guarantors guarantees of the Credit Facility and the Notes upon any
ratings upgrades and, therefore, such guarantees remain in effect. In addition, on June 20, 2008,
given the release of the collateral which had secured the Credit Facility and the related
guarantees, Moodys lowered the investment grade rating for the Credit Facility from Baa1 to Baa3.
The collateral for the Credit Facility, Notes and related guarantees will be reinstated if RAIs
corporate credit rating issued by each of S&P and Moodys is lowered to at least one level below
the lowest rating level established as investment grade, or if RAIs corporate credit rating issued
by either S&P or Moodys is lowered to at least two levels below the lowest rating level
established as investment grade.
Note 11Financial Instruments
RAI and RJR use interest rate swaps to manage interest rate risk on a portion of their
respective debt obligations. When entered into, these financial instruments are designated as
hedges of underlying exposures.
15
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Swaps existed on $1.6 billion principal amount of debt as of September 30, 2008. Including
the impact of swaps, the average interest rate on the principal amount of RAIs consolidated $4.4
billion long-term debt was 5.87% as of September 30, 2008.
The interest rate swaps notional amounts and termination dates match those of the
corresponding outstanding notes. As of September 30, 2008, these fair value hedges were perfectly
effective, resulting in no recognized net gain or loss. The unrealized gains on the hedges
resulting from the change in the hedges fair value were $106 million and $119 million at September
30, 2008, and December 31, 2007, respectively, included in other assets and deferred charges in the
condensed consolidated balance sheets (unaudited) and were equal to the increase in the fair value of the
hedged long-term debt.
Under certain conditions, any fair value that results in a liability position of certain
interest rate swaps may require full collateralization with cash or securities. No swaps were in a
liability position as of September 30, 2008.
Note 12Commitments and Contingencies
Tobacco Litigation General
Introduction
Various legal proceedings or claims, including litigation claiming that cancer and other
diseases, as well as addiction, have resulted from the use of, or exposure to, RAIs operating
subsidiaries products, are pending or may be instituted against RJR Tobacco, the Conwood companies
or their affiliates, including RAI and RJR, or indemnitees, including B&W. These pending legal
proceedings include claims relating to cigarette products manufactured by RJR Tobacco or certain of
its affiliates and indemnitees, as well as claims relating to smokeless tobacco products
manufactured by the Conwood companies. A discussion of the legal proceedings relating to cigarette
products is set forth below under the heading Litigation Affecting the Cigarette Industry. All
of the references under that heading to tobacco-related litigation, smoking and health litigation
and other similar references are references to legal proceedings relating to cigarette products and
are not references to legal proceedings involving smokeless tobacco products, and case numbers
under that heading include only cases involving cigarette products. The legal proceedings
relating to the smokeless tobacco products manufactured by the Conwood companies are discussed
separately under the heading Smokeless Tobacco Litigation below.
In connection with the B&W business combination, RJR Tobacco agreed to indemnify B&W and its
affiliates against certain liabilities, costs and expenses incurred by B&W or its affiliates
arising out of the U.S. cigarette and tobacco business of B&W. As a result of this indemnity, RJR
Tobacco has assumed the defense of pending B&W-specific tobacco-related litigation, has paid the
judgments and costs related to certain pre-business combination tobacco-related litigation of B&W,
and has posted bonds on behalf of B&W, where necessary, in connection with cases decided since the
B&W business combination. In addition, pursuant to this indemnity, RJR Tobacco expensed less than
$1 million during the first nine months of 2008 and $2 million during the first nine months of
2007, for funds to be reimbursed to BAT for costs and expenses incurred arising out of certain
tobacco-related litigation.
Certain Terms and Phrases
Certain terms and phrases used in this disclosure may require some explanation. The term
judgment or final judgment refers to the final decision of the court resolving the dispute and
determining the rights and obligations of the parties. At the trial court level, for example, a
final judgment generally is entered by the court after a jury verdict and after post-verdict
motions have been decided. In most cases, the losing party can appeal a verdict only after a final
judgment has been entered by the trial court.
The term damages refers to the amount of money sought by a plaintiff in a complaint, or
awarded to a party by a jury or, in some cases, by a judge. Compensatory damages are awarded to
compensate the prevailing party for actual losses suffered, if liability is proved. In cases in
which there is a finding that a defendant has acted willfully, maliciously or fraudulently,
generally based on a higher burden of proof than is required for a finding of liability for
compensatory damages, a plaintiff also may be awarded punitive damages. Although damages may be
awarded at the trial court stage, a losing party generally may be protected from paying any damages
until all appellate avenues have been exhausted by posting a supersedeas bond. The amount of such a
bond is governed by the law of the relevant
16
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
jurisdiction and generally is set at the amount of
damages plus some measure of statutory interest, modified at the discretion of the appropriate
court or subject to limits set by court or statute.
The term settlement refers to certain types of cases in which cigarette manufacturers,
including RJR Tobacco and B&W, have agreed to resolve disputes with certain plaintiffs without
resolving the case through trial. The principal terms of certain settlements entered into by RJR
Tobacco and B&W are explained below under Accounting for Tobacco-Related Litigation
Contingencies.
Theories of Recovery
The plaintiffs seek recovery on a variety of legal theories, including negligence, strict
liability in tort, design defect, special duty, voluntary undertaking, breach of warranty, failure
to warn, fraud, misrepresentation, unfair trade practices, conspiracy, unjust enrichment, medical
monitoring, public nuisance and violations of state and federal antitrust laws. In certain of these
cases, the plaintiffs claim that cigarette smoking exacerbated injuries caused by exposure to
asbestos.
The plaintiffs seek various forms of relief, including compensatory and punitive damages,
treble or multiple damages and statutory damages and penalties, creation of medical monitoring and
smoking cessation funds, disgorgement of profits, and injunctive and other equitable relief.
Although alleged damages often are not determinable from a complaint, and the law governing the
pleading and calculation of damages varies from state to state and jurisdiction to jurisdiction,
compensatory and punitive damages have been specifically pleaded in a number of cases, sometimes in
amounts ranging into the hundreds of millions and even billions of dollars.
Defenses
The defenses raised by RJR Tobacco, the Conwood companies and their affiliates and indemnitees
include, where applicable and otherwise appropriate, preemption by the Federal Cigarette Labeling
and Advertising Act of some or all claims arising after 1969, or by the Comprehensive Smokeless
Tobacco Health Education Act, the lack of any defect in the product, assumption of the risk,
contributory or comparative fault, lack of proximate cause, remoteness, lack of standing and
statutes of limitations or repose. RAI and RJR have asserted additional defenses, including
jurisdictional defenses, in many of the cases in which they are named.
Accounting for Tobacco-Related Litigation Contingencies
In accordance with GAAP, RAI and its subsidiaries, including RJR Tobacco and the Conwood
companies, as applicable, record any loss concerning litigation at such time as an unfavorable
outcome becomes probable and the amount can be reasonably estimated. For the reasons set forth
below, RAIs management continues to conclude that the loss of any particular pending smoking and
health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, or the loss
of any particular claim concerning the use of smokeless tobacco against the Conwood companies, when
viewed on an individual basis, is not probable.
RJR Tobacco and its affiliates believe that they have valid defenses to the smoking and health
tobacco litigation claims against them, as well as valid bases for appeal of adverse verdicts
against them. RAI, RJR Tobacco and their affiliates and indemnitees have, through their counsel,
filed pleadings and memoranda in pending smoking and health tobacco litigation that set forth and
discuss a number of grounds and defenses that they and their counsel believe have a valid basis in
law and fact. RJR Tobacco and its affiliates and indemnitees continue to win the majority of
smoking and health tobacco litigation claims that reach trial, and a very high percentage of the
tobacco-related litigation claims brought against them continue to be dismissed at or before trial.
Based on their experience in the smoking and health tobacco litigation against them and the
strength of the defenses available to them in such litigation, RJR Tobacco and its affiliates
believe that their successful defense of smoking and health tobacco litigation in the past will
continue in the future.
No liability for pending smoking and health tobacco litigation was recorded in RAIs
consolidated balance sheet (unaudited) as of September 30, 2008. RJR has liabilities totaling $94
million that were recorded in 1999 in connection with certain indemnification claims not related to
smoking and health asserted by Japan Tobacco, Inc., referred to as JTI, against RJR and RJR Tobacco
relating to certain activities of Northern Brands International, Inc., a now inactive, indirect
subsidiary of RAI formerly involved in the international tobacco business, referred to as Northern
Brands. For further information on Northern Brands and related litigation and the indemnification
claims of JTI, see
17
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Litigation Affecting the Cigarette Industry Other Litigation and Developments and Other
Contingencies below.
Generally, RJR Tobacco and its affiliates and indemnitees have not settled, and currently RJR
Tobacco and its affiliates do not intend to settle, any smoking and health tobacco litigation
claims. It is the policy of RJR Tobacco and its affiliates to vigorously defend all tobacco-related
litigation claims.
The only smoking and health tobacco litigation claims settled by RJR Tobacco and B&W involved:
the Master Settlement Agreement and other settlement agreements with the states of
Mississippi, Florida, Texas and Minnesota, and the funding by various tobacco companies of a
$5.2 billion trust fund contemplated by the Master Settlement Agreement to benefit tobacco
growers; and
the original Broin flight attendant case discussed below under Litigation Affecting
the Cigarette Industry Class-Action Suits.
The circumstances surrounding the MSA and the funding of a trust fund to benefit the tobacco
growers are readily distinguishable from the current categories of smoking and health cases
involving RJR Tobacco or its affiliates and indemnitees. The claims underlying the MSA were brought
on behalf of the states to recover funds paid for health-care and medical and other assistance to
state citizens suffering from diseases and conditions allegedly related to tobacco use. The MSA
settled all the health-care cost recovery actions brought by, or on behalf of, the settling
jurisdictions and contain releases of various additional present and future claims. In accordance
with the MSA, various tobacco companies agreed to fund a $5.2 billion trust fund to be used to
address the possible adverse economic impact of the MSA on tobacco growers. A discussion of the
MSA, and a table depicting the related payment schedule, is set forth below under Litigation
Affecting the Cigarette Industry Health-Care Cost Recovery Cases MSA.
The states were a unique set of plaintiffs and are not involved in any of the smoking and
health cases remaining against RJR Tobacco or its affiliates and indemnitees. Although RJR Tobacco
and certain of its affiliates and indemnitees continue to be defendants in health-care cost
recovery cases similar in theory to the state cases but involving other plaintiffs, such as
hospitals, Native American tribes and foreign governments, the vast majority of such cases have
been dismissed on legal grounds. RJR Tobacco and its affiliates, including RAI, believe that the
same legal principles that have resulted in dismissal of health-care cost recovery cases either at
the trial court level or on appeal should compel dismissal of the similar pending cases.
The pending U.S. Department of Justice case brought against various industry members,
including RJR Tobacco and B&W, discussed below under Litigation Affecting the Cigarette Industry
Health-Care Cost Recovery Cases, also can be distinguished from the circumstances surrounding
the MSA. Under its Medical Care Recovery Act and Medicare Secondary Payer Act claims, the federal
government made arguments similar to the states and sought to recover federal funds expended in
providing health care to smokers who have developed diseases and injuries alleged to be
smoking-related. These claims were dismissed, and the only claim remaining in the case involves
alleged violations of civil provisions of the federal Racketeer Influenced and Corrupt
Organizations Act, referred to as RICO. A comprehensive discussion of this case is set forth below
under Litigation Affecting the Cigarette Industry Health-Care Cost Recovery Cases.
As with claims that were resolved by the MSA, the other cases settled by RJR Tobacco can be
distinguished from existing cases pending against RJR Tobacco and its affiliates and indemnitees.
The original Broin case, discussed below under Litigation Affecting the Cigarette Industry
Class-Action Suits, was settled in the middle of trial during negotiations concerning a possible
nation-wide settlement of claims similar to those underlying the MSA.
Likewise, RJR Tobacco and B&W separately settled the antitrust case DeLoach v. Philip Morris
Cos., Inc., which was brought by a unique class of plaintiffs: a class of all tobacco growers and
tobacco allotment holders. Despite valid legal defenses, RJR Tobacco and B&W separately settled
this case to avoid a long and contentious trial with the tobacco growers. The DeLoach case and the
antitrust cases currently pending against RJR Tobacco and B&W involve different types of plaintiffs
and different theories of recovery under the antitrust laws than other cases pending against RJR
Tobacco and its affiliates and indemnitees.
Finally, as discussed under Litigation Affecting the Cigarette Industry MSA - Enforcement
and Validity, RJR Tobacco and B&W each has settled certain cases brought by states concerning the
enforcement of the
MSA. Despite valid legal defenses, these cases were settled to avoid further contentious
litigation with the states involved. Each MSA enforcement action involves alleged breaches of the
MSA based on specific actions taken by the
18
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
particular defendant. Accordingly, any future MSA
enforcement action will be reviewed by RJR Tobacco on the merits and should not be affected by the
settlement of prior MSA enforcement cases.
The Conwood companies also believe that they have valid defenses to the smokeless tobacco
litigation against them. The Conwood companies have asserted and will continue to assert some or
all of these defenses in each case at the time and in the manner deemed appropriate by the Conwood
companies and their counsel. No verdict or judgment has been returned or entered against the
Conwood companies on any claim for personal injuries allegedly resulting from the use of smokeless
tobacco. The Conwood companies intend to defend vigorously all smokeless tobacco litigation claims
asserted against them. No liability for pending smokeless tobacco litigation was recorded in RAIs
consolidated balance sheet (unaudited) as of September 30, 2008.
Cautionary Statement
Even though RAIs management continues to conclude that the loss of any particular pending
smoking and health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees,
or the loss of any particular pending case concerning the use of smokeless tobacco against the
Conwood companies, when viewed on an individual basis, is not probable, the possibility of material
losses related to such litigation is more than remote. Litigation is subject to many uncertainties,
and generally it is not possible to predict the outcome of any particular litigation pending
against RJR Tobacco, the Conwood companies or their affiliates or indemnitees, or to reasonably
estimate the amount or range of any possible loss.
Although RJR Tobacco believes that it has valid bases for appeals of adverse verdicts in its
pending cases, and RJR Tobacco and RAI believe they have valid defenses to all actions, and intend
to defend all actions vigorously, it is possible that there could be further adverse developments
in pending cases, and that additional cases could be decided unfavorably against RAI, RJR Tobacco
or their affiliates or indemnitees. Determinations of liability or adverse rulings in such cases or
in similar cases involving other cigarette manufacturers as defendants, even if such judgments are
not final, could materially adversely affect the litigation against RJR Tobacco or its affiliates
or indemnitees and could encourage the commencement of additional tobacco-related litigation. In
addition, a number of political, legislative, regulatory and other developments relating to the
tobacco industry and cigarette smoking have received wide media attention. These developments may
negatively affect the outcomes of tobacco-related legal actions and encourage the commencement of
additional similar litigation.
Although it is impossible to predict the outcome of such events on pending litigation and the
rate new lawsuits are filed against RJR Tobacco or its affiliates or indemnitees, a significant
increase in litigation or in adverse outcomes for tobacco defendants could have a material adverse
effect on any or all of these entities. Moreover, notwithstanding the quality of defenses available
to it and its affiliates and indemnitees in litigation matters, it is possible that RAIs results
of operations, cash flows or financial position could be materially adversely affected by the
ultimate outcome of certain pending litigation matters against RJR Tobacco or its affiliates or
indemnitees.
Similarly, smokeless tobacco litigation is subject to many uncertainties. Notwithstanding the
quality of defenses available to the Conwood companies, it is possible that RAIs results of
operations, cash flows or financial position could be materially adversely affected by the ultimate
outcome of certain pending litigation matters against the Conwood companies.
Litigation Affecting the Cigarette Industry
Overview
Introduction. In connection with the B&W business combination, RJR Tobacco agreed to
indemnify B&W and its affiliates against, among other things, certain litigation liabilities, costs
and expenses incurred by B&W or its affiliates arising out of the U.S. cigarette and tobacco
business of B&W. Accordingly, the cases discussed below include cases brought solely against RJR
Tobacco and its affiliates, including RAI and RJR; cases brought against both RJR Tobacco, its
affiliates and B&W; and cases brought solely against B&W and assumed by RJR Tobacco in the B&W
business combination.
During the third quarter of 2008, 24 tobacco-related cases were served against RJR Tobacco or
its affiliates or indemnitees. On September 30, 2008, there were 3,207 cases, including 686
individual smoker cases pending in West Virginia state court as a consolidated action and 2,310
Engle Progeny Cases, involving 8,827 individual plaintiffs,
pending in the United States against RJR Tobacco or its affiliates or indemnitees, as compared
with 1,283 total cases on
19
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
September 30, 2007, and 1,419 total cases on September 30, 2006, pending
in the United States against RJR Tobacco or its affiliates or indemnitees.
As of October 10, 2008, 922 tobacco-related cases were pending against RJR Tobacco or its
affiliates or indemnitees: 917 in the United States; one in Puerto Rico; three in Canada; and one
in Israel. Of the 917 total U.S. cases, 25 cases are pending against B&W that are not also pending
against RJR Tobacco. The U.S. case number does not include the 2,620 Broin II or the 2,310 Engle
Progeny Cases, as discussed below, pending as of October 10, 2008. The following table lists the
number of U.S. tobacco-related cases by state that were pending against RJR Tobacco or its
affiliates or indemnitees as of October 10, 2008, exclusive of the Broin II and Engle Progeny
Cases:
|
|
|
|
|
|
|
Number of |
State |
|
U.S. Cases |
West Virginia |
|
|
692 |
* |
Maryland |
|
|
38 |
|
New York |
|
|
24 |
|
Florida |
|
|
24 |
|
Missouri |
|
|
20 |
|
Louisiana |
|
|
17 |
|
Mississippi |
|
|
14 |
|
California |
|
|
11 |
|
Illinois |
|
|
7 |
|
Connecticut |
|
|
4 |
|
Ohio |
|
|
4 |
|
Pennsylvania |
|
|
4 |
|
Kentucky |
|
|
4 |
|
District of Columbia |
|
|
3 |
|
Georgia |
|
|
3 |
|
Delaware |
|
|
2 |
|
Washington |
|
|
2 |
|
Alabama |
|
|
2 |
|
Kansas |
|
|
2 |
|
Maine |
|
|
2 |
|
Minnesota |
|
|
2 |
|
New Mexico |
|
|
2 |
|
North Carolina |
|
|
2 |
|
South Dakota |
|
|
2 |
|
Tennessee |
|
|
2 |
|
Vermont |
|
|
2 |
|
Wisconsin |
|
|
2 |
|
Arizona |
|
|
1 |
|
Michigan |
|
|
1 |
|
New Jersey |
|
|
1 |
|
Oregon |
|
|
1 |
|
South Carolina |
|
|
1 |
|
Alaska |
|
|
1 |
|
Arkansas |
|
|
1 |
|
Colorado |
|
|
1 |
|
Hawaii |
|
|
1 |
|
Idaho |
|
|
1 |
|
Indiana |
|
|
1 |
|
Iowa |
|
|
1 |
|
Mariana Islands |
|
|
1 |
|
Massachusetts |
|
|
1 |
|
Montana |
|
|
1 |
|
Nebraska |
|
|
1 |
|
Nevada |
|
|
1 |
|
New Hampshire |
|
|
1 |
|
20
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
Number of |
State |
|
U.S. Cases |
North Dakota |
|
|
1 |
|
Oklahoma |
|
|
1 |
|
Rhode Island |
|
|
1 |
|
Utah |
|
|
1 |
|
Virginia |
|
|
1 |
|
Wyoming |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
917 |
** |
|
|
|
|
|
|
|
|
* |
|
687 of the 692 cases are pending as a consolidated action In re: Tobacco Litigation Personal Injury
Cases, Circuit Court, Ohio County, West Virginia, consolidated January 11, 2000. On February 11, 2008,
the trial court stayed the trial of the initial phase indefinitely pending the U.S. Supreme Court review
in Good v. Altria Group, Inc., a lights class action filed in August 2005 in the United States
District Court for the District of Maine against Philip Morris USA and its parent company, Altria Group,
Inc. On February 25, 2008, the U.S. Supreme Court denied the defendants petition for certiorari asking
the Court to review the trial plan for the West Virginia cases. Oral argument in Good v. Altria Group,
Inc. occurred in the U.S. Supreme Court on October 6, 2008. A decision is pending. |
|
** |
|
Of the 917 pending U.S. cases, 30 are pending in federal court, 886 in state court and 1 in tribal court. |
The following table lists the categories of the U.S. tobacco-related cases pending against RJR
Tobacco or its affiliates or indemnitees as of October 10, 2008, compared with the number of cases
pending against RJR Tobacco, its affiliates or indemnitees as of July 11, 2008, as reported in
RAIs Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2008, filed with the SEC
on August 4, 2008, and a cross-reference to the discussion of each case type.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in Number |
|
|
|
|
RJR Tobaccos |
|
of Cases Since |
|
|
|
|
Case Numbers as of |
|
July 11, 2008 |
|
|
Case Type |
|
October 10, 2008 |
|
Increase/(Decrease) |
|
Page Reference |
Individual Smoking and Health |
|
|
825 |
|
|
|
8 |
|
|
|
29 |
|
Engle Progeny (Number of Plaintiffs)* |
|
|
2,310 (8,825) |
|
|
|
67 |
|
|
|
30 |
|
Broin II |
|
|
2,620 |
|
|
|
(1 |
) |
|
|
31 |
|
Class-Action |
|
|
15 |
|
|
|
(1 |
) |
|
|
31 |
|
Health-Care Cost Recovery |
|
|
4 |
|
|
No Change |
|
|
36 |
|
MSA-Enforcement and Validity |
|
|
60 |
|
|
No Change |
|
|
40 |
|
Antitrust |
|
|
2 |
|
|
No Change |
|
|
42 |
|
Other Litigation |
|
|
11 |
|
|
|
1 |
|
|
|
43 |
|
|
|
|
* |
|
The Engle Progeny Cases have been separated from the
Individual Smoking and Health cases for reporting purposes.
Plaintiffs counsel are attempting to include multiple
plaintiffs in most of the cases filed. The increase in the
number of cases includes new cases served and new cases
filed by severed plaintiffs. |
Four pending cases against RJR Tobacco and B&W have attracted significant attention: the
Florida state court class-action case, Engle v. R. J. Reynolds Tobacco Co., the Louisiana state
court class-action case, Scott v. American Tobacco Co., the federal RICO case brought by the
U.S. Department of Justice, and the federal lights class action Schwab [McLaughlin] v. Philip
Morris USA, Inc.
In 2000, a jury in Engle rendered a punitive damages verdict in favor of the Florida class
of approximately $145 billion against all defendants. On July 6, 2006, the Florida Supreme Court,
among other things, affirmed an appellate courts reversal of the punitive damages award,
decertified the class going forward, preserved several class-wide findings from the trial,
including that nicotine is addictive and cigarettes are defectively designed, and authorized class
members to avail themselves of these findings in individual lawsuits under certain conditions.
After subsequent motions were resolved, the Florida Supreme Court issued its mandate on January 11,
2007, thus beginning a one-year period in which former class members were permitted to file
individual lawsuits. On October 1, 2007, the U.S. Supreme Court denied the defendants petition for
writ of certiorari. As of October 10, 2008, RJR Tobacco had been served in
2,310 Engle Progeny Cases in both state and federal courts in Florida. These cases include
approximately 8,825 plaintiffs. The number of cases likely will change due to individual plaintiffs
being severed from multi-plaintiff cases.
21
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
In 2004, a jury in Scott returned a verdict in favor of the Louisiana class for $591 million
to establish a state-wide smoking cessation program. In 2007, the Louisiana Court of Appeals
upheld class certification, significantly reduced the scope of recovery, and remanded the case for
further proceedings. The Louisiana and U.S. Supreme Courts denied the defendants applications for
writ of certiorari. In July 2008, the trial court entered an amended judgment in favor of the
class for approximately $263 million plus interest from
June 30, 2004. The defendants have filed an
emergency application for writ of mandamus or supervisory writ with the Louisiana Court of Appeals.
In the U.S. Department of Justice case, brought in 1999 in the U.S. District Court for the
District of Columbia, the government sought, among other forms of relief, the disgorgement of
profits pursuant to the civil provisions of RICO. The U.S. Court of Appeals for the District of
Columbia ruled in 2005 that disgorgement is not an available remedy in the case. The bench trial
ended in June 2005, and the court, in August 2006, issued its ruling, among other things, finding
certain defendants, including RJR Tobacco and B&W, liable for the RICO claims, imposing no direct
financial penalties on the defendants, but ordering the defendants to make certain corrective
communications in a variety of media and enjoining the defendants from using certain brand
descriptors. Both sides have appealed to the U.S. Court of Appeals for the District of Columbia,
and the trial courts order has been stayed pending the appeal. Oral argument occurred on October
14, 2008. A decision is pending.
In September 2006, the U.S. District Court for the Eastern District of New York in Schwab
certified a nation-wide class of lights smokers. On November 16, 2006, the U.S. Court of Appeals
for the Second Circuit granted the defendants motions to stay the district court proceedings and
for review of the class certification ruling. On April 3, 2008, the Second Circuit decertified
the class. The case was returned to the trial court for further proceedings.
For a detailed description of these cases, see Class-Action Suits Engle Case,
Class-Action Suits
Medical Monitoring and Smoking Cessation Cases, Health-Care Cost Recovery Cases Department of
Justice Case and Class-Action Suits Lights Cases below.
In November 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W,
entered into the MSA with 46 U.S. states and certain U.S. territories and possessions. These
cigarette manufacturers previously settled four other cases, brought on behalf of Mississippi,
Florida, Texas and Minnesota, by separate agreements with each state. The MSA, including the four
other state settlement agreements:
settled all health-care cost recovery actions brought by, or on behalf of, the settling
jurisdictions;
released the major U.S. cigarette manufacturers from various additional present and
potential future claims;
imposed payment obligations in perpetuity on RJR Tobacco, B&W and other major
U.S. cigarette manufacturers; and
placed significant restrictions on their ability to market and sell tobacco products.
MSA payments are subject to adjustments for, among other things, the volume of cigarettes
sold, market share and inflation. See Health-Care Cost Recovery Cases MSA below for a
detailed discussion of the MSA, including RAIs operating subsidiaries monetary obligations under
these agreements. RJR Tobacco records the allocation of settlement charges as products are shipped.
Scheduled Trials. Trial schedules are subject to change, and many cases are dismissed before
trial. The following table lists the trial schedule, as of October 10, 2008, for RJR Tobacco or its
affiliates and indemnitees through September 30, 2009.
|
|
|
|
|
|
|
Trial Date |
|
Case Name/Type |
|
Defendant(s) |
|
Jurisdiction |
|
October 6, 2008
[ONGOING]
|
|
Vermont v. R.J. Reynolds Tobacco
Co.
|
|
RJR Tobacco
|
|
Superior Court
Chittenden County |
|
|
[MSA Enforcement (Eclipse)]
|
|
|
|
(Burlington, VT) |
|
November 24, 2008
|
|
Hess v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
22
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
Trial Date |
|
Case Name/Type |
|
Defendant(s) |
|
Jurisdiction |
|
December 1, 2008
|
|
Sherman v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
December 17, 2008
|
|
Williams v. Brown & Williamson
|
|
RJR Tobacco, B&W
|
|
Circuit Court |
|
|
[Individual]
|
|
|
|
City of St. Louis |
|
|
|
|
|
|
(St. Louis, MO) |
|
January 5, 2009
|
|
Hargroves v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Hillsborough County |
|
|
|
|
|
|
(Miami, FL) |
|
January 5, 2009
|
|
Brown v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
January 5, 2009
|
|
Cohen v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
January 5, 2009
|
|
Stephens v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
January 19, 2009
|
|
Levine v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco, B&W
|
|
Circuit Court |
|
|
[Individual]
|
|
|
|
Palm Beach County |
|
|
|
|
|
|
(West Palm Beach, FL) |
|
February 2, 2009
|
|
Tate v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
February 2, 2009
|
|
Cohen v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
February 2, 2009
|
|
Goldthorpe v. R.J. Reynolds
Tobacco Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
March 9, 2009
|
|
Gelep v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Pinellas County |
|
|
|
|
|
|
(St. Petersburg, FL) |
|
April 27, 2009
|
|
Abbott v. Philip Morris USA Inc.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Barbanell v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Bronstein v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Cohen v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court
|
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Dawson v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Kaplan v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Lapidus-Carlson v. R.J. Reynolds
Tobacco Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
23
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
Trial Date |
|
Case Name/Type |
|
Defendant(s) |
|
Jurisdiction |
|
April 27, 2009
|
|
Lopez v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Marrazzo v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Morrissette-Stege v. R.J. Reynolds
Tobacco Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Palmieri v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Rohr v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Salvino v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Tucci v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court
|
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
April 27, 2009
|
|
Walsh v. R.J. Reynolds Tobacco Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County
(Ft. Lauderdale, FL) |
|
June 29, 2009
|
|
Digati v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
June 29, 2009
|
|
Greene v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
June 29, 2009
|
|
Grossman v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
June 29, 2009
|
|
Naugle v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco
|
|
Circuit Court |
|
|
[Engle Progeny]
|
|
|
|
Broward County |
|
|
|
|
|
|
(Ft. Lauderdale, FL) |
|
June 29, 2009
|
|
Samuels v. R.J. Reynolds Tobacco
Co.
[Engle Progeny]
|
|
RJR Tobacco
|
|
Circuit Court
Broward County
(Ft. Lauderdale, FL) |
|
July 13, 2009
|
|
Bell v. Brown & Williamson Tobacco
Corp.
[Individual]
|
|
RJR Tobacco; B&W
|
|
Circuit Court
Jackson County |
|
|
|
|
|
|
(Independence, MO) |
|
August 3, 2009
|
|
Woods v. R.J. Reynolds Tobacco Co.
|
|
RJR Tobacco; B&W
|
|
U.S. District Court |
|
|
[Individual]
|
|
|
|
Southern District |
|
|
|
|
|
|
(Jackson, MS) |
|
August 5, 2009
|
|
Coley v. 3M Company
|
|
RJR Tobacco
|
|
Superior Court |
|
|
[Other]
|
|
|
|
New Castle County |
|
|
|
|
|
|
(Wilmington, DE) |
|
Trial Results. From January 1, 1999 through October 10, 2008, 54 smoking and health and
health-care cost recovery cases in which RJR Tobacco or B&W were defendants were tried. Verdicts in
favor of RJR Tobacco, B&W and, in some cases, RJR Tobacco, B&W and other defendants, were returned
in 37 cases, including four mistrials, tried in Florida (11), New York (4), Missouri (4), Tennessee
(3), Mississippi (2), California (2), West Virginia (2), Ohio (2), Connecticut (1), Louisiana (1),
New Jersey (1), Pennsylvania (1), South Carolina (1), Texas (1) and Washington (1).
24
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Additionally, from January 1, 1999 through October 10, 2008, verdicts were returned in 22
smoking and health cases in which RJR Tobacco, B&W, or their respective affiliates were not
defendants. Verdicts were returned in favor of the defendants in 13 cases five in Florida, three
in California, and one in each of New Hampshire, New York, Pennsylvania, Rhode Island and
Tennessee. Verdicts in favor of the plaintiffs were returned in nine cases four in California,
two in each of Florida and Oregon and one in Illinois.
No cases were tried in the first nine months of 2008 in which RJR Tobacco was a defendant.
The following chart reflects the verdicts and post-trial developments in the smoking and
health cases that have been tried and remain pending as of October 10, 2008, in which verdicts have
been returned in favor of the plaintiffs and against RJR Tobacco or B&W, or both.
|
|
|
|
|
|
|
|
|
Date of Verdict |
|
Case Name/Type |
|
Jurisdiction |
|
Verdict |
|
Post-Trial Status |
|
July 7, 1999-Phase I
April 7, 2000-Phase II
July 14, 2000-Phase
III
|
|
Engle v. R. J.
Reynolds Tobacco
Co.
[Class Action]
|
|
Circuit Court,
Miami-Dade County
(Miami, FL)
|
|
$12.7 million
compensatory
damages against all
the defendants;
$145 billion
punitive damages
against all the
defendants, of
which approximately
$36.3 billion and
$17.6 billion was
assigned to RJR
Tobacco and B&W,
respectively.
|
|
On May 21, 2003,
Floridas Third
District Court of
Appeal reversed the
trial court and
remanded the case
to the Miami-Dade
County Circuit
Court with
instructions to
decertify the
class. The Florida
Supreme Court on
July 6, 2006,
affirmed the
dismissal of the
punitive damages
award and
decertified, on a
going-forward
basis, the class.
The court preserved
a number of
class-wide findings
from Phase I of the
Engle trial, and
authorized class
members to avail
themselves of those
findings in
individual
lawsuits, provided
they commence those
lawsuits within one
year of the date
the courts
decision becomes
final. In
addition, the court
reinstated
compensatory damage
verdicts in favor
of two plaintiffs
in the amounts of
$2.85 million and
$4.023 million,
respectively. In
the third quarter
of 2007, the U.S.
Supreme Court
denied the
defendants
petition for writ
of certiorari and
petition for
rehearing. As a
result, on February
8, 2008, RJR
Tobacco paid
approximately $5.9
million relating to
the damages
verdicts mentioned
above, which was
determined using
the total amount of
the verdicts
together with
accrued interest
beginning November
7, 2000. On May
14, 2008, the trial
court granted the
parties |
25
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict |
|
Case Name/Type |
|
Jurisdiction |
|
Verdict |
|
Post-Trial Status |
|
|
|
|
|
|
|
|
|
motion to
sever moving
plaintiffs claims.
Plaintiffs Raymond
Lacey, Michael
Matyi and Loren
Lowery have filed
new cases.
Plaintiff Howard
Engle filed a
stipulation for
dismissal with
prejudice, which
the court ordered
on July 2, 2008.
On July 2, 2008,
plaintiff Marilyn
Calhoun filed a
motion for relief
from judgment. |
|
|
|
|
|
|
|
|
|
June 11, 2002
|
|
Lukacs v. R. J.
Reynolds Tobacco
Co.
[Engle class member]
|
|
Circuit Court,
Miami-Dade County
(Miami, FL)
|
|
$500,000 economic
damages, $24.5
million
non-economic
damages and $12.5
million loss of
consortium damages
against Philip
Morris, B&W and
Liggett, of which
B&W was assigned
22.5% of liability.
Final judgment was
entered in the
amount of $24.8
million plus
interest applicable
at the yearly
statutory rates
from July 11, 2002.
RJR Tobacco was
dismissed from the
case in May 2002,
prior to trial.
|
|
Judge reduced
damages to $25.125
million of which
B&Ws share is
approximately $6
million. On
January 2, 2007,
the defendants
moved to set aside
the June 11, 2002,
verdict and to
dismiss the
plaintiffs
punitive damages
claim. On January
3, 2007, the
plaintiffs filed a
motion for entry of
judgment, which the
court deferred
until the U.S.
Supreme Court
completed review of
Engle and after
further submissions
by the parties. On
January 28, 2008,
the defendants
filed a submission
asking the court to
set aside the
verdict and to
dismiss the case.
The court granted
the plaintiffs
motion for entry of
judgment on August
14, 2008. Pursuant
to that verdict,
the plaintiff will
recover the sum of
$24.8 million plus
interest at the
yearly statutory
rates from July 11,
2002. On August
25, 2008, the
defendants filed a
motion for
reconsideration of,
or in the
alternative, to
alter or amend the
order on the
plaintiffs motion
for entry of
judgment. A
hearing occurred on
October 21, 2008.
A decision is
pending. |
|
|
|
|
|
|
|
|
|
December 18, 2003
|
|
Frankson v. Brown &
Williamson Tobacco
Corp.
[Individual]
|
|
Supreme Court,
Kings County
(Brooklyn, NY)
|
|
$350,000
compensatory
damages; 50% fault
assigned to B&W and
two industry
organizations; $20
|
|
On January 21,
2005, the plaintiff
stipulated to the
courts reduction
in the amount of
punitive damages
from $20 |
26
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict |
|
Case Name/Type |
|
Jurisdiction |
|
Verdict |
|
Post-Trial Status |
|
|
|
|
|
|
|
million in punitive
damages, of which
$6 million was
assigned to B&W, $2
million to a
predecessor company
and $12 million to
two industry
organizations.
|
|
million to
$5 million,
apportioned as
follows: $0 to
American Tobacco;
$4 million to B&W;
$500,000 to the
Council for Tobacco
Research and
$500,000 to the
Tobacco Institute.
On June 26,
2007, final
judgment was
entered in the
amount of
approximately $6.8
million, including
interest and costs.
The defendants
filed a notice of
appeal on July 3,
2007. Briefing is
complete. Oral
argument has not
been scheduled.
Pursuant to its
agreement to
indemnify B&W, RJR
Tobacco posted a
supersedeas bond in
the amount of
$8.018 million on
July 5, 2007. |
|
|
|
|
|
|
|
|
|
May 21, 2004
|
|
Scott v. American
Tobacco Co.
[Class Action]
|
|
District Court,
Orleans Parish
(New Orleans, LA)
|
|
$591 million
against RJR
Tobacco, B&W,
Philip Morris,
Lorillard, and the
Tobacco Institute,
jointly and
severally, for a
smoking cessation
program.
|
|
On September 29,
2004, the
defendants posted a
$50 million bond
and noticed their
appeal to the
Louisiana Court of
Appeal. RJR
Tobacco posted $25
million toward the
bond. On February
7, 2007, the
Louisiana Court of
Appeals limited the
size of the class,
and rejected the
award of
pre-judgment
interest and most
of the specific
components of the
smoking cessation
program. However,
the court upheld
the class
certification and
found the
defendants
responsible for
funding smoking
cessation for
eligible class
members.
On July
21, 2008, the trial
court entered an
amended judgment in
the case. The
court found that
the defendants are
jointly and
severally liable
for funding the
cost of a
court-supervised
smoking cessation
program and ordered
the defendants to
deposit
approximately $263
million, together
with interest from
June 30, 2004, into
a trust for the
funding of the
program. The court
also stated that it
would favorably |
27
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict |
|
Case Name/Type |
|
Jurisdiction |
|
Verdict |
|
Post-Trial Status |
|
|
|
|
|
|
|
|
|
consider a motion
to return to
defendants a
portion of unused
funds at the close
of each program
year in the event
the monies
allocated for the
preceding program
year were not fully
expended because of
a reduction in
class size or
underutilization by
the remaining
plaintiffs. On
August 27, 2008,
the court denied
the defendants
request for
permission to
pursue an appeal.
On September 9,
2008, the
defendants filed an
emergency
application for
writ of mandamus or
supervisory writ
with request for
stay and expedited
consideration.
The same day, the
Louisiana Court of
Appeals stayed all
proceedings pending
further order of
the court. |
|
|
|
|
|
|
|
|
|
February 2, 2005
|
|
Smith v. Brown &
Williamson Tobacco
Corp.
[Individual]
|
|
Circuit Court,
Jackson County
(Independence, MO)
|
|
$2 million in
compensatory
damages which was
reduced to $500,000
because of jurys
findings that the
plaintiff was 75%
at fault; $20
million in punitive
damages.
|
|
On June 1, 2005,
B&W filed its
notice of appeal.
On July 31, 2007,
the Missouri Court
of Appeals affirmed
the compensatory
damages award but
ordered a new trial
on punitive
damages. The
Missouri Supreme
Court accepted
transfer of the
case from the court
of appeals, but on
July 31, 2008,
retransferred the
case to the
Missouri Court of
Appeals. |
|
|
|
|
|
|
|
|
|
March 18, 2005
|
|
Rose v. Brown &
Williamson Tobacco
Corp.
[Individual]
|
|
Supreme Court,
New York County
(Manhattan, NY)
|
|
RJR Tobacco found
not liable; $3.42
million in
compensatory
damages against B&W
and Philip Morris,
of which $1.71
million was
assigned to B&W;
$17 million in
punitive damages
against Philip
Morris only.
|
|
On August 18, 2005,
B&W filed its
notice of appeal.
Pursuant to its
agreement to
indemnify B&W, RJR
Tobacco posted a
supersedeas bond in
the amount of
$2.058 million on
February 7, 2006.
On April 10, 2008,
the New York
Supreme Court,
Appellate Division
reversed the
judgment in the
plaintiffs favor
and ordered that
the case be
dismissed. On May
8, 2008, the
plaintiffs filed a
notice of appeal.
Oral argument is
scheduled for
November 18, 2008. |
28
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
|
|
Date of Verdict |
|
Case Name/Type |
|
Jurisdiction |
|
Verdict |
|
Post-Trial Status |
|
August 17, 2006
|
|
United States v.
Philip Morris USA,
Inc.
[Governmental
Health-Care Cost
Recovery]
|
|
U.S. District Court,
District of Columbia
(Washington, DC)
|
|
RJR Tobacco and B&W
were found liable
for civil RICO
claims; were
enjoined from using
certain brand
descriptors and
from making certain
misrepresentations;
and were ordered to
make corrective
communications on
five subjects,
including smoking
and health and
addiction, to
reimburse the U.S.
Department of
Justice appropriate
costs associated
with the lawsuit,
and to maintain
document web sites.
|
|
On September 11,
2006, RJR Tobacco
and B&W filed their
notices of appeal.
On October 16,
2006, the
government filed
its notice of
appeal. The court
of appeals granted
the defendants
motion to stay the
district courts
order on October
31, 2006. Oral
argument occurred
on October 14,
2008. A decision
is pending. |
|
|
|
|
|
|
|
|
|
May 2, 2007
|
|
Whiteley v. R.J.
Reynolds Tobacco
Co.
[Individual]
|
|
Superior Court,
San Francisco County,
(San Francisco, CA)
|
|
$2.46 million in
compensatory
damages jointly
against RJR Tobacco
and Philip Morris;
$250,000 punitive
damages against RJR
Tobacco only.
|
|
On September 5,
2007, the court
denied RJR
Tobaccos motion
for judgment
notwithstanding the
verdict or, in the
alternative, for a
new trial. RJR
Tobacco filed its
notice of appeal on
October 3, 2007.
Briefing is
underway. On May 5,
2008, the court
issued an order
approving deposit
in lieu of
appellate bond.
RJR Tobacco
purchased and
deposited with the
court
approximately $2.6
million in U.S.
Treasury bills in
lieu of a
supersedeas bond to
stay enforcement of
the judgment
pending appeal. |
Individual Smoking and Health Cases
As of October 10, 2008, 825 individual cases, including 687 individual smoker cases in West
Virginia state court in a consolidated action, were pending in the United States against RJR
Tobacco, B&W, as its indemnitee, or both. This category of cases includes smoking and health cases
alleging personal injury brought by or on behalf of individual plaintiffs, but does not include the
Broin II or Engle Progeny Cases discussed below. A total of 822 of the individual cases are brought
by or on behalf of individual smokers or their survivors, while the remaining three cases are
brought by or on behalf of individuals or their survivors alleging personal injury as a result of
exposure to ETS.
Below is a description of the individual smoking and health cases against RJR Tobacco or B&W,
or both, which went to trial or were decided during the period from January 1, 2008, to
September 30, 2008, or remained on appeal as of September 30, 2008.
In Whiteley v. R. J. Reynolds Tobacco Co., the retrial of Whiteley v. Raybestos-Manhattan, a
case filed in April 1999 in Superior Court, San Francisco County, California and originally tried
in 2000, the jury awarded the plaintiff $2.46 million in compensatory damages jointly against RJR
Tobacco and Philip Morris on May 2, 2007, and returned a punitive damages verdict award of $250,000
against RJR Tobacco on May 9, 2007. RJR Tobaccos motion for judgment notwithstanding the verdict
or, in the alternative, for a new trial was denied on September 5, 2007. RJR Tobacco filed its
notice of appeal to the Court of Appeal for the State of California, First Appellate District, on
October 3, 2007. Briefing is underway. On May 5, 2008, the court issued an order approving
deposit in lieu of appellate bond. RJR Tobacco purchased and deposited with the court
approximately $2.6 million in U.S. Treasury bills in lieu of a supersedeas bond to stay enforcement
of the judgment pending appeal.
29
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
On August 15, 2003, a jury returned a verdict in favor of B&W in Eiser v. Brown & Williamson
Tobacco Corp., a case filed in March 1999 in the Court of Common Pleas, Philadelphia County,
Pennsylvania. The plaintiff, Lois Eiser, sought compensatory and punitive damages in an amount in
excess of $50,000, together with interest, costs and attorneys fees in this wrongful death action
against B&W. On January 19, 2006, the Superior Court of Pennsylvania affirmed the verdict. On
September 22, 2006, the Pennsylvania Supreme Court granted the plaintiffs petition to appeal, and
on December 28, 2007, remanded the case to the Eastern District of the Superior Court for further
review. Briefing is underway.
On December 18, 2003, in Frankson v. Brown & Williamson Tobacco Corp., a case filed in August
2000 in Supreme Court, Kings County, New York, a jury awarded $350,000 in compensatory damages
against B&W and two former tobacco industry organizations, the Tobacco Institute and the Council
for Tobacco Research, in an action brought against the major U.S. cigarette manufacturers,
including RJR Tobacco, who was dismissed prior to trial, and B&W, seeking $270 million in
compensatory damages, unspecified punitive damages, attorneys fees, costs and disbursements. Other
manufacturers were dismissed before trial. The plaintiff, Gladys Frankson, alleged that
Mr. Frankson became addicted to nicotine, was unable to cease smoking, developed lung cancer and
died as a result. The defendants as a group and the deceased smoker were each found to be 50% at
fault. On January 8, 2004, the jury awarded $20 million in punitive damages, assigning $6 million
to B&W, $2 million to American Tobacco, a predecessor company to B&W, and $6 million to each of the
Council for Tobacco Research and the Tobacco Institute. On June 22, 2004, the trial judge granted a
new trial unless the parties consented to an increase in compensatory damages to $500,000 and a
decrease in punitive damages to $5 million, of which $4 million would be assigned to B&W. On
January 21, 2005, the plaintiff stipulated to the reduction in punitive damages.
After all post-trial motions, and appeals there from, were denied, judgment was entered in
favor of the plaintiffs for $175,000 in compensatory damages, the original jury award reduced by
50%, and $5 million in punitive damages, the amount to which the plaintiff stipulated. On June 26,
2007, final judgment was entered against the defendants in the amount of approximately
$6.8 million, including interest and costs. The defendants filed a notice of appeal to the
Appellate Division, New York Supreme Court, Second Department on July 3, 2007. Briefing is
complete. Oral argument has not been scheduled. Pursuant to its agreement to indemnify B&W, RJR
Tobacco posted a supersedeas bond in the amount of $8.018 million on July 5, 2007.
On February 1, 2005, a jury returned a split verdict in Smith v. Brown & Williamson Tobacco
Corp., a case filed in May 2003 in Circuit Court, Jackson County, Missouri, finding in favor of B&W
on two counts, fraudulent concealment and conspiracy, and finding in favor of the plaintiff on
negligence, which incorporates failure to warn and product defect claims. The plaintiff, Lincoln
Smith, claimed that the defendants tobacco products caused Mrs. Smiths death from lung cancer and
sought an unspecified amount of compensatory and punitive damages. The plaintiff was awarded
$2 million in compensatory damages and $20 million in punitive damages; however, the jury found the
plaintiff to be 75% at fault, and B&W 25% at fault, and thus the compensatory award was reduced to
$500,000. B&W appealed to the Missouri Court of Appeals, and on July 31, 2007, the court affirmed
the compensatory damages and ordered a new trial on punitive damages. The Missouri Supreme Court
agreed to accept transfer of the case from the court of appeals, and on July 31, 2008,
retransferred the case to the Missouri Court of Appeals.
On March 18, 2005, in Rose v. Brown & Williamson Tobacco Corp., a case filed in December 1996
in New York Supreme Court, County of New York, a jury returned a verdict in favor of RJR Tobacco,
but returned a $3.42 million compensatory damages verdict against B&W and Philip Morris, of which
$1.71 million was assigned to B&W. A punitive damages verdict of $17 million against Philip Morris
only was returned by the jury on March 28, 2005. The action was brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover $15 million in
compensatory damages and $35 million in punitive damages. The plaintiffs, Norma Rose and Leonard
Rose, allege that their use of the defendants products caused them to become addicted to nicotine
and develop lung cancer, chronic obstructive pulmonary disease and other smoking related conditions
and/or diseases. Oral argument on B&Ws appeal in the Appellate Division, New York Supreme Court,
First Department occurred on December 12, 2006. Pursuant to its agreement to indemnify B&W, RJR
Tobacco posted a supersedeas bond in the amount of $2.058 million on February 7, 2006. On April
10, 2008, the Appellate Division reversed the judgment in the plaintiffs favor and ordered that
the case be dismissed. On May 8, 2008, the plaintiffs filed a notice of appeal. Oral argument is
scheduled for November 18, 2008.
Engle Progeny Cases
30
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Pursuant to the Florida Supreme Courts July 6, 2006, ruling in Engle v. R. J. Reynolds
Tobacco Co., which decertified the class, former class members had one year from January 11, 2007,
in which to file individual lawsuits. In addition, some individuals who filed suit prior to
January 11, 2007, and who claim they meet the conditions in Engle, also are attempting to avail
themselves of the Engle ruling. Lawsuits by individuals requesting the benefit of the Engle ruling,
whether filed before or after the January 11, 2007, mandate, are referred to as the Engle Progeny
Cases. As of October 10, 2008, RJR Tobacco had been served in 2,310 Engle Progeny Cases in both
state and federal courts in Florida. These cases include approximately 8,825 plaintiffs. The
number of cases likely will change due to individual plaintiffs being severed from multi-plaintiff
cases. For further information on the Engle case, see Class-Action Suits Engle Case, below.
Broin II Cases
As of October 10, 2008, there were 2,620 lawsuits pending in Florida brought by individual
flight attendants for personal injury as a result of illness allegedly caused by exposure to ETS in
airplane cabins, referred to as the Broin II cases. In these lawsuits, filed pursuant to the terms
of the settlement of the Broin v. Philip Morris, Inc. class action, discussed below under
Class-Action Suits, each individual flight attendant will be required to prove that he or she
has a disease and that the individuals exposure to ETS in airplane cabins caused the disease.
Punitive damages are not available in these cases.
On October 5, 2000, the Broin court entered an order applicable to all Broin II cases that the
terms of the Broin settlement agreement do not require the individual Broin II plaintiffs to prove
the elements of strict liability, breach of warranty or negligence. Under this order, there is a
rebuttable presumption in the plaintiffs favor on those elements, and the plaintiffs bear the
burden of proving that their alleged adverse health effects actually were caused by exposure to ETS
in airplane cabins, that is, specific causation. Below is a description of the only Broin II case
against RJR Tobacco and B&W that went to trial or was decided during the period from July 1, 2008
to September 30, 2008, or remained on appeal as of September 30, 2008.
In Janoff v. Philip Morris, Inc., a case filed in February 2000 in Circuit Court, Miami-Dade
County, Florida, a jury found in favor of the defendants, including RJR Tobacco and B&W, on
September 5, 2002, in an action brought against the major U.S. cigarette manufacturers seeking to
recover compensatory damages pursuant to the Broin settlement. The plaintiff, Suzette Janoff,
alleged that as a result of exposure to ETS in airline cabins, she suffered from, among other
illnesses, chronic sinusitis, chronic bronchitis and other respiratory and pulmonary problems. The
judge granted the plaintiffs motion for a new trial on January 8, 2003. The new trial date has
not been scheduled.
Class-Action Suits
Overview. As of October 10, 2008, 15 class-action cases, exclusive of antitrust class
actions, were pending in the United States against RJR Tobacco or its affiliates or indemnitees. In
May 1996, in Castano v. American Tobacco Co., the Fifth Circuit Court of Appeals overturned the
certification of a nation-wide class of persons whose claims related to alleged addiction to
tobacco products. Since this ruling by the Fifth Circuit, most class-action suits have sought
certification of state-wide, rather than nation-wide, classes. Class-action suits based on claims
similar to those asserted in Castano or claims that class members are at a greater risk of injury
or injured by the use of tobacco or exposure to ETS are pending against RJR Tobacco and its
affiliates and indemnitees in state or federal courts in California, Florida, Illinois, Louisiana,
Minnesota, Missouri, New York and West Virginia. All pending class-action cases are discussed
below.
The pending class-actions against RJR Tobacco or its affiliates or indemnitees include seven
cases alleging that the use of the term lights constitutes unfair and deceptive trade practices
under state law or violates the federal RICO statute. Such suits are pending in state or federal
courts in Illinois, Minnesota, Missouri and New York.
Finally, certain third-party payers have filed health-care cost recovery actions in the form
of class-actions.
Few smoker class-action complaints have been certified or, if certified, have survived on
appeal. Eighteen federal courts, including two courts of appeals, and most state courts that have
considered the issue have rejected class certification in such cases. Apart from the Castano case
discussed above, only two smoker class actions have been certified by a federal court: In re Simon
(II) Litigation and Schwab [McLaughlin] v. Philip Morris USA, Inc., discussed
below under Lights Cases, both of which were filed in the U.S. District Court for the
Eastern District of New York and ultimately decertified.
31
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Medical Monitoring and Smoking Cessation Cases. On November 5, 1998, in Scott v. American
Tobacco Co., a case filed in May 1996 in District Court, Orleans Parish, Louisiana, the trial court
certified a medical monitoring or smoking cessation class of Louisiana residents who were smokers
on or before May 24, 1996, in an action brought against the major U.S. cigarette manufacturers,
including RJR Tobacco and B&W, seeking to recover an unspecified amount of compensatory and
punitive damages. The plaintiffs allege that their use of the defendants products caused them to
become addicted to nicotine. On July 28, 2003, the jury returned a verdict in favor of the
defendants on the plaintiffs claim for medical monitoring and found that cigarettes were not
defectively designed. However, the jury also made certain findings against the defendants on claims
relating to fraud, conspiracy, marketing to minors and smoking cessation. Notwithstanding these
findings, this portion of the trial did not determine liability as to any class member or class
representative. What primarily remained in the case was a class-wide claim that the defendants pay
for a program to help people stop smoking.
On March 31, 2004, phase two of the trial began to address only the scope and cost of smoking
cessation programs. On May 21, 2004, the jury returned a verdict in the amount of $591 million on
the classs claim for a smoking cessation program. On September 29, 2004, the defendants posted a
$50 million bond, pursuant to legislation that limits the amount of the bond to $50 million
collectively for MSA signatories, and noticed their appeal. RJR Tobacco posted $25 million, that
is, the portions for RJR Tobacco and B&W, towards the bond. On February 7, 2007, the Louisiana
Court of Appeals upheld the class certification and found the defendants responsible for funding
smoking cessation for eligible class members. The appellate court also ruled, however, that the
defendants were not liable for any post-1988 claims, rejected the award of prejudgment interest and
struck eight of the 12 components of the smoking cessation program. In particular, the appellate
court ruled that no class member, who began smoking after September 1, 1988, could receive any
relief, and that only those smokers, whose claims accrued on or before September 1, 1988, would be
eligible for the smoking cessation program. Plaintiffs have expressly represented to the trial
court that none of their claims accrued before 1988 and that the class claims did not accrue until
around 1996, when the case was filed. On March 2, 2007, the defendants application for rehearing
and clarification was denied. The defendants application for writ of certiorari with the Louisiana
Supreme Court was denied on January 7, 2008. The defendants petition for writ of certiorari with
the U.S. Supreme Court was denied on June 10, 2008. On July 21, 2008, the trial court entered an
amended judgment in the case. The court found that the defendants are jointly and severally liable
for funding the cost of a court-supervised smoking cessation program and ordered the defendants to
deposit approximately $263 million, together with interest from June 30, 2004, into a trust for the
funding of the program. The court also stated that it would favorably consider a motion to return
to defendants a portion of unused funds at the close of each program year in the event the monies
allocated for the preceding program year were not fully expended because of a reduction in class
size or underutilization by the remaining plaintiffs.
On August 27, 2008, the court denied the defendants request for permission to pursue an
appeal. On September 9, 2008, the defendants filed an emergency application for writ of mandamus
or supervisory writ with request for stay and expedited consideration. The same day, the Louisiana
Court of Appeals stayed all proceedings pending further orders of the court.
Engle Case. Trial began in July 1998 in Engle v. R. J. Reynolds Tobacco Co., a case filed in
May 1994, and pending in Circuit Court, Miami-Dade County, Florida, in which a class consisting of
Florida residents, or their survivors, alleges diseases or medical conditions caused by their
alleged addiction to cigarettes. The action was brought against the major U.S. cigarette
manufacturers, including RJR Tobacco and B&W, seeking actual damages and punitive damages in excess
of $100 billion each and the creation of a medical fund to compensate individuals for future
health-care costs. On July 7, 1999, the jury found against RJR Tobacco, B&W and the other
cigarette-manufacturer defendants in the initial phase, which included common issues related to
certain elements of liability, general causation and a potential award of, or entitlement to,
punitive damages.
The second phase of the trial, which consisted of the claims of three of the named class
representatives, began on November 1, 1999. On April 7, 2000, the jury returned a verdict against
all the defendants. It awarded plaintiff Mary Farnan $2.85 million, the estate of plaintiff Angie
Della Vecchia $4.023 million and plaintiff Frank Amodeo $5.831 million.
The trial court also ordered the jury in the second phase of the trial to determine punitive
damages, if any, on a class-wide basis. On July 14, 2000, the jury returned a punitive damages
verdict in favor of the Florida class of
approximately $145 billion against all the defendants, with approximately $36.3 billion and
$17.6 billion being assigned to RJR Tobacco and B&W, respectively.
32
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
On November 6, 2000, the trial judge denied all post-trial motions and entered judgment. In
November 2000, RJR Tobacco and B&W posted appeal bonds in the amount of $100 million each and
initiated the appeals process. On May 21, 2003, Floridas Third District Court of Appeal reversed
the trial courts final judgment and remanded the case to the Miami-Dade County Circuit Court with
instructions to decertify the class. The class appealed, and the Florida Supreme Court accepted the
case on May 12, 2004.
On July 6, 2006, the court affirmed the dismissal of the punitive damages award and
decertified the class, on a going-forward basis. The court preserved a number of class-wide
findings from Phase I of the trial, including that cigarettes can cause certain diseases, that
nicotine is addictive and that defendants placed defective and unreasonably dangerous cigarettes on
the market, and authorized former class members to avail themselves of those findings under certain
conditions in individual lawsuits, provided they commence those lawsuits within one year of the
date the courts decision became final. The court specified that the class is confined to those
Florida citizen residents who suffered or died from smoking-related illnesses that manifested
themselves on or before November 21, 1996, and that were caused by an addiction to cigarettes. In
addition, the court reinstated the compensatory damages awards of $2.85 million to Mary Farnan and
$4.023 million to Angie Della Vecchia, but ruled that the claims of Frank Amodeo were barred by the
statute of limitations. Finally, the court reversed the Third District Court of Appeals 2003
ruling that class counsels improper statements during trial required reversal.
On August 7, 2006, RJR Tobacco and the other defendants filed a rehearing motion arguing,
among other things, that the findings from the Engle trial are not sufficiently specific to serve
as the basis for further proceedings and that the Florida Supreme Courts decision denied
defendants due process. On the same day, the plaintiffs also filed a rehearing motion arguing that
some smokers who became sick after November 21, 1996, and who are therefore not class members,
should nevertheless have the statute of limitations tolled since they may have refrained from
filing suit earlier in the mistaken belief that they were Engle class members. On December 21,
2006, the Florida Supreme Court withdrew its July 6, 2006, decision and issued a revised opinion,
in which it set aside the jurys findings of a conspiracy to misrepresent and clarified that the
Engle jurys finding on express warranty were preserved for use by eligible plaintiffs. The court
also denied the plaintiffs motion and confirmed that the class was limited to those individuals
who developed alleged smoking-related illnesses that manifested themselves on or before
November 21, 1996. The court issued its mandate on January 11, 2007, which began the one-year
period for former class members to file individual lawsuits. As of October 10, 2008, 2,310
individual cases were filed in Florida as a result of the Engle decision. These cases include
approximately 8,825 plaintiffs. For further information on the individual cases, see Engle
Progeny Cases above.
On April 17, 2007, RJR Tobaccos motions for discharge of RJR Tobaccos and B&Ws civil
supersedeas bonds related to the punitive damages award were granted. During the second quarter of
2007, RJR Tobacco received the full amount of the $100 million cash collateral that it had posted.
On October 1, 2007, the defendants petition for writ of certiorari with the U.S. Supreme Court was
denied. On November 26, 2007, the defendants petition for rehearing with the U.S. Supreme Court
was denied. As a result, the verdicts in favor of Mary Farnan and Angie Della Vecchia, mentioned
above, became final. On February 8, 2008, RJR Tobacco paid approximately $5.9 million relating to
the compensatory damages verdicts mentioned above, which amount was determined using the total
amount of the verdicts together with accrued interest beginning November 7, 2000. A final
computation of interest due on those judgments will be determined by the trial court in 2008. On
May 14, 2008, the court entered an order granting the motion for discharge and return of
compensatory damages supersedeas bond. During the second quarter of 2008, RJR Tobacco received the
cash collateral of $3.8 million that it posted for the compensatory damages bond. Also on May 14,
2008, plaintiffs Mary Farnan and Ralph Della Vecchia, as representative of the estate of Angie
Della Vecchia, filed satisfactions of judgment and waived all claims for punitive damages and
acknowledged full payment in satisfaction of the November 7, 2000, amended final judgment. The
same day, the court granted the parties joint motion to sever moving plaintiffs claims.
Plaintiffs Raymond Lacey, Michael Matyi and Loren Lowery have filed new cases. Plaintiff Howard
Engle filed a stipulation for dismissal with prejudice, which the court ordered on July 2, 2008.
On July 2, 2008, plaintiff Marilyn Calhoun filed a motion for relief from judgment.
Prior to the Florida Supreme Court ruling on July 6, 2006, RJR Tobacco and/or B&W were named
as a defendant(s) in several individual cases filed by members of the Engle class. One such case,
Lukacs v. Philip Morris, Inc., a case filed in February 2001, and pending in Circuit Court,
Miami-Dade County, Florida, was tried against Philip Morris, Liggett and B&W, and resulted in a
verdict for the plaintiffs on June 11, 2002, in a personal injury action brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and B&W, seeking to recover an unspecified
amount in compensatory and punitive damages. The plaintiff, John Lukacs, alleged that his use of
the
defendants brands caused his development of bladder, throat, oral cavity and tongue cancer.
RJR Tobacco was voluntarily dismissed on May 1, 2002. The Florida state court jury awarded the
plaintiffs a total of $37.5 million in compensatory damages. The jury assigned 22.5% fault to B&W,
72.5% fault to the other defendants and 5% fault to
33
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
plaintiff John Lukacs. On April 1, 2003, the
Miami-Dade County Circuit Court granted in part the defendants motion for remittitur and reduced
the jurys award to plaintiff Yolanda Lukacs, on the loss of consortium claim, from $12.5 million
to $0.125 million decreasing the total award to $25.125 million. On August 2, 2006, the plaintiffs
filed a motion for entry of partial judgment and notice of jury trial on punitive damages. On
January 2, 2007, the defendants asked the court to set aside the jurys June 11, 2002, verdict for
the plaintiffs and to dismiss the plaintiffs punitive damages claim. On January 3, 2007, the
plaintiffs filed a motion for entry of judgment, which the court deferred until the U.S. Supreme
Court has completed its review of Engle and after further submissions by the parties. On
January 28, 2008, the defendants filed a submission asking the court to set aside the verdict and
to dismiss the case. The court granted the plaintiffs motion for entry of judgment on August 14,
2008. Pursuant to the verdict rendered, the plaintiff, Robin Lukacs, as personal representative of
the estate of John and Yolanda Lukacs, will recover the sum of $24,835,000 and interest applicable
at the yearly statutory rates from June 11, 2002. On August 25, 2008, the defendants filed a
motion for reconsideration of, or in the alternative, to alter or amend the order on the
plaintiffs motion for entry of judgment. A hearing on the motion occurred on October 21, 2008. A
decision is pending. On October 17, 2008, the plaintiff withdrew her request for punitive damages.
California Business and Professions Code Cases. On April 11, 2001, in Brown v. American
Tobacco Co., Inc., a case filed in June 1997 in Superior Court, San Diego County, California, the
court granted in part the plaintiffs motion for certification of a class composed of residents of
California who smoked at least one of the defendants cigarettes from June 10, 1993 through
April 23, 2001, and who were exposed to the defendants marketing and advertising activities in
California. The action was brought against the major U.S. cigarette manufacturers, including RJR
Tobacco and B&W, seeking to recover restitution, disgorgement of profits and other equitable relief
under California Business and Professions Code § 17200 et seq. and § 17500 et seq. Certification
was granted as to the plaintiffs claims that the defendants violated § 17200 of the California
Business and Professions Code pertaining to unfair competition. The court, however, refused to
certify the class under the California Legal Remedies Act and on the plaintiffs common law claims.
On March 7, 2005, the court granted the defendants motion to decertify the class. On September 5,
2006, the California Court of Appeal affirmed the judges order decertifying the class. On
November 1, 2006, the plaintiffs petition for review with the California Supreme Court was
granted. Supplemental briefing is complete. A decision is pending.
Lights Cases. As noted above, lights class-action cases are pending against RJR Tobacco
or B&W in Illinois (2), Missouri (2), Minnesota (2) and New York (1). The classes in these cases
generally seek to recover $50,000 to $75,000 per class member for compensatory and punitive
damages, injunctive and other forms of relief, and attorneys fees and costs from RJR Tobacco
and/or B&W. In general, the plaintiffs allege that RJR Tobacco or B&W made false and misleading
claims that lights cigarettes were lower in tar and nicotine and/or were less hazardous or less
mutagenic than other cigarettes. The cases typically are filed pursuant to state consumer
protection and related statutes.
The seminal lights class-action case involved RJR Tobaccos competitor, Philip Morris, Inc.
Trial began in Price v. Philip Morris, Inc. in January 2003. In March 2003, the trial judge entered
judgment against Philip Morris in the amount of $7.1 billion in compensatory damages and $3 billion
in punitive damages to the State of Illinois. Based on Illinois law, the bond required to stay
execution of the judgment was set initially at $12 billion. Philip Morris pursued various avenues
of relief from the $12 billion bond requirement. In December 2005, the Illinois Supreme Court
reversed the lower courts decision and sent the case back to the trial court with instructions to
dismiss the case. In December 2006, the defendants motion to dismiss and for entry of final
judgment was granted, and the case was dismissed with prejudice the same day. The plaintiffs
motion to vacate and/or withhold judgment was dismissed by the court on August 30, 2007.
In Turner v. R. J. Reynolds Tobacco Co., a case filed in February 2000 in Circuit Court,
Madison County, Illinois, a judge certified a class on November 14, 2001. On June 6, 2003, RJR
Tobacco filed a motion to stay the case pending Philip Morriss appeal of the Price v. Philip
Morris Inc. case mentioned above, which the judge denied on July 11, 2003. On October 17, 2003, the
Illinois Fifth District Court of Appeals denied RJR Tobaccos emergency stay/supremacy order
request. On November 5, 2003, the Illinois Supreme Court granted RJR Tobaccos motion for a stay
pending the courts final appeal decision in Price. On October 11, 2007, the Illinois Fifth
District Court of Appeals dismissed RJR Tobaccos appeal and remanded the case to the circuit
court. There is currently no activity in the case.
In Howard v. Brown & Williamson Tobacco Corp., another case filed in February 2000 in Circuit
Court, Madison County, Illinois, a judge certified a class on December 18, 2001. On June 6, 2003,
the trial judge issued an order staying all proceedings pending resolution of the Price v. Philip
Morris, Inc. case mentioned above. The plaintiffs
34
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
appealed this stay order to the Illinois Fifth
District Court of Appeals, which affirmed the Circuit Courts stay order on August 19, 2005.
There is currently no activity in the case.
In the event RJR Tobacco and its affiliates or indemnitees lose the Turner or Howard cases, or
one or more of the other pending lights class-action suits, RJR Tobacco could face bonding
difficulties depending upon the amount of damages ordered, if any, which could have a material
adverse effect on RJR Tobaccos, and consequently RAIs, results of operations, cash flows or
financial position.
Schwab [McLaughlin] v. Philip Morris USA, Inc., a nation-wide lights class-action, was filed
on May 11, 2004, in the U.S. District Court for the Eastern District of New York, against RJR
Tobacco and B&W, as well as other tobacco manufacturers. The plaintiffs brought the case pursuant
to RICO, challenging the practices of the defendants in connection with the manufacturing,
marketing, advertising, promotion, distribution and sale of cigarettes that were labeled as
lights or light. On September 25, 2006, the court issued its decision, among other things,
granting class certification. On November 16, 2006, the U.S. Court of Appeals for the Second
Circuit granted the defendants motions to stay the district court proceedings and for review of
the class certification ruling. On April 3, 2008, the Second Circuit decertified the class. The
case was returned to the trial court for further proceedings.
A lights class-action case is pending against each of RJR Tobacco and B&W in Missouri. In
Collora v. R. J. Reynolds Tobacco Co., a case filed in May 2000 in Circuit Court, St. Louis County,
Missouri, a judge in St. Louis certified a class on December 31, 2003. On April 9, 2007, the court
granted the plaintiffs motion to reassign Collora and the following cases to a single general
division: Craft v. Philip Morris Companies, Inc. and Black v. Brown & Williamson Tobacco Corp.,
discussed below. On April 16, 2008, the court stayed the case pending U.S. Supreme Court review in
Good v. Altria Group, Inc., a lights class action pending against Altria and Philip Morris USA.
In Black v. Brown & Williamson Tobacco Corp., a case filed in November 2000 in Circuit Court,
City of St. Louis, Missouri, B&W removed the case to the U.S. District Court for the Eastern
District of Missouri on September 23, 2005. On October 25, 2005, the plaintiffs filed a motion to
remand, which was granted on March 17, 2006. On April 16, 2008, the court stayed the case pending
U.S. Supreme Court review in Good v. Altria Group, Inc.
In Dahl v. R. J. Reynolds Tobacco Co., a case filed in April 2003, and pending in District
Court, Hennepin County, Minnesota, a judge dismissed the case on May 11, 2005, ruling the lights
claims are preempted by the Federal Cigarette Labeling and Advertising Act. On July 11, 2005, the
plaintiffs filed a notice of appeal with the Minnesota Court of Appeals for the Fourth Judicial
District. During the pendency of the appeal, RJR Tobacco removed the case to the U.S. District
Court for the District of Minnesota. On February 28, 2007, the Eighth Circuit remanded the case to
the Minnesota Court of Appeals, which on December 4, 2007, reversed the judgment in favor of the
defendants on preemption grounds and remanded the case to the District Court of Hennepin County. On
February 27, 2008, RJR Tobaccos motion to stay its January 3, 2008 petition for review until the
completion of the U.S. Supreme Court review in Good v. Altria Group, Inc. was granted.
In Thompson v. R. J. Reynolds Tobacco Co., a case filed in February 2005 in District Court,
Hennepin County, Minnesota, RJR Tobacco removed the case on September 23, 2005 to the U.S. District
Court for the District of Minnesota. On August 7, 2006, the parties filed a stipulation to stay the
case pending resolution of the appeal in Dahl v. R. J. Reynolds Tobacco Co. On October 29, 2007,
the U.S. District Court remanded the case to the District Court for Hennepin County. On February 1,
2008, the court stayed the case until the completion of the appeal in Dahl v. R. J. Reynolds
Tobacco Co. and Good v. Altria Group, Inc.
Finally, Rios v. R. J. Reynolds Tobacco Co., a case filed in February 2002 in Circuit Court,
Palm Beach County, Florida, is dormant pending plaintiffs counsels attempt to appeal the Florida
Fourth District Court of Appeals decertification in Hines v. Philip Morris, Inc., a lights
class-action case filed in February 2001 in Circuit Court, Palm Beach County, Florida against
Phillip Morris only. On January 14, 2008, the Florida Supreme Court refused to hear plaintiffs
appeal in Hines v. Philip Morris, Inc. The plaintiffs in Rios brought the action against RJR
Tobacco and RJR. On February 19, 2008, the court dismissed the case.
Other Class Actions. In Cleary v. Philip Morris, Inc., a case filed in June 1998, and pending
in Circuit Court, Cook County, Illinois, the plaintiffs filed their motion for class certification
on December 21, 2001, in an action brought against the major U.S. cigarette manufacturers,
including RJR Tobacco and B&W. The case is brought on behalf of persons who have allegedly been
injured by (1) the defendants purported conspiracy pursuant to which defendants
35
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
concealed material
facts regarding the addictive nature of nicotine, (2) the defendants alleged acts of targeting its
advertising and marketing to minors, and (3) the defendants claimed breach of the public right to
defendants compliance with the laws prohibiting the distribution of cigarettes to minors. The
plaintiffs request that the defendants be required to disgorge all profits unjustly received
through its sale of cigarettes to plaintiffs and the class, which in no event will be greater than
$75,000 per each class member, inclusive of punitive damages, interest and costs. On March 27,
2006, the court dismissed count V, public nuisance, and count VI, unjust enrichment. On July 11,
2006, the plaintiffs filed a renewed motion for class certification.
Young v. American Tobacco Co., Inc., a case filed in November 1997 in Circuit Court, Orleans
Parish, Louisiana, is an ETS class action against U.S. cigarette manufacturers, including RJR
Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, on behalf of
all residents of Louisiana who, though not themselves cigarette smokers, have been exposed to
secondhand smoke from cigarettes which were manufactured by the defendants, and who allegedly
suffered injury as a result of that exposure. The plaintiffs seek to recover an unspecified amount
of compensatory and punitive damages. On October 13, 2004, the trial court stayed this case pending
the outcome of the appeal in Scott v. American Tobacco Co., Inc., discussed above under Medical
Monitoring and Smoking Cessation Cases.
In Parsons v. A C & S, Inc., a case filed in February 1998 in Circuit Court, Ohio County, West
Virginia, the plaintiff sued asbestos manufacturers, U.S. cigarette manufacturers, including RJR
Tobacco and B&W, and parent companies of U.S. cigarette manufacturers, including RJR, seeking to
recover $1 million in compensatory and punitive damages individually and an unspecified amount for
the class in both compensatory and punitive damages. The class is brought on behalf of persons who
allegedly have personal injury claims arising from their exposure to respirable asbestos fibers and
cigarette smoke. The plaintiffs allege that Mrs. Parsons use of tobacco products and exposure to
asbestos products caused her to develop lung cancer and to become addicted to tobacco. The case has
been stayed pending a final resolution of the plaintiffs motion to refer tobacco litigation to the
judicial panel on multi-district litigation filed in In Re: Tobacco Litigation in the Supreme Court
of Appeals of West Virginia. On December 26, 2000, three defendants, Nitral Liquidators, Inc.,
Desseaux Corporation of North American and Armstrong World Industries, filed bankruptcy petitions
in the U.S. Bankruptcy Court for the District of Delaware, In re Armstrong World Industries, Inc.
Pursuant to section 362(a) of the Bankruptcy Code, Parsons is automatically stayed with respect to
all defendants.
Finally, in Jones v. American Tobacco Co., Inc., a case filed in December 1998 in Circuit
Court, Jackson County, Missouri, the defendants removed the case to the U.S. District Court for the
Western District of Missouri on February 16, 1999. The action was brought against the major
U.S. cigarette manufacturers, including RJR Tobacco and B&W, and parent companies of U.S. cigarette
manufacturers, including RJR, on behalf of tobacco product users and purchasers on behalf of all
similarly situated Missouri consumers. The plaintiffs allege that their use of the defendants
tobacco products has caused them to become addicted to nicotine. The plaintiffs seek to recover an
unspecified amount of compensatory and punitive damages. The case was remanded to the Circuit Court
on February 17, 1999. There has been limited activity in this case.
Broin Settlement. RJR Tobacco, B&W and other cigarette manufacturer defendants settled
Broin v. Philip Morris, Inc. in October 1997. This case had been brought in Florida state court on
behalf of flight attendants alleged to have suffered from diseases or ailments caused by exposure
to ETS in airplane cabins. The settlement agreement required the participating tobacco companies to
pay a total of $300 million in three annual $100 million installments, allocated among the
companies by market share, to fund research on the early detection and cure of diseases associated
with tobacco smoke. It also required those companies to pay a total of $49 million for the
plaintiffs counsels fees and expenses. RJR Tobaccos portion of these payments was approximately
$86 million; B&Ws portion of these payments was approximately $57 million. The settlement
agreement bars class members from bringing aggregate claims or obtaining punitive damages and also
bars individual claims to the extent that they are based on fraud, misrepresentation, conspiracy to
commit fraud or misrepresentation, RICO, suppression, concealment or any other alleged intentional
or willful conduct. The defendants agreed that, in any individual case brought by a class member,
the defendant will bear the burden of proof with respect to whether ETS can cause certain
specifically enumerated diseases, referred to as general causation. With respect to all other
issues relating to liability, including whether an individual plaintiffs disease was caused by his
or her exposure to ETS in airplane cabins, referred to as specific causation, the individual
plaintiff will have the burden of proof. On September 7, 1999, the Florida Supreme Court approved
the settlement. The Broin II cases, discussed above, arose out of the settlement of this case.
Health-Care Cost Recovery Cases
36
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Health-care cost recovery cases have been brought by a variety of plaintiffs. Other than
certain governmental actions, these cases largely have been unsuccessful on remoteness grounds,
which means that one who pays an injured persons medical expenses is legally too remote to
maintain an action against the person allegedly responsible for the injury.
As of October 10, 2008, four health-care cost recovery cases were pending in the United States
against RJR Tobacco, B&W, as its indemnitee, or both, as discussed below after the Master
Settlement Agreement discussion.
MSA. In June 1994, the Mississippi attorney general brought an action, Moore v. American
Tobacco Co., against various industry members, including RJR Tobacco and B&W. This case was brought
on behalf of the state to recover state funds paid for health care and other assistance to state
citizens suffering from diseases and conditions allegedly related to tobacco use. Most other
states, through their attorneys general or other state agencies, sued RJR Tobacco, B&W and other
U.S. cigarette manufacturers based on similar theories. The cigarette manufacturer defendants,
including RJR Tobacco and B&W, settled the first four of these cases scheduled for trial
Mississippi, Florida, Texas and Minnesota by separate agreements with each such state.
On November 23, 1998, the major U.S. cigarette manufacturers, including RJR Tobacco and B&W,
entered into the Master Settlement Agreement with attorneys general representing the remaining 46
states, the District of Columbia, Puerto Rico, Guam, the Virgin Islands, American Samoa and the
Northern Marianas. Effective on November 12, 1999, the Master Settlement Agreement settled all the
health-care cost recovery actions brought by, or on behalf of, the settling jurisdictions and
released various additional present and future claims.
In the settling jurisdictions, the MSA released RJR Tobacco, B&W, and their affiliates and
indemnitees, including RAI, from:
all claims of the settling states and their respective political subdivisions and other
recipients of state health-care funds, relating to past conduct arising out of the use, sale,
distribution, manufacture, development, advertising, marketing or health effects of, the
exposure to, or research, statements or warnings about, tobacco products; and
all monetary claims of the settling states and their respective political subdivisions
and other recipients of state health-care funds, relating to future conduct arising out of the
use of or exposure to, tobacco products that have been manufactured in the ordinary course of
business.
Set forth below are tables depicting the unadjusted tobacco industry settlement payment
schedule and the settlement payment schedule for RAIs operating subsidiaries under the MSA,
including the settlement agreements with the states of Mississippi, Florida, Texas and Minnesota,
and related information for 2006 and beyond:
Unadjusted Original Participating Manufacturers Settlement Payment Schedule
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 and |
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
2009 |
|
|
2010 |
|
|
2011 |
|
|
thereafter |
|
First Four States
Settlements: 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mississippi Annual Payment |
|
$ |
136 |
|
|
$ |
136 |
|
|
$ |
136 |
|
|
$ |
136 |
|
|
$ |
136 |
|
|
$ |
136 |
|
|
$ |
136 |
|
Florida Annual Payment |
|
|
440 |
|
|
|
440 |
|
|
|
440 |
|
|
|
440 |
|
|
|
440 |
|
|
|
440 |
|
|
|
440 |
|
Texas Annual Payment |
|
|
580 |
|
|
|
580 |
|
|
|
580 |
|
|
|
580 |
|
|
|
580 |
|
|
|
580 |
|
|
|
580 |
|
Minnesota Annual
Payment |
|
|
204 |
|
|
|
204 |
|
|
|
204 |
|
|
|
204 |
|
|
|
204 |
|
|
|
204 |
|
|
|
204 |
|
Remaining States Settlement: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual Payments 1 |
|
|
7,004 |
|
|
|
7,004 |
|
|
|
8,004 |
|
|
|
8,004 |
|
|
|
8,004 |
|
|
|
8,004 |
|
|
|
8,004 |
|
Base Foundation Funding |
|
|
25 |
|
|
|
25 |
|
|
|
25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Growers Trust 2 |
|
|
500 |
|
|
|
500 |
|
|
|
500 |
|
|
|
295 |
|
|
|
295 |
|
|
|
|
|
|
|
|
|
37
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 and |
|
|
|
2006 |
|
|
2007 |
|
|
2008 |
|
|
2009 |
|
|
2010 |
|
|
2011 |
|
|
thereafter |
|
Offset by federal tobacco
buyout 2 |
|
|
(500 |
) |
|
|
(500 |
) |
|
|
(500 |
) |
|
|
(295 |
) |
|
|
(295 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
8,389 |
|
|
$ |
8,389 |
|
|
$ |
9,389 |
|
|
$ |
9,364 |
|
|
$ |
9,364 |
|
|
$ |
9,364 |
|
|
$ |
9,364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RAIs Operating Subsidiaries Settlement Expenses and Payment Schedule
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlement expenses |
|
$ |
2,611 |
|
|
$ |
2,821 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlement cash payments |
|
$ |
2,631 |
|
|
$ |
2,616 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected settlement
expenses |
|
|
|
|
|
|
|
|
|
$ |
>2,700 |
|
|
$ |
>2,600 |
|
|
$ |
>2,600 |
|
|
$ |
>2,500 |
|
|
$ |
>2,500 |
|
Projected settlement
cash payments |
|
|
|
|
|
|
|
|
|
$ |
>2,800 |
|
|
$ |
>2,700 |
|
|
$ |
>2,600 |
|
|
$ |
>2,500 |
|
|
$ |
>2,500 |
|
|
|
|
1 |
|
Subject to adjustments for changes in sales volume,
inflation and other factors. All payments are to be
allocated among the companies on the basis of relative
market share. |
|
2 |
|
The Growers Trust payments scheduled to expire in 2010 will
be offset by obligations resulting from the federal tobacco
buyout legislation, not included in this table, signed in
October 2004. See Tobacco Buyout Legislation and Related
Litigation. |
The MSA also contains provisions restricting the marketing of tobacco products. Among these
provisions are restrictions or prohibitions on the use of cartoon characters, brand-name
sponsorships, apparel and other merchandise, outdoor and transit advertising, payments for product
placement, free sampling and lobbying. Furthermore, the MSA required the dissolution of three
industry-sponsored research and trade organizations.
The MSA has materially adversely affected RJR Tobaccos shipment volumes. RAI believes that
these settlement obligations may materially adversely affect the results of operations, cash flows
or financial position of RAI and RJR Tobacco in future periods. The degree of the adverse impact
will depend, among other things, on the rate of decline in U.S. cigarette sales in the premium and
value categories, RJR Tobaccos share of the domestic premium and value cigarette categories, and
the effect of any resulting cost advantage of manufacturers not subject to the MSA.
Department of Justice Case. On September 22, 1999, the U.S. Department of Justice brought an
action against RJR Tobacco, B&W and other tobacco companies in the U.S. District Court for the
District of Columbia. The government initially sought to recover federal funds expended by the
federal government in providing health care to smokers who developed diseases and injuries alleged
to be smoking-related. In addition, the government sought, pursuant to the civil provisions of
RICO, disgorgement of profits the government contends were earned as a consequence of a RICO
racketeering enterprise. In September 2000, the court dismissed the governments claims asserted
under the Medical Care Recovery Act as well as those under the Medicare Secondary Payer provisions
of the Social Security Act, but did not dismiss the RICO claims. In February 2005, the U.S. Court
of Appeals for the District of Columbia ruled that disgorgement is not an available remedy in this
case. The governments petition for writ of certiorari with the U.S. Supreme Court was denied in
October 2005. The non-jury, bench trial began in September 2004, and closing arguments concluded on
June 10, 2005.
On August 17, 2006, the court found certain defendants, including RJR Tobacco and B&W, liable
for the RICO claims, but did not impose any direct financial penalties. The court instead enjoined
the defendants from committing future racketeering acts, participating in certain trade
organizations, making misrepresentations concerning smoking and health and youth marketing, and
using certain brand descriptors such as low tar, light, ultra light, mild and natural.
The court also ordered defendants to issue corrective communications on five subjects, including
smoking and health and addiction, and to comply with further undertakings, including maintaining
web sites of historical corporate documents and disseminating certain marketing information on a
confidential basis to the government. In addition, the court placed restrictions on the ability of
the defendants to dispose of certain assets for use in the United States, unless the transferee
agrees to abide by the terms of the courts order, and ordered the defendants to reimburse the U.S.
Department of Justice its taxable costs incurred in connection with the case.
Certain defendants, including RJR Tobacco, filed notices of appeal to the U.S. Court of
Appeals for the District of Columbia on September 11, 2006. The government filed its notice of
appeal on October 16, 2006. In addition, the
38
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
defendants, including RJR Tobacco, filed joint motions asking the district court to clarify
and to stay its order pending the defendants appeal. On September 28, 2006, the district court
denied the defendants motion to stay. On September 29, 2006, the defendants, including RJR
Tobacco, filed a motion asking the court of appeals to stay the district courts order pending the
defendants appeal. The court granted the motion on October 31, 2006.
On November 28, 2006, the court of appeals stayed the appeals pending the trial courts ruling
on the defendants motion for clarification. The defendants motion for clarification was granted
in part and denied in part on March 16, 2007. The defendants motion as to the meaning and
applicability of the general injunctive relief of the August 17, 2006 order was denied. The request
for clarification as to the scope of the provisions in the order prohibiting the use of descriptors
and requiring corrective statements at retail point of sale was granted. The court also ruled that
the provisions prohibiting the use of express or implied health messages or descriptors do apply to
the actions of the defendants taken outside of the United States. Oral argument occurred on
October 14, 2008. A decision is pending.
The stay of the district courts order suspends the enforcement of the order pending the
outcome of the defendants appeal. RJR Tobacco does not know the timing of an appellate decision
or, if the order is affirmed, the compliance deadlines that will be imposed. If the order is
affirmed without modification, then RJR Tobacco believes that certain provisions of the order, such
as the ban on certain brand style descriptors and the corrective advertising requirements, would
have adverse business effects on the marketing of RJR Tobaccos current product portfolio and that
such effects could be material. Also, if the order is affirmed, then RJR Tobacco would incur costs
in connection with complying with the order, such as the costs of changing its current packaging to
conform to the ban on certain brand descriptors and the costs of corrective communications. Given
the uncertainty over the timing and substance of an appellate decision, RJR Tobacco currently is
not able to estimate reasonably the costs of such compliance. Moreover, if the order were
ultimately affirmed and RJR Tobacco were to fail to comply with the order on a timely basis, then
RJR Tobacco could be subject to substantial monetary fines or penalties.
International Cases. A number of foreign countries have filed suit against RJR Tobacco, B&W
and other tobacco industry defendants to recover funds for health-care, medical and other
assistance paid by those foreign governments to their citizens. No such cases currently are pending
in the United States against RJR Tobacco and its affiliates or indemnitees.
Three health-care reimbursement cases are pending against RJR Tobacco or B&W outside the
United States, two in Canada and one in Israel. Pursuant to the terms of the 1999 sale of RJR
Tobaccos international tobacco business, JTI assumed RJR Tobaccos liability, if any, in the
health-care cost recovery cases brought by foreign countries.
On November 12, 1998, the government of British Columbia enacted legislation creating a civil
cause of action permitting the government to recover the costs of health-care benefits incurred for
B.C. residents arising from tobacco-related disease. The governments subsequent suit against
Canadian defendants and foreign defendants, including RJR Tobacco was dismissed in February 2000,
when the B.C. Supreme Court ruled that the legislation was unconstitutional and set aside service
ex juris against the foreign defendants for that reason. The government then enacted a revised
statute and brought a new action, filed in January 2001, and pending in Supreme Court, British
Columbia. The plaintiff seeks to recover the present value of the total expenditure by the
government for health-care benefits provided for insured persons resulting from tobacco-related
disease or the risk of tobacco-related disease, the present value of the estimated total
expenditure by the government for health-care benefits that reasonably could be expected to be
provided for those insured persons resulting from tobacco-related disease or the risk of
tobacco-related disease, court ordered interest, and costs, or in the alternative, special or
increased costs. The plaintiff alleges that the defendants are liable under the following theories:
defective product, failure to warn, sale of cigarettes to children and adolescents, strict
liability, deceit and misrepresentation, and violation of trade practice and competition acts.
Trial is scheduled for September 6, 2010.
On September 1, 1998, the General Health Services filed a statement of claim against certain
cigarette manufacturers, including RJR Tobacco and B&W, in the District Court of Jerusalem, Israel.
The plaintiff seeks to recover the past and future value of the total expenditures for health-care
services provided to residents of Israel resulting from tobacco-related disease, court ordered
interest for past expenditures from date of filing the statement of claim, increased and/or
punitive and/or exemplary damages and costs. The plaintiff alleges that the defendants are liable
under the following theories: negligence, public nuisance, fraud, misleading advertisement,
defective product, failure to warn, sale of cigarettes to children and adolescents, strict
liability, deceit, concealment, misrepresentation and conspiracy. In 2002, the plaintiff obtained
leave to serve RJR Tobacco and B&W outside the jurisdiction. On behalf of
39
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
RJR Tobacco, JTI filed a motion challenging the grant of leave, which was denied. JTI appealed
the decision to the Supreme Court of Israel. A hearing occurred on March 28, 2005. A decision is
pending.
On March 13, 2008, a case was filed on behalf of Her Majesty the Queen in Right of the
Province of New Brunswick, Canada against certain cigarette manufacturers, including RJR Tobacco,
in the Trial Division in the Court of Queens Bench of New Brunswick. The plaintiff seeks to
recover the present value of total expenditures by the Province for health care benefits resulting
or expected to result from tobacco-related diseases or risk of tobacco-related diseases, costs or
special or increased costs. The plaintiff alleges that the defendants are liable under the
following theories: deceit and misrepresentation, failure to warn, promotion of cigarettes to
children and adolescents, negligent design and manufacture, breaches of other common law, equitable
and statutory duties and obligations and conspiracy and concerted action in Canada. On June 26,
2008, RJR Tobacco filed a notice of intent to defend.
Native American Tribe Cases. As of October 10, 2008, one Native American tribe case was
pending before a tribal court in South Dakota against RJR Tobacco and B&W, Crow Creek Sioux Tribe
v. American Tobacco Co., a case filed in September 1997 in Tribal Court, Crow Creek Sioux, South
Dakota. The plaintiffs seek to recover actual and punitive damages, restitution, funding of a
clinical cessation program, funding of a corrective public education program, and disgorgement of
unjust profits from sales to minors. The plaintiffs claim that the defendants are liable under the
following theories: unlawful marketing and targeting of minors, contributing to the delinquency of
minors, unfair and deceptive acts or practices, unreasonable restraint of trade and unfair method
of competition, negligence, negligence per se, conspiracy and restitution of unjust enrichment. The
case is dormant.
Hospital Cases. As of October 10, 2008, one case brought by hospitals was pending against
cigarette manufacturers, including RJR Tobacco and B&W: City of St. Louis v. American Tobacco Co.,
Inc., filed in November 1998, and pending in the Circuit Court of the City of St. Louis, Missouri.
This case seeks recovery of uncompensated, unreimbursed health-care costs expended or to be
expended by hospitals on behalf of patients who suffer, or have suffered, from illnesses allegedly
resulting from the use of cigarettes. On June 28, 2005, the court granted the defendants motion
for summary judgment as to claims for damages which accrued prior to November 16, 1993. The claims
for damages which accrued after November 16, 1993, are still pending. The case is in discovery.
Trial is scheduled for January 11, 2010. On July 11, 2008, certain defendants, including RJR
Tobacco and B&W, filed a motion for summary judgment based on the plaintiffs lack of proof linking
the defendants allegedly wrongful conduct with the claimed damages.
Other Cases. On May 20, 2008, the National Committee to Preserve Social Security and Medicare
filed a case against the major U.S. cigarette manufacturers, including RJR Tobacco, in the U.S.
District Court for the Eastern District of New York. The case seeks to recover twice the amount
paid by Medicare for the health care services provided to Medicare beneficiaries to treat their
diseases attributable to smoking the defendants cigarettes from May 21, 2002 to the present, for
which treatment the defendants allegedly were required or responsible...to make payment under the
Medicare Secondary Payer Act. On July 21, 2008, the defendants filed a motion to dismiss for
failure to state a claim and lack of standing. On the same day, the plaintiffs filed a motion for
summary judgment as to liability under the Federal Rules of Civil Procedure 56(d)(2).
MSA-Enforcement and Validity
As of October 10, 2008, there were 60 cases concerning the enforcement, validity or
interpretation of the MSA in which RJR Tobacco or B&W is a party. This number includes those cases,
discussed below, relating to disputed payments under the MSA.
On March 28, 2005, the National Association of Attorneys General, referred to as NAAG, sent a
notice, signed by 40 Attorneys General that one or more of the states intended to initiate
proceedings against RJR Tobacco for violating Section III (r) of the MSA, the various Consent
Decrees implementing the MSA and/or consumer fraud statutes in various states, all in connection
with RJR Tobaccos advertisements for Eclipse cigarettes. After a June 2005 meeting between
representatives of RJR Tobacco and NAAG, the Vermont Attorney General filed suit in July 2005, in
the Vermont Superior Court, Chittenden County, alleging that certain advertising for the Eclipse
cigarette brand violated both the MSA and the Vermont Consumer Fraud Statute. The State of Vermont
is seeking declaratory, injunctive, and monetary relief. Trial in this action began October 6,
2008, and is estimated to last four to six weeks.
On April 13, 2005, the Mississippi Attorney General notified B&W of its intent to seek
approximately $3.9 million in additional payments under the Mississippi Settlement Agreement. The
Mississippi Attorney General asserts that B&W failed to report in its net operating profit or its
shipments cigarettes manufactured by B&W under
40
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
contract for Star Tobacco or its parent, Star Scientific, Inc. On April 28, 2005, B&W advised the state
that it did not owe the state any money. On August 11, 2005, the Mississippi Attorney General filed
in the Chancery Court of Jackson County, Mississippi, a Notice of Violation, Motion to Enforce
Settlement Agreement, and Request for an Accounting by Defendant Brown & Williamson Holdings, Inc.,
formerly known as Brown & Williamson Tobacco Corporation. In this filing, Mississippi estimated
that its damages exceeded $5.0 million. This matter is currently in the discovery phase.
On May 17, 2006, the State of Florida filed a motion, in the Circuit Court of the Fifteenth
Judicial Circuit, in and for Palm Beach County, Florida, to enforce the Settlement Agreement, for
an Accounting by Brown & Williamson Holdings, Inc., and for an Order of Contempt, raising
substantially the same issues as raised by the Mississippi Attorney General and seeking
approximately $12.4 million in additional payments under the Florida Settlement Agreement, as well
as $17.0 million in interest payments. Discovery in this matter is underway.
In December, 2007, the states of California, Connecticut, Illinois, Maine, Maryland, New York,
Ohio, Pennsylvania and Washington sued RJR Tobacco in their respective state courts under the MSA
consent decree claiming, among other things, that a Rolling Stone magazine editorial section and an
adjacent Camel Farm advertisement included cartoon images prohibited under the MSA. The states are
seeking monetary sanctions, injunctive relief and attorneys fees and costs. A hearing on the State
of Ohios claims occurred on January 17, 2008 and February 8, 2008. The judge issued his opinion on
July 30, 2008, and found that while RJR Tobacco did not violate the cartoon ban in the consent
decree in its own Rolling Stone advertisement, RJR Tobacco did violate the consent decree through
its indirect use of cartoon images found in the Rolling Stone editorial. No monetary sanctions or
other penalties were awarded to the State. The States attorneys fees and costs will be
determined at a later hearing date. RJR Tobacco has filed a notice of appeal. After a similar
hearing in Washington in May 2008, the court ruled in favor of RJR Tobacco and held that the
company had not violated the ban on cartoons. Activity continues in the remaining states. In
Stewart v. RJR Tobacco, two artists groups filed a class-action lawsuit on December 17, 2007, in
California state court against RJR Tobacco and Rolling Stones publisher, Wenner Media, claiming
their mention in the editorial section violated their right of publicity. The plaintiffs seek to
recover actual damages in the amount of $750 per violation, per plaintiff and per each class member
and punitive damages in an unspecified amount.
NPM Adjustment. The MSA includes an adjustment, referred to as an NPM Adjustment, that
potentially reduces the annual payment obligations of RJR Tobacco and the other participating
manufacturers, with all participating manufacturers referred to as PMs. Certain requirements must
be satisfied before the NPM Adjustment for a given year is available: (1) an independent auditor
designated under the MSA must determine that the PMs have experienced a market share loss beyond a
triggering threshold to those manufacturers that do not participate in the MSA, such
non-participating manufacturers referred to as NPMs, and (2) in a binding arbitration proceeding, a
firm of independent economic consultants must find that the disadvantages of the MSA were a
significant factor contributing to the loss. When these two requirements are satisfied, the MSA
provides that the NPM Adjustment applies to reduce the annual payment obligation of the PMs.
However, an individual settling state may avoid its share of the NPM Adjustment if it had in place
and diligently enforced during the entirety of the relevant year a Qualifying Statute that
imposes escrow obligations on NPMs that are comparable to what the NPMs would have owed if they had
joined the MSA. In such event, the states share of the NPM Adjustment is reallocated to other
settling states, if any, that did not have in place and diligently enforce a Qualifying Statute.
NPM Adjustment Claim for 2003. For 2003, the MSA independent auditor determined that the PMs
suffered a market share loss sufficient to trigger an NPM Adjustment. In March 2006, the
independent economic consulting firm issued a final, non-appealable determination that the
disadvantages of the MSA were a significant factor contributing to the 2003 market share loss.
Based on these determinations, on April 17, 2006, RJR Tobacco placed approximately $647 million of
its MSA payment into a disputed payments account, in accordance with a procedure established by the
MSA. That amount represented RJR Tobaccos share of the 2003 NPM Adjustment as calculated by the
MSA independent auditor. On March 28, 2007, the independent auditor issued revised calculations
that reduced RJR Tobaccos share of the NPM Adjustment for 2003 to approximately $615 million. As a
result, on April 19, 2007, RJR Tobacco instructed the independent auditor to release to the
settling states approximately $32 million from the disputed payments account.
Following RJR Tobaccos payment of a portion of its 2006 MSA payment into the disputed
payments account, 37 of the settling states filed legal proceedings in their respective MSA courts
seeking declaratory orders that they diligently enforced their Qualifying Statutes during 2003
and/or orders compelling RJR Tobacco and the other PMs that placed money in the disputed payments
account to pay the disputed amounts to the settling states. In response, RJR
41
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Tobacco and other PMs,
pursuant to the MSAs arbitration provisions, moved to compel arbitration of the parties dispute concerning the 2003 NPM Adjustment, including the states diligent enforcement claims,
before a single, nationwide arbitration panel of three former federal judges. The settling states
opposed these motions, arguing, among other things, that the issue of diligent enforcement must be
resolved by MSA courts in each of the 52 settling states and territories.
As of October 10, 2008, all 48 courts that had addressed the question whether the dispute
concerning the 2003 NPM Adjustment is arbitrable had ruled that arbitration is required under the
MSA. In 42 states, the orders compelling arbitration are final and/or non-appealable.
At this time, it is not possible to estimate a date by which arbitration of the dispute
concerning the 2003 NPM Adjustment will commence or how many states will ultimately participate.
NPM Adjustment Claim for 2004. During 2006, proceedings were initiated with respect to an NPM
Adjustment for 2004. The MSA independent auditor again determined that the PMs had suffered a
market share loss sufficient to trigger an NPM Adjustment for 2004. On April 17, 2006, RJR Tobacco
and other PMs initiated the significant factor proceeding before the independent economic
consultant called for under the MSA with respect to the 2004 NPM Adjustment. On February 12, 2007,
the independent economic consulting firm issued a final, non-appealable determination that the
disadvantages of the MSA were a significant factor contributing to the 2004 market share loss. On
April 16, 2007, RJR Tobacco placed approximately $561 million of its 2007 MSA payment into the
disputed payments account. That amount represented RJR Tobaccos share of the 2004 NPM Adjustment
as calculated by the MSA independent auditor.
NPM Adjustment Claim for 2005. During 2007, proceedings were initiated with respect to an NPM
Adjustment for 2005. The MSA independent auditor again determined that the PMs had suffered a
market share loss sufficient to trigger an NPM Adjustment for 2005. On April 18, 2007, RJR Tobacco
and other PMs initiated the significant factor proceeding called for under the MSA with respect
to the 2005 NPM Adjustment. On February 7, 2008, the independent economic consulting firm issued a
final, non-appealable determination that the disadvantages of the MSA were a significant factor
contributing to the 2005 market share loss. On April 15, 2008, RJR Tobacco placed approximately
$431 million of its 2008 MSA payment into the disputed payments account. That amount represented
RJR Tobaccos share of the 2005 NPM Adjustment as calculated by the MSA independent auditor, net of
certain slight adjustments to reflect revised independent auditor calculations of RJR Tobaccos
share of the 2003 and 2004 NPM Adjustments.
NPM Adjustment Claim for 2006. During 2008, proceedings were initiated with respect to an NPM
Adjustment for 2006. The MSA independent auditor again determined that the PMs had suffered a
market share loss sufficient to trigger an NPM Adjustment for 2006. On April 29, 2008, RJR Tobacco
and other PMs initiated the significant factor proceeding called for under the MSA with respect
to the 2006 NPM Adjustment. On October 6, 2008, RJR Tobacco filed its initial briefs and expert
reports in connection with the significant factor proceeding.
Due to the uncertainty over the final resolution of the NPM Adjustment claims asserted by RJR
Tobacco, no assurances can be made related to the amounts, if any, that will be realized.
Antitrust Cases
A number of tobacco wholesalers and consumers have sued U.S. cigarette manufacturers,
including RJR Tobacco and B&W, in federal and state courts, alleging that cigarette manufacturers
combined and conspired to set the price of cigarettes in violation of antitrust statutes and
various state unfair business practices statutes. In these cases, the plaintiffs asked the court to
certify the lawsuits as class actions on behalf of other persons who purchased cigarettes directly
or indirectly from one or more of the defendants. As of October 10, 2008, all of the federal and
state court cases on behalf of indirect purchasers have been dismissed, except for one state court
case pending in each of Kansas and in New Mexico.
In Smith v. Philip Morris Cos., Inc., a case filed in February 2000, and pending in District
Court, Seward County, Kansas, the court granted class certification on November 15, 2001, in an
action brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and
the parent companies of the major U.S. cigarette manufacturers, including RJR, seeking to recover
an unspecified amount in actual and punitive damages. The plaintiffs
42
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
allege that the defendants
participated in a conspiracy to fix or maintain the price of cigarettes sold in the United States.
The parties currently are engaged in discovery.
In Romero v. Philip Morris Cos., Inc., a case filed in April 2000 in District Court, Rio
Arriba County, New Mexico, the court granted class certification on May 14, 2003, in an action
brought against the major U.S. cigarette manufacturers, including RJR Tobacco and B&W, and the
parent companies of the major U.S. cigarette manufacturers, including RJR, seeking to recover an
amount not to exceed $74,000 per class member in actual and punitive damages, exclusive of interest
and costs. The plaintiffs allege that the defendants conspired to fix, raise, advance and/or
stabilize prices for cigarettes in the State of New Mexico from at least as early as January 1,
1998, through the present. On June 30, 2006, the court granted the defendants motion for summary
judgment. On August 14, 2006, the plaintiff appealed to the New Mexico Court of Appeals. The
parties completed briefing of the issues on appeal on August 27, 2007, and await a decision.
Other Litigation and Developments
By purchase agreement dated May 12, 1999, referred to as the 1999 Purchase Agreement, RJR and
RJR Tobacco sold the international tobacco business to JTI. RJR and RJR Tobacco retained certain
liabilities relating to the activities of Northern Brands, including those relating to a 1998
guilty plea entered in the U.S. District Court for the Northern District of New York, as well as an
investigation conducted by the Royal Canadian Mounted Police, referred to as RCMP, for possible
violations of Canadian law related to the activities that led to the Northern Brands guilty plea
and certain conduct by Stanley Smith, a former executive of RJR-Macdonald, Inc., referred to as
RJR-MI, which led to the termination of his severance agreement. Under its reading of the
indemnification provisions of the 1999 Purchase Agreement, JTI has requested indemnification for
any damages arising out of the matters described below.
|
|
|
In February 2003, the RCMP filed criminal charges in the Province of Ontario
against, and purported to serve summonses on, JTI-Macdonald Corp., referred to as
JTI-MC, Northern Brands, R. J. Reynolds Tobacco International, Inc., referred to as
RJR-TI, R. J. Reynolds Tobacco Co., Puerto Rico, referred to as RJR-PR, and eight
individuals associated with RJR-MI and/or RJR-TI during the period January 1, 1991,
through December 31, 1996. The charges allege fraud and conspiracy to defraud Canada
and the Provinces of Ontario and Quebec in connection with the purchase, sale, export,
import and/or re-export of cigarettes and/or fine cut tobacco. In October 2003,
Northern Brands, RJR-TI and RJR-PR each challenged both the propriety of the service of
the summonses and the jurisdiction of the court. On February 9, 2004, the Superior
Court of Justice ruled in favor of these companies. The government filed a notice of
appeal from that ruling on February 18, 2004, but did not perfect its appeal until May
8, 2007. At the oral argument on October 29, 2007, the Court of Appeal announced a
unanimous decision in favor of the companies position and dismissed the governments
appeal. A final written order dismissing the appeal was entered by the Court of Appeal
on December 3, 2007. |
A preliminary hearing was commenced on April 11, 2005, for the purpose of
determining whether the Canadian prosecutor had sufficient evidence supporting the
criminal charges to justify a trial of the defendants that had been properly served to
date. On May 30, 2007, the court announced its decision to issue an order committing two
of the accused, JTI-MC and Edward Lang, to stand trial on the charges filed in February
2003 and discharging the other six accused. JTI-MC and Mr. Lang separately filed papers
seeking an order quashing the order committing them to stand trial, and the government
filed papers seeking an order quashing the order discharging six of the accused. On
December 19, 2007, JTI-MC abandoned its effort to have the order committing it to trial
quashed. On February 19, 2008, the Superior Court of Justice in Ontario denied Mr.
Langs request to quash the order committing him to trial. The court granted the
governments request to quash the order discharging six individuals and remanded the
matter to the preliminary hearing judge for reconsideration. No appeals were taken from
that decision.
On July 31, 2007, each of the accused companies, including RJR-TI, RJR-PR and
Northern Brands, and each of the remaining seven accused individuals were given notice
that the Canadian prosecutor had requested the Attorney General of Ontario to consent to
the issuance of preferred indictments against each of them. RJR-TI, RJR-PR and Northern
Brands as well as the other accused filed written submissions with the Attorney General
opposing the issuance of the indictments against them. On October 31, 2007, the office
of the Attorney General of Ontario confirmed that the prosecutors request for preferred
indictments against RJR-TI, RJR-PR and Northern Brands had been denied at that point in
time.
43
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
In July 2003, a Statement of Claim was filed against JTI-MC and others in the
Superior Court of Justice, Ontario, Canada by Leslie and Kathleen Thompson. Mr.
Thompson is a former employee of Northern
Brands and JTI-MCs predecessor, RJR-MI. Mr. and Mrs. Thompson have alleged breach of
contract, breach of fiduciary duty and negligent misrepresentation, among other claims.
They are seeking lost wages and other damages, including punitive damages, in an
aggregate amount exceeding $12 million. |
|
|
|
|
On September 18, 2003, RJR, RJR Tobacco, RJR-TI, RJR-PR, and Northern Brands
were served with a Statement of Claim filed in August 2003 by the Attorney General of
Canada in the Superior Court of Justice, Ontario, Canada. Also named as defendants are
JTI and a number of its affiliates. The Statement of Claim seeks to recover taxes and
duties allegedly not paid as a result of cigarette smuggling and related activities. As
filed, the Attorney Generals Statement of Claim seeks to recover $1.5 billion Canadian
in compensatory damages and $50 million Canadian in punitive damages, as well as
equitable and other forms of relief. However, in the Companies Creditor Arrangement
Act proceeding described below, the Attorney General amended and increased Canadas
claim to $4.3 billion Canadian. The parties have agreed to a stay of all proceedings
pending in the Superior Court of Justice, subject to notice by one of the parties that
it wishes to terminate the stay. On January 19, 2007, the court ordered that the case
be scheduled for trial no later than December 31, 2008, subject to further order of the
court. |
|
|
|
|
In August 2004, the Quebec Ministry of Revenue (1) issued a tax assessment,
covering the period January 1, 1990, through December 31, 1998, against JTI-MC for
alleged unpaid duties, penalties and interest in an amount of about $1.36 billion
Canadian; (2) issued an order for the immediate payment of that amount; and (3)
obtained an ex parte judgment to enforce the payment of that amount. On August 24,
2004, JTI-MC applied for protection under the Companies Creditor Arrangement Act in
the Ontario Superior Court of Justice, Toronto, Canada, referred to as CCAA
Proceedings, and the court entered an order staying the Quebec Ministry of Revenues
proceedings as well as other claims and proceedings against JTI-MC. The stay has been
extended to July 21, 2009. In November 2004, JTI-MC filed a motion in the Superior
Court, Province of Quebec, District of Montreal, seeking a declaratory judgment to set
aside, annul and declare inoperative the tax assessment and all ancillary enforcement
measures and to require the Quebec Minister of Revenue to reimburse JTI-MC for funds
unduly appropriated, along with interest and other relief. Pursuant to a court-imposed
deadline, Canada and several Provinces filed Crown claims against JTI-MC in the CCAA
Proceedings in the following amounts: Canada, $4.3 billion Canadian; Ontario, $1.5
billion Canadian; New Brunswick, $1.5 billion Canadian; Quebec, $1.4 billion Canadian;
British Columbia, $450 million Canadian; Nova Scotia, $326 million Canadian; Prince
Edward Island, $75 million Canadian and Manitoba, $23 million Canadian. In the CCAA
Proceedings, the Canadian federal government and some of the provincial governments
have asserted that they can make the same tax and related claims against RJR and
certain of its subsidiaries, including RJR Tobacco. To date, none of those provincial
governments have filed and served RJR or any of its affiliates with a formal Statement
of Claim like the Canadian federal government did in August and September 2003.
Discussions regarding possible agreed-upon procedures for adjudicating and appellate
review of the claims and defenses asserted in the CCAA Proceedings are taking place.
Without waiving any of their rights and defenses, RJR and certain of its subsidiaries,
including RJR Tobacco, may participate in those proceedings, if procedures are agreed
upon, approved by the court and implemented. |
|
|
|
|
On November 17, 2004, a Statement of Claim was filed against JTI-MC in the
Supreme Court of British Columbia by Stanley Smith, a former executive of RJR-MI, for
alleged breach of contract and other legal theories. Mr. Smith is claiming $840,000
Canadian for salary allegedly owed under his severance agreement with RJR-MI, as well
as other unspecified compensatory and punitive damages. |
|
|
|
|
In a letter dated March 31, 2006, counsel for JTI stated that JTI would be
seeking indemnification under the 1999 Purchase Agreement for any damages it may incur
or may have incurred arising out of a Southern District of New York grand jury
investigation, a now-terminated Eastern District of North Carolina grand jury
investigation, and various actions filed by the European Community and others in the
U.S. District Court for the Eastern District of New York, referred to as the EDNY,
against RJR Tobacco and certain of its affiliates on November 3, 2000, August 6, 2001,
and (as discussed in greater detail below) October 30, 2002, and against JTI on January
11, 2002. |
|
|
|
|
On December 14, 2007, the European Community and 26 of its member states entered into a
series of agreements with JTI and/or its subsidiaries regarding, principally, contraband
and counterfeit cigarettes |
44
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
bearing JTI trademarks in the European Community.
Collectively, those agreements resolved, in pertinent part, all claims that the European
Community and the member states either had or might have had prior to
December 14, 2007 against JTI and/or its subsidiaries with respect to any such
contraband and counterfeit cigarettes and claims for which JTI could become the subject
of a claim for indemnity by RJR under the terms of the 1999 Purchase Agreement. In
addition, the European Community and signatory member states agreed to release RJR and
its affiliates from those same claims. |
Although RJR and RJR Tobacco recognize that, under certain circumstances, they may have
indemnification obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree
with JTI as to whether the circumstances relating to any of these matters give rise to any
indemnification obligation by RJR and RJR Tobacco. RJR and RJR Tobacco conveyed their position to
JTI, and the parties have agreed to resolve their differences at a later time. In the interim, RJR
and RJR Tobacco are paying defense costs and expenses in connection with certain of the Canadian
litigation described above. Indemnification to JTI was $10 million in the first nine months of 2008
and $6 million in the first nine months of 2007. In addition, RJR has liabilities of $94 million
that were recorded in 1999 in connection with certain of the indemnification claims asserted by
JTI. For further information on the JTI indemnification claims, see Other Contingencies below.
On May 15, 2007, RAI was served with a subpoena issued by the U.S. District Court for the
Middle District of North Carolina. The subpoena seeks documents relating primarily to the business
of RJR-TI regarding the manufacture and sale of Canadian brand cigarettes during the period 1990
through 1996. The subpoena was issued at the request of Canada pursuant to a Mutual Legal
Assistance Treaty between the United States and Canada.
On October 30, 2002, the European Community and ten of its member states filed a complaint in
the EDNY against RJR, RJR Tobacco and several currently and formerly related companies. The
complaint contains many of the same or similar allegations found in an earlier complaint, now
dismissed, filed in August 2001 and also alleges that the defendants, together with certain
identified and unidentified persons, engaged in money laundering and other conduct violating civil
RICO and a variety of common laws. The complaint also alleges that the defendants manufactured
cigarettes that were eventually sold in Iraq in violation of U.S. sanctions. The plaintiffs seek
compensatory, punitive and treble damages among other types of relief. This matter has been stayed.
The European Community and the member states have recently suggested that they may file similar
claims regarding the U.S. tobacco business of B&W, which was acquired in 2004 in the B&W business
combination.
RJR Tobacco was named a defendant in a number of lawsuits originally filed in various federal
courts in 2002 by plaintiffs alleging descent from persons held in slavery in the United States and
seeking damages from numerous corporate defendants for having allegedly profited from historic
slavery. In October 2002, those actions were consolidated by the Judicial Panel on Multidistrict
Litigation for pre-trial proceedings in the U.S. District Court for the Northern District of
Illinois. On July 6, 2005, the court dismissed the entire action on a variety of grounds. On
December 13, 2006, the U.S. Court of Appeals for the Seventh Circuit affirmed dismissal in all
respects but one. It remanded some cases for further proceedings limited to the claims by some
plaintiffs that present-day representations about historic ties to slavery by some defendants
violated state consumer fraud laws. On October 1, 2007, the U.S. Supreme Court denied plaintiffs
petition for a writ of certiorari. The plaintiffs in all but one of the cases either voluntarily
dismissed their claims or otherwise abandoned the litigation. On August 11, 2008, the district
court granted the defendants motion to dismiss the remaining plaintiffs and terminated the case.
However, the motion to dismiss excluded plaintiffs Timothy and Chester Hurdle, who filed a third
amended complaint on July 31, 2007. No ruling was made on the motion to dismiss the Hurdle
plaintiffs and the plaintiffs named in the third amended complaint.
On May 23, 2001, and July 30, 2002, Star Scientific, Inc., referred to as Star, filed two
patent infringement actions, which have been consolidated, against RJR Tobacco in the U.S. District
Court for the District of Maryland. Both patents at issue are entitled Method of Treating Tobacco
to Reduce Nitrosamine Content, and Products Produced Thereby, and bear U.S. Patent Nos. 6,202,649
and 6,425,401. The plaintiffs sought: the entry of an injunction restraining RJR Tobacco from
further acts of infringement, inducement of infringement, or contributory infringement of the
patents; an award of damages, including a reasonable royalty, to compensate for the infringement;
an award of enhanced damages on account that the defendants conduct was willful; an award of
pre-judgment interest and a further award of post-judgment interest; an award of reasonable
attorneys fees; and an order requiring RJR Tobacco to deliver up to the court for destruction all
products manufactured from any process which infringes upon, directly or indirectly or otherwise,
any claim of such patent. RJR Tobacco filed counterclaims seeking a declaration that the claims of
the two Star patents are invalid, unenforceable and not infringed by RJR Tobacco. Between January
31 and February 8, 2005, the court held a first bench trial on RJR Tobaccos affirmative defense
and counterclaim based upon inequitable
45
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
conduct. Additionally, in response to the courts
invitation, RJR Tobacco filed two summary judgment motions on January 20, 2005.
On January 19, 2007, the court granted RJR Tobaccos motion for summary judgment of invalidity
based on indefiniteness. The court granted in part and denied in part RJR Tobaccos other summary
judgment motion concerning the effective filing date of the patents in suit. On June 26, 2007, the
court ruled that Stars patents are unenforceable due to inequitable conduct by Star and its
representatives in the U.S. Patent & Trademark Office. On June 26, 2007, the court also entered
final judgment in favor of RJR Tobacco and against Star, dismissing all of Stars claims with
prejudice. On June 27, 2007, Star filed a notice of appeal with the U.S. Court of Appeals for the
Federal Circuit. Oral argument occurred on March 7, 2008, and the judges asked for a letter brief
concerning the inequitable conduct issue addressing circumstances regarding intent to deceive and
circumstances surrounding the transfer of files during Stars patent procurement activities. On
July 9, 2007, RJR Tobacco filed a bill of costs seeking reimbursement of its recoverable costs as
the prevailing party, and a motion seeking reimbursement of its attorneys fees and excess costs
incurred in defending Stars lawsuit. By agreement of the parties, the trial court deferred that
motion pending the appeal. On August 25, 2008, the Federal Circuit issued a decision reversing the
district courts holdings that Stars patents are unenforceable due to inequitable conduct and
invalid for indefiniteness, and remanded the case to the district court for further proceedings on
the issues of validity and infringement. On September 2, 2008, Star filed a motion for
re-assignment of the case on remand to a new trial judge. On September 5, 2008, the Federal
Circuit denied that motion. The Federal Circuit denied RJR
Tobaccos combined petition for panel rehearing and
rehearing en banc on October 22, 2008.
A Civil Investigative Demand, referred to as the CID, was issued by the Federal Trade
Commission, referred to as the FTC, to RJR Tobacco on August 23, 2007, to determine whether RJR
Tobaccos advertising and marketing related to the Camel No. 9 cigarette brand may violate the FTC
Act. The CID requires RJR Tobacco to produce documents and answer interrogatories. On January 7,
2008, RJR Tobacco certified as complete its production of documents to the FTC.
Finally, in the first quarter of 2005, Commonwealth Brands, Inc., referred to as Commonwealth,
was served with an individual smoking and health case, Croft v. Akron Gasket in Cuyahoga County,
Ohio. Commonwealth requested indemnity from RJR Tobacco pursuant to the Asset Purchase Agreement
dated July 24, 1996, between Commonwealth and B&W, referred to as the 1996 Purchase Agreement. As a
result of the B&W business combination, RJR Tobacco agreed to indemnify Commonwealth for this claim
to the extent, if any, required by the 1996 Purchase Agreement. The scope of the indemnity will be
at issue and has not been determined.
Smokeless Tobacco Litigation
As of October 10, 2008, Conwood Company, LLC was a defendant in six actions brought by
individual plaintiffs in West Virginia state court seeking damages in connection with personal
injuries allegedly sustained as a result of the usage of the Conwood companies smokeless tobacco
products. These actions are pending before the same West Virginia court as the 687 consolidated
individual smoker cases against RJR Tobacco, B&W, as RJR Tobaccos indemnitee, or both. Pursuant to
the Courts December 3, 2001 order, the smokeless tobacco claims and the defendants remain severed.
Pursuant to a second amended complaint filed in September 2006, Conwood Company, LLC is a
defendant in Vassallo v. United States Tobacco Company, pending in the Eleventh Circuit Court in
Miami-Dade County, Florida. The individual plaintiff in this case alleges that he sustained
personal injuries, including addiction and cancer, as a result of his use of smokeless tobacco
products, allegedly including products manufactured by the Conwood companies. The plaintiff seeks
unspecified compensatory and consequential damages in an amount greater than $15,000. There is not
a punitive damages demand in this case, though the plaintiff retains the right to seek leave of
court to add such a demand later. Discovery is underway.
Tobacco Buyout Legislation and Related Litigation
On October 22, 2004, the President signed the Fair and Equitable Tobacco Reform Act of 2004,
referred to as FETRA, eliminating the U.S. governments tobacco production controls and price
support program. The buyout of tobacco quota holders provided for in FETRA is funded by a direct
quarterly assessment on every tobacco product manufacturer and importer, on a market-share basis
measured on volume to which federal excise tax is applied. The aggregate cost of the buyout to the
industry is approximately $9.9 billion, including approximately $9.6 billion payable
46
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
to quota
tobacco holders and growers through industry assessments over ten years and approximately $290
million for the liquidation of quota tobacco stock. As a result of the tobacco buyout legislation,
the MSA Phase II obligations
established in 1999 will be continued as scheduled through the end of 2010, but will be offset
against the tobacco quota buyout obligations. RAIs operating subsidiaries annual expense under
FETRA, excluding the tobacco stock liquidation assessment, is estimated to be approximately $230
million to $260 million.
RAIs operating subsidiaries will record the FETRA assessment on a quarterly basis as cost of
goods sold. RAIs operating subsidiaries estimate that their overall share of the buyout will
approximate $2.4 billion to $2.8 billion prior to the deduction of permitted offsets under the MSA.
In addition, future market pricing could impact the carrying value of inventory, and adversely
affect RJR Tobaccos financial position and results of operations.
As noted above, the MSA Phase II obligations will be offset against the tobacco quota buyout
obligations. Because growers in two states, Maryland and Pennsylvania, did not participate in the
quota system, they are not eligible for payments under FETRA. Given that the assessments paid by
tobacco product manufacturers and importers under FETRA would fully offset their MSA Phase II
payment obligations, the growers in Maryland and Pennsylvania would no longer receive payments
under the MSA Phase II program. Thus, the growers in these two states would not receive payment
under either FETRA or the MSA Phase II program.
On December 17, 2004, Maryland and Pennsylvania filed in the North Carolina Business Court a
Motion for Clarification or Modification of the Trust, that is, the Growers Trust that created the
MSA Phase II obligations. They later supplemented this filing with a Statement of Claim, filed on
June 24, 2005. Maryland and Pennsylvania contend that they are entitled to relief from the
operation of the tax offset adjustment provision of the Growers Trust and that payments under the
Growers Trust to the growers in their states should continue. Following discovery, the parties
filed cross-motions for summary judgment on May 5, 2006. On August 17, 2007, the Business Court
issued an Order and Opinion granting summary judgment in favor of Maryland and Pennsylvania and
denying summary judgment to the tobacco manufacturers, including RJR Tobacco, that were the
settlors of the Growers Trust. The Business Court ruled that the Growers Trust, as written and
without judicial modification, requires continuing payments to the Growers Trust for the benefit of
tobacco growers in Maryland and Pennsylvania. RJR Tobacco and the other tobacco
manufacturer/settlors filed their Notice of Appeal on September 14, 2007. On January 14, 2008, RJR
Tobacco and the other tobacco manufacturer/settlors filed a petition seeking direct discretionary
review by the North Carolina Supreme Court. On February 25, 2008, the North Carolina Supreme Court
denied the petition. On March 17, 2008, RJR Tobacco and the other tobacco manufacturer/settlors
filed their opening brief before the North Carolina Court of Appeals. Maryland and Pennsylvania
filed a response brief on March 21, 2008. RJR Tobacco and the other tobacco manufactuer/settlors
filed a reply brief on June 9, 2008. On August 20, 2008, oral argument was held before the North
Carolina Court of Appeals. The case is now pending decision.
ERISA Litigation
On May 13, 2002, in Tatum v. The R.J.R. Pension Investment Committee of the R. J. Reynolds
Tobacco Company Capital Investment Plan, an employee of RJR Tobacco filed a class-action suit in
the U.S. District Court for the Middle District of North Carolina, alleging that the defendants,
RJR, RJR Tobacco, the RJR Employee Benefits Committee and the RJR Pension Investment Committee,
violated the Employee Retirement Income Security Act of 1974, referred to as ERISA. The actions
about which the plaintiff complains stem from a decision made in 1999 by RJR Nabisco Holdings
Corp., subsequently renamed Nabisco Group Holdings Corp., referred to as NGH, to spin off RJR,
thereby separating NGHs tobacco business and food business. As part of the spin-off, the 401(k)
plan for the previously related entities had to be divided into two separate plans for the now
separate tobacco and food businesses. The plaintiff contends that the defendants violated ERISA by
not overriding an amendment to RJRs 401(k) plan requiring that, prior to February 1, 2000, the
stock funds of the companies involved in the food business, NGH and Nabisco Holdings Corp.,
referred to as Nabisco, be eliminated as investment options from RJRs 401(k) plan. In his
complaint, the plaintiff requests, among other things, that the court require the defendants to pay
as damages to the RJR 401(k) plan an amount equal to the subsequent appreciation that was
purportedly lost as a result of the liquidation of the NGH and Nabisco funds.
On July 29, 2002, the defendants filed a motion to dismiss, which the court granted on
December 10, 2003. On December 14, 2004, the U.S. Court of Appeals for the Fourth Circuit reversed
the dismissal of the complaint and remanded the case for further proceedings. On January 20, 2005,
the defendants filed a second motion to dismiss on other grounds. On March 7, 2007, the court
granted the plaintiff leave to file an amended complaint and denied all pending motions as moot. On
April 6, 2007, the defendants moved to dismiss the amended complaint. On May 31, 2007, the court
granted the motion in part and denied it in part, dismissing all claims against the RJR Employee
Benefits Committee and the RJR Pension Investment Committee. The remaining defendants, RJR and RJR
Tobacco, filed their answer and affirmative defenses on June 14, 2007. On June 28, 2007, the
plaintiff filed a motion to amend the complaint to add as parties defendant the six members of the
RJR Pension Investment Committee and the RJR Employee Benefits Committee. On March 13, 2008, the
court denied this motion. On November 19, 2007, the plaintiff
47
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
filed a motion for class
certification, which the court granted on September 29, 2008. Court ordered mediation occurred on
July 10, 2008, but no resolution of the case was reached at that time. On May 29, 2008, the
defendants filed a
motion for judgment on the pleadings, which asked the court to dismiss the claims asserted by
class members who voluntarily transferred their 401(k) investments from the NGH and Nabisco funds
before January 31, 2000. That motion remains outstanding. Finally, on September 18, 2008, each of
the plaintiffs and the defendants filed motions for summary judgment; briefing on these motions is
continuing.
Employment Litigation
On March 19, 2007, in Marshall v. R.J. Reynolds Tobacco Co., the plaintiff filed a collective
action complaint against RJR Tobacco in the U.S. District Court for the Western District of
Missouri alleging violations of the Fair Labor Standards Act, referred to as the FLSA. The
allegations include failure to keep accurate records of all hours worked by RJR Tobaccos employees
and failure to pay wages and overtime compensation to non-exempt retail representatives. The opt-in
period to join the collective action ended on May 1, 2008, with 423 current or former retail
representatives having opted in to the lawsuit.
Two new cases alleging violations of the FLSA were filed in February 2008: Radcliffe v. R.J.
Reynolds Tobacco Co., filed on February 14, 2008, in federal court in California, was served on May
9, 2008; and Dinino v. R.J. Reynolds Tobacco Co., filed on February 29, 2008, in federal court in
New York, was served on April 18, 2008. The Dinino and Radcliffe matters have been transferred to
the Missouri court in conjunction with the already pending Marshall case due to the similarity of
issues to be resolved. The deadline for plaintiffs in the Dinino and Radcliffe matters to move for
Rule 23 class certification of the state law claims is November 6, 2008. The total number of
former and current retail representatives that could be included out of New York and California for
Rule 23 class certification is limited to approximately 44 from New York and 61 from California.
Environmental Matters
RAI and its subsidiaries are subject to federal, state and local environmental laws and
regulations concerning the discharge, storage, handling and disposal of hazardous or toxic
substances. Such laws and regulations provide for significant fines, penalties and liabilities,
sometimes without regard to whether the owner or operator of the property knew of, or was
responsible for, the release or presence of hazardous or toxic substances. In addition, third
parties may make claims against owners or operators of properties for personal injuries and
property damage associated with releases of hazardous or toxic substances. In the past, RJR Tobacco
has been named a potentially responsible party with third parties under the Comprehensive
Environmental Response, Compensation and Liability Act with respect to several superfund sites. RAI
and its subsidiaries are not aware of any current environmental matters that are expected to have a
material adverse effect on the business, results of operations or financial position of RAI or its
subsidiaries.
Regulations promulgated by the U.S. Environmental Protection Agency and other governmental
agencies under various statutes have resulted in, and likely will continue to result in,
substantial expenditures for pollution control, waste treatment, plant modification and similar
activities. RAI and its subsidiaries are engaged in a continuing program to comply with federal,
state and local environmental laws and regulations, and dependent upon the probability of
occurrence and reasonable estimation of cost, accrue or disclose any material liability. Although
it is difficult to reasonably estimate the portion of capital expenditures or other costs
attributable to compliance with environmental laws and regulations, RAI does not expect such
expenditures or other costs to have a material adverse effect on the business, results of
operations or financial position of RAI or its subsidiaries.
Other Contingencies
In connection with the sale of the international tobacco business to JTI, on May 12, 1999,
pursuant to the purchase agreement, RJR and RJR Tobacco agreed to indemnify JTI against:
|
|
|
any liabilities, costs and expenses arising out of the imposition or assessment
of any tax with respect to the international tobacco business arising prior to the
sale, other than as reflected on the closing balance sheet; |
|
|
|
|
any liabilities, costs and expenses that JTI or any of its affiliates,
including the acquired entities, may incur after the sale with respect to any of RJRs
or RJR Tobaccos employee benefit and welfare plans; and |
48
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
any liabilities, costs and expenses incurred by JTI or any of its affiliates
arising out of certain activities of Northern Brands. |
As described above in Litigation Affecting the Cigarette Industry Other Litigation and
Developments, RJR Tobacco has received several claims for indemnification from JTI. Although RJR
and RJR Tobacco recognize that, under certain circumstances, they may have indemnification
obligations to JTI under the 1999 Purchase Agreement, RJR and RJR Tobacco disagree whether the
circumstances described in such claims give rise to any indemnification obligations by RJR and RJR
Tobacco. RJR and RJR Tobacco have conveyed their position to JTI, and the parties have agreed to
resolve their differences at a later date. RJR has liabilities totaling $94 million that were
recorded in 1999 in connection with these indemnification claims.
RJR Tobacco, Santa Fe, the Conwood companies and Lane have entered into agreements to
indemnify certain distributors and retailers from liability and related defense costs arising out
of the sale or distribution of their products. Additionally, Santa Fe has entered into an agreement
to indemnify a supplier from liability and related defense costs arising out of the sale or use of
Santa Fes products. The cost has been, and is expected to be, insignificant. RJR Tobacco,
Santa Fe, the Conwood companies and Lane believe that the indemnified claims are substantially
similar in nature and extent to the claims that they are already exposed to by virtue of their
having manufactured those products.
Under certain circumstances, any fair value that results in a liability position of certain
interest rate swaps may require full collateralization with cash or securities.
Except as otherwise noted above, RAI is not able to estimate the maximum potential amount of
future payments, if any, related to these indemnification obligations.
Note 13Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
Total |
|
|
|
|
|
|
Common |
|
|
Paid-In |
|
|
Accumulated |
|
|
Comprehensive |
|
|
Shareholders |
|
|
Comprehensive |
|
|
|
Stock |
|
|
Capital |
|
|
Deficit |
|
|
Loss |
|
|
Equity |
|
|
Income |
|
Balance as of December 31,
2007 |
|
$ |
|
|
|
$ |
8,653 |
|
|
$ |
(873 |
) |
|
$ |
(314 |
) |
|
$ |
7,466 |
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
1,080 |
|
|
|
|
|
|
|
1,080 |
|
|
$ |
1,080 |
|
Retirement benefits SFAS
No. 158, net of $9
million tax expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
|
|
13 |
|
|
|
13 |
|
Unrealized loss on
long-term investments, net
of $12 million tax benefit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18 |
) |
|
|
(18 |
) |
|
|
(18 |
) |
Cumulative translation
adjustment, net of $5
million tax benefit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11 |
) |
|
|
(11 |
) |
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends $2.55 per share |
|
|
|
|
|
|
|
|
|
|
(748 |
) |
|
|
|
|
|
|
(748 |
) |
|
|
|
|
Common stock repurchased |
|
|
|
|
|
|
(207 |
) |
|
|
|
|
|
|
|
|
|
|
(207 |
) |
|
|
|
|
Equity incentive award
plan and stock-based
compensation |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
11 |
|
|
|
|
|
Excess tax benefit on
stock-based compensation
plans |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September
30, 2008 |
|
$ |
|
|
|
$ |
8,459 |
|
|
$ |
(541 |
) |
|
$ |
(330 |
) |
|
$ |
7,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On February 5, 2008, the board of directors of RAI authorized the repurchase of up to $30
million of outstanding shares of RAI common stock to offset the dilution from shares issued under
certain equity-based benefit plans. This $30 million repurchase program was superseded on April
29, 2008, when RAIs board of directors authorized RAIs repurchase, from time to time on or before
April 30, 2009, of up to $350 million of outstanding shares of RAI common stock in open-market or
privately negotiated transactions. The repurchases are subject to prevailing market and business
conditions, and the program may be terminated or suspended at any time. In connection with the
share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has agreed
to participate in the repurchase program on a basis approximately proportionate with B&Ws 42%
ownership of RAIs equity.
49
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Due to RAIs incorporation in North Carolina, which does not recognize treasury shares, any
shares repurchased are cancelled at the time of repurchase. As of September 30, 2008, RAI had
repurchased and cancelled 3,817,095 shares of RAI common stock for $207 million under the above
repurchase programs.
On February 5, 2008, the board of directors of RAI approved a grant, to key employees of RAI
and its subsidiaries, of shares of restricted RAI common stock under the Reynolds American Inc.
Long-Term Incentive Plan, referred to as the LTIP, effective March 6, 2008. The 321,991 restricted
shares were granted based on the per share closing price of RAI common stock on March 6, 2008, of
$61.89. On August 1, 2008, 594 additional shares were granted based on the $55.13 per share
closing price of RAI common stock on such date. The shares of the restricted RAI common stock
generally will vest on March 6, 2011. As an equity-based grant, compensation expense includes the
vesting period elapsed. Dividends on shares of outstanding restricted stock, which are paid
concurrently with dividends on outstanding unrestricted shares of stock, are recognized as a
reduction of equity.
On each of February 5, 2008, May 6, 2008, and July 18, 2008, RAIs board of directors declared
a quarterly cash dividend of $0.85 per common share, or $3.40 on an annualized basis.
Note 14Segment Information
RAIs reportable operating segments are RJR Tobacco and Conwood. The RJR Tobacco segment
consists of the primary operations of R. J. Reynolds Tobacco Company. The Conwood segment consists
of the Conwood companies and Lane. RAIs wholly owned operating subsidiaries Santa Fe and GPI,
among others, are included in All Other. The segments were identified based on how RAIs chief
operating decision maker allocates resources and assesses performance.
RAIs largest reportable operating segment, RJR Tobacco, is the second largest cigarette
manufacturer in the United States. RJR Tobaccos largest-selling cigarette brands, CAMEL, KOOL,
PALL MALL, DORAL and WINSTON, are five of the ten best-selling brands of cigarettes in the United
States as of September 30, 2008. Those brands, and its other brands, including SALEM, MISTY and
CAPRI, are manufactured in a variety of styles and marketed in the United States. RJR Tobacco also
manages contract manufacturing of cigarettes and tobacco products through arrangements with BAT
affiliates. On January 1, 2008, the contract manufacturing business of GPI was transferred to RJR
Tobacco.
RAIs other reportable operating segment, Conwood, is the second largest smokeless tobacco
products manufacturer in the United States. Conwoods primary
brands include its largest-selling
moist snuff brands, GRIZZLY and KODIAK, two of the seven best-selling brands of moist snuff in the
United States. Conwoods other products include loose leaf chewing tobacco, dry snuff, plug and
twist tobacco products. Conwoods products currently hold the first or second position in market
share in each category. In addition, Conwood also distributes a variety of other tobacco products
including WINCHESTER and CAPTAIN BLACK little cigars, and BUGLER roll-your-own tobacco.
Santa Fe manufactures and markets cigarettes and other tobacco products under the NATURAL
AMERICAN SPIRIT brand. As of January 1, 2008, the management of super premium brands, including
DUNHILL and STATE EXPRESS 555, was transferred to Santa Fe from RJR Tobacco. GPI manufactures and
exports tobacco products to U.S. territories, U.S. duty-free shops and U.S. overseas military bases
and manages the international businesses of Conwood and Santa Fe. The financial position and
results of operations of these operating segments do not meet the materiality criteria to be
reportable.
The amounts presented for prior periods have been reclassified to reflect the current segment
composition.
Intersegment revenues and items below the operating income line of the consolidated statements
of income are not presented by segment, since they are excluded from the measure of segment
profitability reviewed by RAIs chief operating decision maker.
50
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Segment Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months |
|
|
For the Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco |
|
$ |
1,977 |
|
|
$ |
2,019 |
|
|
$ |
5,798 |
|
|
$ |
5,995 |
|
Conwood |
|
|
181 |
|
|
|
166 |
|
|
|
536 |
|
|
|
495 |
|
All Other |
|
|
114 |
|
|
|
112 |
|
|
|
334 |
|
|
|
303 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated net sales |
|
$ |
2,272 |
|
|
$ |
2,297 |
|
|
$ |
6,668 |
|
|
$ |
6,793 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco |
|
$ |
293 |
|
|
$ |
499 |
|
|
$ |
1,231 |
|
|
$ |
1,483 |
|
Conwood |
|
|
98 |
|
|
|
90 |
|
|
|
275 |
|
|
|
260 |
|
All Other |
|
|
35 |
|
|
|
37 |
|
|
|
112 |
|
|
|
107 |
|
Corporate expense |
|
|
(27 |
) |
|
|
(24 |
) |
|
|
(76 |
) |
|
|
(79 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated operating income |
|
$ |
399 |
|
|
$ |
602 |
|
|
$ |
1,542 |
|
|
$ |
1,771 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation to income from continuing
operations before income taxes and
extraordinary item: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
$ |
399 |
|
|
$ |
602 |
|
|
$ |
1,542 |
|
|
$ |
1,771 |
|
Interest and debt expense |
|
|
68 |
|
|
|
81 |
|
|
|
208 |
|
|
|
257 |
|
Interest income |
|
|
(16 |
) |
|
|
(33 |
) |
|
|
(51 |
) |
|
|
(94 |
) |
Gain on termination of joint
venture |
|
|
|
|
|
|
|
|
|
|
(328 |
) |
|
|
|
|
Other (income) expense, net |
|
|
13 |
|
|
|
(7 |
) |
|
|
3 |
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes and extraordinary
item |
|
$ |
334 |
|
|
$ |
561 |
|
|
$ |
1,710 |
|
|
$ |
1,600 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2008 |
|
|
2007 |
|
Assets: |
|
|
|
|
|
|
|
|
RJR Tobacco |
|
$ |
15,480 |
|
|
$ |
15,956 |
|
Conwood |
|
|
4,481 |
|
|
|
4,559 |
|
All Other |
|
|
1,386 |
|
|
|
1,104 |
|
Corporate |
|
|
15,831 |
|
|
|
16,336 |
|
Elimination adjustments |
|
|
(18,760 |
) |
|
|
(19,326 |
) |
|
|
|
|
|
|
|
Consolidated assets |
|
$ |
18,418 |
|
|
$ |
18,629 |
|
|
|
|
|
|
|
|
Note 15Related Party Transactions
RAIs operating subsidiaries engage in transactions with related parties in the normal course
of business. The following is a summary of balances and transactions with affiliates of BAT.
Balances:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
|
|
2008 |
|
2007 |
|
Receivables |
|
$ |
67 |
|
|
$ |
80 |
|
Payables |
|
|
2 |
|
|
|
7 |
|
Deferred revenue |
|
|
13 |
|
|
|
35 |
|
Transactions for the nine months ended September 30:
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
2007 |
Net sales |
|
$ |
338 |
|
|
$ |
374 |
|
Legal indemnification expenses |
|
|
|
|
|
|
2 |
|
Purchases |
|
|
11 |
|
|
|
13 |
|
Research and development services |
|
|
2 |
|
|
|
2 |
|
51
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
RAIs operating subsidiaries have entered into various transactions with affiliates of BAT.
RAIs operating subsidiaries sell contract-manufactured cigarettes, processed strip leaf, pipe
tobacco and little cigars to BAT affiliates. Pricing for contract-manufactured cigarettes was
generally calculated based on 2004 prices, using B&Ws forecasted 2004 manufacturing costs plus
10%, increased by a multiple equal to the increase in the Producer Price Index for subsequent
years, reported by the U.S. Bureau of Labor Statistics. During the nine months ended September 30,
2008, net sales to BAT affiliates, primarily cigarettes, represented 5% of RAIs total net sales.
RJR Tobacco recorded deferred sales revenue relating to leaf sold to BAT affiliates that had
not been delivered as of September 30, 2008, given that RJR Tobacco had a legal right to bill the
BAT affiliates. Leaf sales revenue to BAT affiliates will be recognized when the product is
shipped to the customer.
52
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Note 16RAI Guaranteed, Unsecured Notes Condensed Consolidating Financial Statements
The following condensed consolidating financial statements have been prepared pursuant to Rule
3-10 of Regulation S-X, relating to the guarantors of RAIs $4.4 billion guaranteed, unsecured
notes. RAIs direct, wholly owned subsidiaries and certain of its indirectly owned subsidiaries
have fully and unconditionally, and jointly and severally, guaranteed these notes. The following
condensed consolidating financial statements include: the accounts and activities of RAI, the
parent issuer; RJR, RJR Tobacco, the Conwood companies, Conwood Holdings, Inc., Santa Fe, Lane,
GPI, RJR Acquisition Corp., and certain of RJR Tobaccos other subsidiaries, the guarantors; other
indirect subsidiaries of RAI that are not guarantors; and elimination adjustments.
Condensed Consolidating Statements of Income
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
For the Three Months Ended September 30,
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
2,148 |
|
|
$ |
41 |
|
|
$ |
(33 |
) |
|
$ |
2,156 |
|
Net sales, related party |
|
|
|
|
|
|
116 |
|
|
|
|
|
|
|
|
|
|
|
116 |
|
Cost of products sold |
|
|
|
|
|
|
1,242 |
|
|
|
20 |
|
|
|
(33 |
) |
|
|
1,229 |
|
Selling, general and administrative expenses |
|
|
8 |
|
|
|
349 |
|
|
|
18 |
|
|
|
|
|
|
|
375 |
|
Amortization expense |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
5 |
|
Restructuring charge |
|
|
6 |
|
|
|
81 |
|
|
|
4 |
|
|
|
|
|
|
|
91 |
|
Trademark impairment charge |
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(14 |
) |
|
|
414 |
|
|
|
(1 |
) |
|
|
|
|
|
|
399 |
|
Interest and debt expense |
|
|
65 |
|
|
|
2 |
|
|
|
1 |
|
|
|
|
|
|
|
68 |
|
Interest income |
|
|
|
|
|
|
(10 |
) |
|
|
(6 |
) |
|
|
|
|
|
|
(16 |
) |
Intercompany interest (income) expense |
|
|
(23 |
) |
|
|
22 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
11 |
|
|
|
|
|
Other expense, net |
|
|
1 |
|
|
|
11 |
|
|
|
1 |
|
|
|
|
|
|
|
13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
(57 |
) |
|
|
400 |
|
|
|
2 |
|
|
|
(11 |
) |
|
|
334 |
|
Provision for (benefit from) income taxes |
|
|
(21 |
) |
|
|
144 |
|
|
|
|
|
|
|
|
|
|
|
123 |
|
Equity income from subsidiaries |
|
|
247 |
|
|
|
3 |
|
|
|
|
|
|
|
(250 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
211 |
|
|
$ |
259 |
|
|
$ |
2 |
|
|
$ |
(261 |
) |
|
$ |
211 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30,
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
2,170 |
|
|
$ |
33 |
|
|
$ |
(29 |
) |
|
$ |
2,174 |
|
Net sales, related party |
|
|
|
|
|
|
123 |
|
|
|
|
|
|
|
|
|
|
|
123 |
|
Cost of products sold |
|
|
|
|
|
|
1,263 |
|
|
|
15 |
|
|
|
(28 |
) |
|
|
1,250 |
|
Selling, general and administrative expenses |
|
|
12 |
|
|
|
413 |
|
|
|
16 |
|
|
|
(1 |
) |
|
|
440 |
|
Amortization expense |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(12 |
) |
|
|
612 |
|
|
|
2 |
|
|
|
|
|
|
|
602 |
|
Interest and debt expense |
|
|
78 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
81 |
|
Interest income |
|
|
(1 |
) |
|
|
(30 |
) |
|
|
(2 |
) |
|
|
|
|
|
|
(33 |
) |
Intercompany interest (income) expense |
|
|
(27 |
) |
|
|
26 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
11 |
|
|
|
|
|
Other (income) expense, net |
|
|
1 |
|
|
|
(4 |
) |
|
|
(4 |
) |
|
|
|
|
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
extraordinary item |
|
|
(63 |
) |
|
|
628 |
|
|
|
7 |
|
|
|
(11 |
) |
|
|
561 |
|
Provision for (benefit from) income taxes |
|
|
(22 |
) |
|
|
225 |
|
|
|
|
|
|
|
|
|
|
|
203 |
|
Equity income from subsidiaries |
|
|
399 |
|
|
|
7 |
|
|
|
|
|
|
|
(406 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
358 |
|
|
$ |
410 |
|
|
$ |
7 |
|
|
$ |
(417 |
) |
|
$ |
358 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Income
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
For the Nine Months Ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
6,307 |
|
|
$ |
117 |
|
|
$ |
(94 |
) |
|
$ |
6,330 |
|
Net sales, related party |
|
|
|
|
|
|
338 |
|
|
|
|
|
|
|
|
|
|
|
338 |
|
Cost of products sold |
|
|
|
|
|
|
3,737 |
|
|
|
55 |
|
|
|
(94 |
) |
|
|
3,698 |
|
Selling, general and administrative expenses |
|
|
17 |
|
|
|
1,082 |
|
|
|
49 |
|
|
|
|
|
|
|
1,148 |
|
Amortization expense |
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
16 |
|
Restructuring charge |
|
|
6 |
|
|
|
81 |
|
|
|
4 |
|
|
|
|
|
|
|
91 |
|
Trademark impairment charge |
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(23 |
) |
|
|
1,556 |
|
|
|
9 |
|
|
|
|
|
|
|
1,542 |
|
Interest and debt expense |
|
|
200 |
|
|
|
7 |
|
|
|
1 |
|
|
|
|
|
|
|
208 |
|
Interest income |
|
|
(1 |
) |
|
|
(38 |
) |
|
|
(12 |
) |
|
|
|
|
|
|
(51 |
) |
Intercompany interest (income) expense |
|
|
(63 |
) |
|
|
59 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
32 |
|
|
|
|
|
Gain on termination of joint venture |
|
|
|
|
|
|
|
|
|
|
(328 |
) |
|
|
|
|
|
|
(328 |
) |
Other expense, net |
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
(162 |
) |
|
|
1,560 |
|
|
|
344 |
|
|
|
(32 |
) |
|
|
1,710 |
|
Provision for (benefit from) income taxes |
|
|
(57 |
) |
|
|
686 |
|
|
|
1 |
|
|
|
|
|
|
|
630 |
|
Equity income from subsidiaries |
|
|
1,185 |
|
|
|
344 |
|
|
|
|
|
|
|
(1,529 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,080 |
|
|
$ |
1,218 |
|
|
$ |
343 |
|
|
$ |
(1,561 |
) |
|
$ |
1,080 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
6,404 |
|
|
$ |
80 |
|
|
$ |
(65 |
) |
|
$ |
6,419 |
|
Net sales, related party |
|
|
|
|
|
|
374 |
|
|
|
|
|
|
|
|
|
|
|
374 |
|
Cost of products sold |
|
|
|
|
|
|
3,800 |
|
|
|
32 |
|
|
|
(64 |
) |
|
|
3,768 |
|
Selling, general and administrative expenses |
|
|
41 |
|
|
|
1,157 |
|
|
|
39 |
|
|
|
|
|
|
|
1,237 |
|
Amortization expense |
|
|
|
|
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(41 |
) |
|
|
1,804 |
|
|
|
9 |
|
|
|
(1 |
) |
|
|
1,771 |
|
Interest and debt expense |
|
|
246 |
|
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
257 |
|
Interest income |
|
|
(3 |
) |
|
|
(88 |
) |
|
|
(3 |
) |
|
|
|
|
|
|
(94 |
) |
Intercompany interest (income) expense |
|
|
(89 |
) |
|
|
86 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
32 |
|
|
|
|
|
Other (income) expense, net |
|
|
23 |
|
|
|
(6 |
) |
|
|
(9 |
) |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
extraordinary item |
|
|
(218 |
) |
|
|
1,833 |
|
|
|
18 |
|
|
|
(33 |
) |
|
|
1,600 |
|
Provision for (benefit from) income taxes |
|
|
(73 |
) |
|
|
662 |
|
|
|
1 |
|
|
|
|
|
|
|
590 |
|
Equity income from subsidiaries |
|
|
1,156 |
|
|
|
17 |
|
|
|
|
|
|
|
(1,173 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before extraordinary item |
|
|
1,011 |
|
|
|
1,188 |
|
|
|
17 |
|
|
|
(1,206 |
) |
|
|
1,010 |
|
Extraordinary item gain on acquisition |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,011 |
|
|
$ |
1,189 |
|
|
$ |
17 |
|
|
$ |
(1,206 |
) |
|
$ |
1,011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Cash Flows
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
For the Nine Months Ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) operating activities |
|
$ |
649 |
|
|
$ |
899 |
|
|
$ |
32 |
|
|
$ |
(752 |
) |
|
$ |
828 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments |
|
|
(8 |
) |
|
|
(48 |
) |
|
|
|
|
|
|
|
|
|
|
(56 |
) |
Proceeds from sale of short-term investments |
|
|
|
|
|
|
208 |
|
|
|
|
|
|
|
|
|
|
|
208 |
|
Proceeds from settlement of long-term
investments |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
6 |
|
Capital expenditures |
|
|
|
|
|
|
(90 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
(95 |
) |
Distributions from equity investees |
|
|
|
|
|
|
|
|
|
|
27 |
|
|
|
|
|
|
|
27 |
|
Proceeds from termination of joint venture |
|
|
|
|
|
|
|
|
|
|
164 |
|
|
|
|
|
|
|
164 |
|
Other, net |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
10 |
|
Net intercompany investments |
|
|
|
|
|
|
(1 |
) |
|
|
1 |
|
|
|
|
|
|
|
|
|
Intercompany notes receivable |
|
|
40 |
|
|
|
(28 |
) |
|
|
|
|
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from investing activities |
|
|
32 |
|
|
|
57 |
|
|
|
187 |
|
|
|
(12 |
) |
|
|
264 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock |
|
|
(752 |
) |
|
|
(720 |
) |
|
|
|
|
|
|
720 |
|
|
|
(752 |
) |
Dividends paid on preferred stock |
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
32 |
|
|
|
|
|
Excess tax benefit from stock-based
compensation |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Proceeds from stock options exercised |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Repurchase of common stock |
|
|
(207 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(207 |
) |
Other, net |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Intercompany notes payable |
|
|
98 |
|
|
|
(40 |
) |
|
|
(70 |
) |
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows (used in) from financing
activities |
|
|
(889 |
) |
|
|
(760 |
) |
|
|
(70 |
) |
|
|
764 |
|
|
|
(955 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of
exchange rate changes on cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
(23 |
) |
|
|
|
|
|
|
(23 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
(208 |
) |
|
|
196 |
|
|
|
126 |
|
|
|
|
|
|
|
114 |
|
Cash and cash equivalents at beginning of period |
|
|
243 |
|
|
|
1,885 |
|
|
|
87 |
|
|
|
|
|
|
|
2,215 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
35 |
|
|
$ |
2,081 |
|
|
$ |
213 |
|
|
$ |
|
|
|
$ |
2,329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) operating activities |
|
$ |
702 |
|
|
$ |
672 |
|
|
$ |
1 |
|
|
$ |
(87 |
) |
|
$ |
1,288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments |
|
|
|
|
|
|
(3,663 |
) |
|
|
|
|
|
|
|
|
|
|
(3,663 |
) |
Proceeds from sale of short-term investments |
|
|
|
|
|
|
4,154 |
|
|
|
|
|
|
|
|
|
|
|
4,154 |
|
Capital expenditures |
|
|
(7 |
) |
|
|
(82 |
) |
|
|
(6 |
) |
|
|
|
|
|
|
(95 |
) |
Distributions from (investments in) equity
investees |
|
|
|
|
|
|
(1 |
) |
|
|
10 |
|
|
|
|
|
|
|
9 |
|
Other, net |
|
|
|
|
|
|
(1 |
) |
|
|
(3 |
) |
|
|
|
|
|
|
(4 |
) |
Intercompany notes receivable |
|
|
40 |
|
|
|
(295 |
) |
|
|
|
|
|
|
255 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from investing activities |
|
|
33 |
|
|
|
112 |
|
|
|
1 |
|
|
|
255 |
|
|
|
401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock |
|
|
(665 |
) |
|
|
(55 |
) |
|
|
|
|
|
|
55 |
|
|
|
(665 |
) |
Dividends paid on preferred stock |
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
32 |
|
|
|
|
|
Repayment of long-term debt |
|
|
(254 |
) |
|
|
(75 |
) |
|
|
|
|
|
|
|
|
|
|
(329 |
) |
Issuance of long-term debt |
|
|
1,547 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,547 |
|
Repayment of term loan |
|
|
(1,542 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,542 |
) |
Deferred debt issuance cost |
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15 |
) |
Excess tax benefit from stock-based compensation |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Repurchase of common stock |
|
|
(60 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(60 |
) |
Intercompany notes payable |
|
|
288 |
|
|
|
(40 |
) |
|
|
7 |
|
|
|
(255 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) financing
activities |
|
|
(732 |
) |
|
|
(170 |
) |
|
|
7 |
|
|
|
(168 |
) |
|
|
(1,063 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
3 |
|
|
|
614 |
|
|
|
9 |
|
|
|
|
|
|
|
626 |
|
Cash and cash equivalents at beginning of period |
|
|
296 |
|
|
|
1,065 |
|
|
|
72 |
|
|
|
|
|
|
|
1,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
299 |
|
|
$ |
1,679 |
|
|
$ |
81 |
|
|
$ |
|
|
|
$ |
2,059 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
55
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Balance Sheets
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
35 |
|
|
$ |
2,081 |
|
|
$ |
213 |
|
|
$ |
|
|
|
$ |
2,329 |
|
Short-term investments |
|
|
8 |
|
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
52 |
|
Accounts receivable, net |
|
|
|
|
|
|
64 |
|
|
|
15 |
|
|
|
|
|
|
|
79 |
|
Accounts receivable, related party |
|
|
|
|
|
|
67 |
|
|
|
|
|
|
|
|
|
|
|
67 |
|
Notes receivable |
|
|
|
|
|
|
1 |
|
|
|
32 |
|
|
|
|
|
|
|
33 |
|
Other receivables |
|
|
35 |
|
|
|
27 |
|
|
|
1 |
|
|
|
|
|
|
|
63 |
|
Inventories |
|
|
|
|
|
|
1,039 |
|
|
|
35 |
|
|
|
(2 |
) |
|
|
1,072 |
|
Deferred income taxes, net |
|
|
16 |
|
|
|
836 |
|
|
|
|
|
|
|
|
|
|
|
852 |
|
Prepaid expenses and other |
|
|
7 |
|
|
|
131 |
|
|
|
5 |
|
|
|
|
|
|
|
143 |
|
Short-term intercompany notes and interest
receivable |
|
|
81 |
|
|
|
58 |
|
|
|
|
|
|
|
(139 |
) |
|
|
|
|
Other intercompany receivables |
|
|
216 |
|
|
|
|
|
|
|
|
|
|
|
(216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
398 |
|
|
|
4,348 |
|
|
|
301 |
|
|
|
(357 |
) |
|
|
4,690 |
|
Property, plant and equipment, net |
|
|
7 |
|
|
|
1,022 |
|
|
|
24 |
|
|
|
|
|
|
|
1,053 |
|
Trademarks, net |
|
|
|
|
|
|
3,229 |
|
|
|
|
|
|
|
|
|
|
|
3,229 |
|
Goodwill |
|
|
|
|
|
|
8,166 |
|
|
|
8 |
|
|
|
|
|
|
|
8,174 |
|
Other intangibles, net |
|
|
|
|
|
|
188 |
|
|
|
3 |
|
|
|
|
|
|
|
191 |
|
Long-term intercompany notes |
|
|
2,080 |
|
|
|
1,409 |
|
|
|
|
|
|
|
(3,489 |
) |
|
|
|
|
Investment in subsidiaries |
|
|
11,240 |
|
|
|
433 |
|
|
|
|
|
|
|
(11,673 |
) |
|
|
|
|
Other assets and deferred charges |
|
|
170 |
|
|
|
773 |
|
|
|
165 |
|
|
|
(27 |
) |
|
|
1,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
13,895 |
|
|
$ |
19,568 |
|
|
$ |
501 |
|
|
$ |
(15,546 |
) |
|
$ |
18,418 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals |
|
$ |
|
|
|
$ |
2,159 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,159 |
|
Accounts payable and other accrued liabilities |
|
|
410 |
|
|
|
884 |
|
|
|
33 |
|
|
|
|
|
|
|
1,327 |
|
Due to related party |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Deferred revenue, related party |
|
|
|
|
|
|
13 |
|
|
|
|
|
|
|
|
|
|
|
13 |
|
Current maturities of long-term debt |
|
|
189 |
|
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
200 |
|
Short-term intercompany notes and interest payables |
|
|
36 |
|
|
|
81 |
|
|
|
22 |
|
|
|
(139 |
) |
|
|
|
|
Other intercompany payables |
|
|
|
|
|
|
215 |
|
|
|
1 |
|
|
|
(216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
635 |
|
|
|
3,365 |
|
|
|
56 |
|
|
|
(355 |
) |
|
|
3,701 |
|
Intercompany notes |
|
|
1,409 |
|
|
|
2,080 |
|
|
|
|
|
|
|
(3,489 |
) |
|
|
|
|
Long-term debt (less current maturities) |
|
|
4,183 |
|
|
|
121 |
|
|
|
|
|
|
|
|
|
|
|
4,304 |
|
Deferred income taxes, net |
|
|
|
|
|
|
1,247 |
|
|
|
|
|
|
|
(27 |
) |
|
|
1,220 |
|
Long-term retirement benefits (less
current portion) |
|
|
50 |
|
|
|
1,104 |
|
|
|
12 |
|
|
|
|
|
|
|
1,166 |
|
Other noncurrent liabilities |
|
|
30 |
|
|
|
408 |
|
|
|
1 |
|
|
|
|
|
|
|
439 |
|
Shareholders equity |
|
|
7,588 |
|
|
|
11,243 |
|
|
|
432 |
|
|
|
(11,675 |
) |
|
|
7,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
13,895 |
|
|
$ |
19,568 |
|
|
$ |
501 |
|
|
$ |
(15,546 |
) |
|
$ |
18,418 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
243 |
|
|
$ |
1,885 |
|
|
$ |
87 |
|
|
$ |
|
|
|
$ |
2,215 |
|
Short-term investments |
|
|
|
|
|
|
377 |
|
|
|
|
|
|
|
|
|
|
|
377 |
|
Accounts receivable, net |
|
|
|
|
|
|
61 |
|
|
|
12 |
|
|
|
|
|
|
|
73 |
|
Accounts receivable, related party |
|
|
|
|
|
|
80 |
|
|
|
|
|
|
|
|
|
|
|
80 |
|
Notes receivable |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Other receivables |
|
|
7 |
|
|
|
18 |
|
|
|
|
|
|
|
|
|
|
|
25 |
|
Inventories |
|
|
|
|
|
|
1,167 |
|
|
|
31 |
|
|
|
(2 |
) |
|
|
1,196 |
|
Deferred income taxes, net |
|
|
11 |
|
|
|
833 |
|
|
|
1 |
|
|
|
|
|
|
|
845 |
|
Prepaid expenses and other |
|
|
6 |
|
|
|
169 |
|
|
|
3 |
|
|
|
2 |
|
|
|
180 |
|
Short-term intercompany notes and
interest receivable |
|
|
82 |
|
|
|
127 |
|
|
|
|
|
|
|
(209 |
) |
|
|
|
|
Other intercompany receivables |
|
|
153 |
|
|
|
|
|
|
|
23 |
|
|
|
(176 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Total current assets |
|
|
502 |
|
|
|
4,718 |
|
|
|
157 |
|
|
|
(385 |
) |
|
|
4,992 |
|
Property, plant and equipment, net |
|
|
8 |
|
|
|
1,046 |
|
|
|
20 |
|
|
|
(1 |
) |
|
|
1,073 |
|
Trademarks, net |
|
|
|
|
|
|
3,407 |
|
|
|
|
|
|
|
|
|
|
|
3,407 |
|
Goodwill |
|
|
|
|
|
|
8,166 |
|
|
|
8 |
|
|
|
|
|
|
|
8,174 |
|
Other intangibles, net |
|
|
|
|
|
|
199 |
|
|
|
3 |
|
|
|
|
|
|
|
202 |
|
Long-term intercompany notes |
|
|
2,120 |
|
|
|
1,310 |
|
|
|
|
|
|
|
(3,430 |
) |
|
|
|
|
Investment in subsidiaries |
|
|
10,848 |
|
|
|
104 |
|
|
|
|
|
|
|
(10,952 |
) |
|
|
|
|
Other assets and deferred charges |
|
|
186 |
|
|
|
571 |
|
|
|
49 |
|
|
|
(25 |
) |
|
|
781 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
13,664 |
|
|
$ |
19,521 |
|
|
$ |
237 |
|
|
$ |
(14,793 |
) |
|
$ |
18,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals |
|
$ |
|
|
|
$ |
2,449 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,449 |
|
Accounts payable and other accrued liabilities |
|
|
391 |
|
|
|
993 |
|
|
|
27 |
|
|
|
1 |
|
|
|
1,412 |
|
Due to related party |
|
|
|
|
|
|
5 |
|
|
|
2 |
|
|
|
|
|
|
|
7 |
|
Deferred revenue, related party |
|
|
|
|
|
|
35 |
|
|
|
|
|
|
|
|
|
|
|
35 |
|
Short-term intercompany notes and
interest payable |
|
|
34 |
|
|
|
82 |
|
|
|
93 |
|
|
|
(209 |
) |
|
|
|
|
Other intercompany payables |
|
|
|
|
|
|
176 |
|
|
|
|
|
|
|
(176 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
425 |
|
|
|
3,740 |
|
|
|
122 |
|
|
|
(384 |
) |
|
|
3,903 |
|
Intercompany notes |
|
|
1,310 |
|
|
|
2,120 |
|
|
|
|
|
|
|
(3,430 |
) |
|
|
|
|
Long-term debt |
|
|
4,383 |
|
|
|
132 |
|
|
|
|
|
|
|
|
|
|
|
4,515 |
|
Deferred income taxes, net |
|
|
|
|
|
|
1,209 |
|
|
|
|
|
|
|
(25 |
) |
|
|
1,184 |
|
Long-term retirement benefits (less
current portion) |
|
|
44 |
|
|
|
1,112 |
|
|
|
11 |
|
|
|
|
|
|
|
1,167 |
|
Other noncurrent liabilities |
|
|
36 |
|
|
|
358 |
|
|
|
|
|
|
|
|
|
|
|
394 |
|
Shareholders equity |
|
|
7,466 |
|
|
|
10,850 |
|
|
|
104 |
|
|
|
(10,954 |
) |
|
|
7,466 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
13,664 |
|
|
$ |
19,521 |
|
|
$ |
237 |
|
|
$ |
(14,793 |
) |
|
$ |
18,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Note 17RJR Guaranteed, Unsecured Notes Condensed Consolidating Financial Statements
The following condensed consolidating financial statements have been prepared pursuant to Rule
3-10 of Regulation S-X, relating to the guarantees of RJRs $72 million unsecured notes. RAI and
certain of its direct or indirect, wholly owned subsidiaries, have fully and unconditionally, and
jointly and severally, guaranteed these notes. The following condensed consolidating financial
statements include: the accounts and activities of RAI, the parent guarantor; RJR, the issuer of
the debt securities; RJR Tobacco, RJR Acquisition Corp. and certain of RJRs other subsidiaries,
the other guarantors; other subsidiaries of RAI and RJR, including Santa Fe, Lane and the Conwood
companies that are not guarantors; and elimination adjustments.
Condensed Consolidating Statements of Income
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
For the Three Months Ended September 30,
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,923 |
|
|
$ |
291 |
|
|
$ |
(58 |
) |
|
$ |
2,156 |
|
Net sales, related party |
|
|
|
|
|
|
|
|
|
|
114 |
|
|
|
2 |
|
|
|
|
|
|
|
116 |
|
Cost of products sold |
|
|
|
|
|
|
|
|
|
|
1,186 |
|
|
|
101 |
|
|
|
(58 |
) |
|
|
1,229 |
|
Selling, general and administrative expenses |
|
|
8 |
|
|
|
|
|
|
|
302 |
|
|
|
65 |
|
|
|
|
|
|
|
375 |
|
Amortization expense |
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
(1 |
) |
|
|
|
|
|
|
5 |
|
Restructuring charge |
|
|
6 |
|
|
|
|
|
|
|
81 |
|
|
|
4 |
|
|
|
|
|
|
|
91 |
|
Trademark impairment charge |
|
|
|
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(14 |
) |
|
|
|
|
|
|
289 |
|
|
|
124 |
|
|
|
|
|
|
|
399 |
|
Interest and debt expense |
|
|
65 |
|
|
|
2 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
68 |
|
Interest income |
|
|
|
|
|
|
(1 |
) |
|
|
(10 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
(16 |
) |
Intercompany interest (income) expense |
|
|
(23 |
) |
|
|
(1 |
) |
|
|
(22 |
) |
|
|
46 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
11 |
|
|
|
|
|
Other expense, net |
|
|
1 |
|
|
|
10 |
|
|
|
1 |
|
|
|
1 |
|
|
|
|
|
|
|
13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
(57 |
) |
|
|
1 |
|
|
|
320 |
|
|
|
81 |
|
|
|
(11 |
) |
|
|
334 |
|
Provision for (benefit from) income taxes |
|
|
(21 |
) |
|
|
(5 |
) |
|
|
123 |
|
|
|
26 |
|
|
|
|
|
|
|
123 |
|
Equity income from subsidiaries |
|
|
247 |
|
|
|
200 |
|
|
|
4 |
|
|
|
|
|
|
|
(451 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
211 |
|
|
$ |
206 |
|
|
$ |
201 |
|
|
$ |
55 |
|
|
$ |
(462 |
) |
|
$ |
211 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30,
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,963 |
|
|
$ |
256 |
|
|
$ |
(45 |
) |
|
$ |
2,174 |
|
Net sales, related party |
|
|
|
|
|
|
|
|
|
|
120 |
|
|
|
3 |
|
|
|
|
|
|
|
123 |
|
Cost of products sold |
|
|
|
|
|
|
|
|
|
|
1,211 |
|
|
|
84 |
|
|
|
(45 |
) |
|
|
1,250 |
|
Selling, general and administrative expenses |
|
|
12 |
|
|
|
|
|
|
|
366 |
|
|
|
62 |
|
|
|
|
|
|
|
440 |
|
Amortization expense |
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(12 |
) |
|
|
|
|
|
|
501 |
|
|
|
113 |
|
|
|
|
|
|
|
602 |
|
Interest and debt expense |
|
|
78 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
81 |
|
Interest income |
|
|
(1 |
) |
|
|
|
|
|
|
(27 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
(33 |
) |
Intercompany interest (income) expense |
|
|
(27 |
) |
|
|
|
|
|
|
(21 |
) |
|
|
48 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
11 |
|
|
|
|
|
Other (income) expense, net |
|
|
1 |
|
|
|
(4 |
) |
|
|
1 |
|
|
|
(5 |
) |
|
|
|
|
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
extraordinary item |
|
|
(63 |
) |
|
|
12 |
|
|
|
548 |
|
|
|
75 |
|
|
|
(11 |
) |
|
|
561 |
|
Provision for (benefit from) income taxes |
|
|
(22 |
) |
|
|
(1 |
) |
|
|
204 |
|
|
|
22 |
|
|
|
|
|
|
|
203 |
|
Equity income from subsidiaries |
|
|
399 |
|
|
|
355 |
|
|
|
10 |
|
|
|
|
|
|
|
(764 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
358 |
|
|
$ |
368 |
|
|
$ |
354 |
|
|
$ |
53 |
|
|
$ |
(775 |
) |
|
$ |
358 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Income
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
For the Nine Months Ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
|
|
|
$ |
5,646 |
|
|
$ |
846 |
|
|
$ |
(162 |
) |
|
$ |
6,330 |
|
Net sales, related party |
|
|
|
|
|
|
|
|
|
|
332 |
|
|
|
6 |
|
|
|
|
|
|
|
338 |
|
Cost of products sold |
|
|
|
|
|
|
|
|
|
|
3,563 |
|
|
|
297 |
|
|
|
(162 |
) |
|
|
3,698 |
|
Selling, general and administrative expenses |
|
|
17 |
|
|
|
1 |
|
|
|
921 |
|
|
|
209 |
|
|
|
|
|
|
|
1,148 |
|
Amortization expense |
|
|
|
|
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
16 |
|
Restructuring charge |
|
|
6 |
|
|
|
|
|
|
|
81 |
|
|
|
4 |
|
|
|
|
|
|
|
91 |
|
Trademark impairment charge |
|
|
|
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(23 |
) |
|
|
(1 |
) |
|
|
1,224 |
|
|
|
342 |
|
|
|
|
|
|
|
1,542 |
|
Interest and debt expense |
|
|
200 |
|
|
|
7 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
208 |
|
Interest income |
|
|
(1 |
) |
|
|
(2 |
) |
|
|
(35 |
) |
|
|
(13 |
) |
|
|
|
|
|
|
(51 |
) |
Intercompany interest (income) expense |
|
|
(63 |
) |
|
|
(7 |
) |
|
|
(69 |
) |
|
|
139 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
32 |
|
|
|
|
|
Gain on termination of joint venture |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(328 |
) |
|
|
|
|
|
|
(328 |
) |
Other (income) expense, net |
|
|
3 |
|
|
|
(2 |
) |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes |
|
|
(162 |
) |
|
|
35 |
|
|
|
1,326 |
|
|
|
543 |
|
|
|
(32 |
) |
|
|
1,710 |
|
Provision for (benefit from) income taxes |
|
|
(57 |
) |
|
|
|
|
|
|
616 |
|
|
|
71 |
|
|
|
|
|
|
|
630 |
|
Equity income from subsidiaries |
|
|
1,185 |
|
|
|
1,055 |
|
|
|
345 |
|
|
|
|
|
|
|
(2,585 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,080 |
|
|
$ |
1,090 |
|
|
$ |
1,055 |
|
|
$ |
472 |
|
|
$ |
(2,617 |
) |
|
$ |
1,080 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
|
|
|
$ |
|
|
|
$ |
5,796 |
|
|
$ |
733 |
|
|
$ |
(110 |
) |
|
$ |
6,419 |
|
Net sales, related party |
|
|
|
|
|
|
|
|
|
|
363 |
|
|
|
11 |
|
|
|
|
|
|
|
374 |
|
Cost of products sold |
|
|
|
|
|
|
|
|
|
|
3,636 |
|
|
|
242 |
|
|
|
(110 |
) |
|
|
3,768 |
|
Selling, general and administrative expenses |
|
|
41 |
|
|
|
|
|
|
|
1,021 |
|
|
|
175 |
|
|
|
|
|
|
|
1,237 |
|
Amortization expense |
|
|
|
|
|
|
|
|
|
|
16 |
|
|
|
1 |
|
|
|
|
|
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
(41 |
) |
|
|
|
|
|
|
1,486 |
|
|
|
326 |
|
|
|
|
|
|
|
1,771 |
|
Interest and debt expense |
|
|
246 |
|
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
257 |
|
Interest income |
|
|
(3 |
) |
|
|
(4 |
) |
|
|
(76 |
) |
|
|
(11 |
) |
|
|
|
|
|
|
(94 |
) |
Intercompany interest (income) expense |
|
|
(89 |
) |
|
|
(2 |
) |
|
|
(54 |
) |
|
|
145 |
|
|
|
|
|
|
|
|
|
Intercompany dividend income |
|
|
|
|
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
32 |
|
|
|
|
|
Other (income) expense, net |
|
|
23 |
|
|
|
(6 |
) |
|
|
1 |
|
|
|
(10 |
) |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and
extraordinary item |
|
|
(218 |
) |
|
|
33 |
|
|
|
1,615 |
|
|
|
202 |
|
|
|
(32 |
) |
|
|
1,600 |
|
Provision for (benefit from) income taxes |
|
|
(73 |
) |
|
|
(1 |
) |
|
|
597 |
|
|
|
67 |
|
|
|
|
|
|
|
590 |
|
Equity income from subsidiaries |
|
|
1,156 |
|
|
|
1,039 |
|
|
|
20 |
|
|
|
|
|
|
|
(2,215 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before extraordinary item |
|
|
1,011 |
|
|
|
1,073 |
|
|
|
1,038 |
|
|
|
135 |
|
|
|
(2,247 |
) |
|
|
1,010 |
|
Extraordinary item-gain on acquisition |
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,011 |
|
|
$ |
1,073 |
|
|
$ |
1,039 |
|
|
$ |
135 |
|
|
$ |
(2,247 |
) |
|
$ |
1,011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Statements of Cash Flows
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
Non- |
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
For the Nine Months Ended September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) operating activities |
|
$ |
649 |
|
|
$ |
646 |
|
|
$ |
841 |
|
|
$ |
75 |
|
|
$ |
(1,383 |
) |
|
$ |
828 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments |
|
|
(8 |
) |
|
|
(11 |
) |
|
|
(28 |
) |
|
|
(9 |
) |
|
|
|
|
|
|
(56 |
) |
Proceeds from sale of short-term investments |
|
|
|
|
|
|
|
|
|
|
208 |
|
|
|
|
|
|
|
|
|
|
|
208 |
|
Proceeds from settlement of long-term
investments |
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
6 |
|
Capital expenditures |
|
|
|
|
|
|
|
|
|
|
(55 |
) |
|
|
(40 |
) |
|
|
|
|
|
|
(95 |
) |
Distributions from equity investees |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27 |
|
|
|
|
|
|
|
27 |
|
Proceeds from termination of joint venture |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
164 |
|
|
|
|
|
|
|
164 |
|
Other, net |
|
|
|
|
|
|
3 |
|
|
|
7 |
|
|
|
|
|
|
|
|
|
|
|
10 |
|
Net intercompany investments |
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
1 |
|
|
|
|
|
|
|
|
|
Intercompany notes receivable |
|
|
40 |
|
|
|
71 |
|
|
|
(100 |
) |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from investing activities |
|
|
32 |
|
|
|
63 |
|
|
|
37 |
|
|
|
143 |
|
|
|
(11 |
) |
|
|
264 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock |
|
|
(752 |
) |
|
|
(650 |
) |
|
|
(631 |
) |
|
|
(70 |
) |
|
|
1,351 |
|
|
|
(752 |
) |
Dividends paid on preferred stock |
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32 |
|
|
|
|
|
Excess tax benefit from stock-based
compensation |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Proceeds from stock options exercised |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Repurchase of common stock |
|
|
(207 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(207 |
) |
Other, net |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Intercompany notes payable |
|
|
98 |
|
|
|
2 |
|
|
|
|
|
|
|
(111 |
) |
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows (used in) from financing
activities |
|
|
(889 |
) |
|
|
(648 |
) |
|
|
(631 |
) |
|
|
(181 |
) |
|
|
1,394 |
|
|
|
(955 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of
exchange rate changes on cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(23 |
) |
|
|
|
|
|
|
(23 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
(208 |
) |
|
|
61 |
|
|
|
247 |
|
|
|
14 |
|
|
|
|
|
|
|
114 |
|
Cash and cash equivalents at beginning of period |
|
|
243 |
|
|
|
25 |
|
|
|
1,623 |
|
|
|
324 |
|
|
|
|
|
|
|
2,215 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
35 |
|
|
$ |
86 |
|
|
$ |
1,870 |
|
|
$ |
338 |
|
|
$ |
|
|
|
$ |
2,329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) operating activities |
|
$ |
702 |
|
|
$ |
220 |
|
|
$ |
440 |
|
|
$ |
152 |
|
|
$ |
(226 |
) |
|
$ |
1,288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of short-term investments |
|
|
|
|
|
|
(2 |
) |
|
|
(3,559 |
) |
|
|
(102 |
) |
|
|
|
|
|
|
(3,663 |
) |
Proceeds from sale of short-term investments |
|
|
|
|
|
|
120 |
|
|
|
4,034 |
|
|
|
|
|
|
|
|
|
|
|
4,154 |
|
Capital expenditures |
|
|
(7 |
) |
|
|
|
|
|
|
(66 |
) |
|
|
(22 |
) |
|
|
|
|
|
|
(95 |
) |
Distributions from (investment in) equity
investees |
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
10 |
|
|
|
|
|
|
|
9 |
|
Net intercompany investments |
|
|
|
|
|
|
(260 |
) |
|
|
260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other, net |
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
(3 |
) |
|
|
|
|
|
|
(4 |
) |
Intercompany notes receivable |
|
|
40 |
|
|
|
|
|
|
|
(337 |
) |
|
|
|
|
|
|
297 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows from (used in) investing
activities |
|
|
33 |
|
|
|
(143 |
) |
|
|
331 |
|
|
|
(117 |
) |
|
|
297 |
|
|
|
401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from (used in) financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid on common stock |
|
|
(665 |
) |
|
|
|
|
|
|
(139 |
) |
|
|
(55 |
) |
|
|
194 |
|
|
|
(665 |
) |
Dividends paid on preferred stock |
|
|
(32 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32 |
|
|
|
|
|
Repayment of long-term debt |
|
|
(254 |
) |
|
|
(75 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(329 |
) |
Issuance of long-term debt |
|
|
1,547 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,547 |
|
Repayment of term loan |
|
|
(1,542 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,542 |
) |
Deferred debt issuance cost |
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15 |
) |
Excess tax benefit from stock-based
compensation |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Repurchase of common stock |
|
|
(60 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(60 |
) |
Intercompany notes payable |
|
|
288 |
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
(297 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flows used in financing activities |
|
|
(732 |
) |
|
|
(75 |
) |
|
|
(139 |
) |
|
|
(46 |
) |
|
|
(71 |
) |
|
|
(1,063 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
|
3 |
|
|
|
2 |
|
|
|
632 |
|
|
|
(11 |
) |
|
|
|
|
|
|
626 |
|
Cash and cash equivalents at beginning of period |
|
|
296 |
|
|
|
22 |
|
|
|
848 |
|
|
|
267 |
|
|
|
|
|
|
|
1,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
299 |
|
|
$ |
24 |
|
|
$ |
1,480 |
|
|
$ |
256 |
|
|
$ |
|
|
|
$ |
2,059 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
Condensed Consolidating Balance Sheets
(Dollars in Millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Non-Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
September 30, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
35 |
|
|
$ |
86 |
|
|
$ |
1,870 |
|
|
$ |
338 |
|
|
$ |
|
|
|
$ |
2,329 |
|
Short-term investments |
|
|
8 |
|
|
|
10 |
|
|
|
25 |
|
|
|
9 |
|
|
|
|
|
|
|
52 |
|
Accounts receivable, net |
|
|
|
|
|
|
|
|
|
|
35 |
|
|
|
44 |
|
|
|
|
|
|
|
79 |
|
Accounts receivable, related party |
|
|
|
|
|
|
|
|
|
|
65 |
|
|
|
2 |
|
|
|
|
|
|
|
67 |
|
Note receivable |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
32 |
|
|
|
|
|
|
|
33 |
|
Other receivables |
|
|
35 |
|
|
|
2 |
|
|
|
21 |
|
|
|
5 |
|
|
|
|
|
|
|
63 |
|
Inventories |
|
|
|
|
|
|
|
|
|
|
785 |
|
|
|
289 |
|
|
|
(2 |
) |
|
|
1,072 |
|
Deferred income taxes, net |
|
|
16 |
|
|
|
|
|
|
|
817 |
|
|
|
19 |
|
|
|
|
|
|
|
852 |
|
Prepaid expenses and other |
|
|
7 |
|
|
|
|
|
|
|
129 |
|
|
|
12 |
|
|
|
(5 |
) |
|
|
143 |
|
Short-term intercompany notes and
interest receivable |
|
|
81 |
|
|
|
35 |
|
|
|
450 |
|
|
|
|
|
|
|
(566 |
) |
|
|
|
|
Other intercompany receivables |
|
|
216 |
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
(235 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
398 |
|
|
|
134 |
|
|
|
4,197 |
|
|
|
769 |
|
|
|
(808 |
) |
|
|
4,690 |
|
Property, plant and equipment, net |
|
|
7 |
|
|
|
|
|
|
|
884 |
|
|
|
163 |
|
|
|
(1 |
) |
|
|
1,053 |
|
Trademarks, net |
|
|
|
|
|
|
|
|
|
|
1,689 |
|
|
|
1,540 |
|
|
|
|
|
|
|
3,229 |
|
Goodwill |
|
|
|
|
|
|
|
|
|
|
5,303 |
|
|
|
2,871 |
|
|
|
|
|
|
|
8,174 |
|
Other intangibles, net |
|
|
|
|
|
|
|
|
|
|
188 |
|
|
|
3 |
|
|
|
|
|
|
|
191 |
|
Long-term intercompany notes |
|
|
2,080 |
|
|
|
207 |
|
|
|
1,408 |
|
|
|
|
|
|
|
(3,695 |
) |
|
|
|
|
Investment in subsidiaries |
|
|
11,240 |
|
|
|
9,652 |
|
|
|
416 |
|
|
|
|
|
|
|
(21,308 |
) |
|
|
|
|
Other assets and deferred charges |
|
|
170 |
|
|
|
39 |
|
|
|
737 |
|
|
|
166 |
|
|
|
(31 |
) |
|
|
1,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
13,895 |
|
|
$ |
10,032 |
|
|
$ |
14,822 |
|
|
$ |
5,512 |
|
|
$ |
(25,843 |
) |
|
$ |
18,418 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals |
|
$ |
|
|
|
$ |
|
|
|
$ |
2,135 |
|
|
$ |
24 |
|
|
$ |
|
|
|
$ |
2,159 |
|
Accounts payable and other accrued liabilities |
|
|
410 |
|
|
|
6 |
|
|
|
817 |
|
|
|
99 |
|
|
|
(5 |
) |
|
|
1,327 |
|
Due to related party |
|
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Deferred revenue, related party |
|
|
|
|
|
|
|
|
|
|
13 |
|
|
|
|
|
|
|
|
|
|
|
13 |
|
Current maturities of long-term debt |
|
|
189 |
|
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200 |
|
Short-term
intercompany notes and interest payable |
|
|
36 |
|
|
|
404 |
|
|
|
2 |
|
|
|
124 |
|
|
|
(566 |
) |
|
|
|
|
Other intercompany payables |
|
|
|
|
|
|
69 |
|
|
|
166 |
|
|
|
|
|
|
|
(235 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
635 |
|
|
|
490 |
|
|
|
3,135 |
|
|
|
247 |
|
|
|
(806 |
) |
|
|
3,701 |
|
Intercompany notes |
|
|
1,409 |
|
|
|
|
|
|
|
|
|
|
|
2,286 |
|
|
|
(3,695 |
) |
|
|
|
|
Long-term debt (less current maturities) |
|
|
4,183 |
|
|
|
121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,304 |
|
Deferred income taxes, net |
|
|
|
|
|
|
|
|
|
|
692 |
|
|
|
559 |
|
|
|
(31 |
) |
|
|
1,220 |
|
Long-term retirement benefits (less current
portion) |
|
|
50 |
|
|
|
17 |
|
|
|
1,035 |
|
|
|
64 |
|
|
|
|
|
|
|
1,166 |
|
Other noncurrent liabilities |
|
|
30 |
|
|
|
91 |
|
|
|
308 |
|
|
|
10 |
|
|
|
|
|
|
|
439 |
|
Shareholders equity |
|
|
7,588 |
|
|
|
9,313 |
|
|
|
9,652 |
|
|
|
2,346 |
|
|
|
(21,311 |
) |
|
|
7,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity. |
|
$ |
13,895 |
|
|
$ |
10,032 |
|
|
$ |
14,822 |
|
|
$ |
5,512 |
|
|
$ |
(25,843 |
) |
|
$ |
18,418 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
243 |
|
|
$ |
25 |
|
|
$ |
1,623 |
|
|
$ |
324 |
|
|
$ |
|
|
|
$ |
2,215 |
|
Short-term investments |
|
|
|
|
|
|
|
|
|
|
377 |
|
|
|
|
|
|
|
|
|
|
|
377 |
|
Accounts receivable, net |
|
|
|
|
|
|
|
|
|
|
41 |
|
|
|
32 |
|
|
|
|
|
|
|
73 |
|
Accounts receivable, related party |
|
|
|
|
|
|
|
|
|
|
75 |
|
|
|
5 |
|
|
|
|
|
|
|
80 |
|
Notes receivable |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Other receivables |
|
|
7 |
|
|
|
1 |
|
|
|
14 |
|
|
|
3 |
|
|
|
|
|
|
|
25 |
|
Inventories |
|
|
|
|
|
|
|
|
|
|
908 |
|
|
|
290 |
|
|
|
(2 |
) |
|
|
1,196 |
|
Deferred income taxes, net |
|
|
11 |
|
|
|
1 |
|
|
|
814 |
|
|
|
19 |
|
|
|
|
|
|
|
845 |
|
Prepaid expenses and other |
|
|
6 |
|
|
|
|
|
|
|
168 |
|
|
|
6 |
|
|
|
|
|
|
|
180 |
|
61
Notes to Condensed Consolidated Financial Statements (Unaudited) (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Parent |
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor |
|
|
Issuer |
|
|
Guarantors |
|
|
Non-Guarantors |
|
|
Eliminations |
|
|
Consolidated |
|
Short-term intercompany notes and interest
receivable |
|
|
82 |
|
|
|
109 |
|
|
|
446 |
|
|
|
|
|
|
|
(637 |
) |
|
|
|
|
Other intercompany receivables |
|
|
153 |
|
|
|
|
|
|
|
|
|
|
|
29 |
|
|
|
(182 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
502 |
|
|
|
137 |
|
|
|
4,466 |
|
|
|
708 |
|
|
|
(821 |
) |
|
|
4,992 |
|
Property, plant and equipment, net |
|
|
8 |
|
|
|
|
|
|
|
936 |
|
|
|
130 |
|
|
|
(1 |
) |
|
|
1,073 |
|
Trademarks, net |
|
|
|
|
|
|
|
|
|
|
1,867 |
|
|
|
1,540 |
|
|
|
|
|
|
|
3,407 |
|
Goodwill |
|
|
|
|
|
|
|
|
|
|
5,302 |
|
|
|
2,872 |
|
|
|
|
|
|
|
8,174 |
|
Other intangibles, net |
|
|
|
|
|
|
|
|
|
|
199 |
|
|
|
3 |
|
|
|
|
|
|
|
202 |
|
Long-term intercompany notes |
|
|
2,120 |
|
|
|
225 |
|
|
|
1,310 |
|
|
|
|
|
|
|
(3,655 |
) |
|
|
|
|
Investment in subsidiaries |
|
|
10,848 |
|
|
|
9,240 |
|
|
|
87 |
|
|
|
|
|
|
|
(20,175 |
) |
|
|
|
|
Other assets and deferred charges |
|
|
186 |
|
|
|
34 |
|
|
|
534 |
|
|
|
51 |
|
|
|
(24 |
) |
|
|
781 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
13,664 |
|
|
$ |
9,636 |
|
|
$ |
14,701 |
|
|
$ |
5,304 |
|
|
$ |
(24,676 |
) |
|
$ |
18,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tobacco settlement accruals |
|
$ |
|
|
|
$ |
|
|
|
$ |
2,425 |
|
|
$ |
24 |
|
|
$ |
|
|
|
$ |
2,449 |
|
Accounts payable and other accrued liabilities |
|
|
391 |
|
|
|
5 |
|
|
|
873 |
|
|
|
143 |
|
|
|
|
|
|
|
1,412 |
|
Due to related party |
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
3 |
|
|
|
|
|
|
|
7 |
|
Deferred revenue, related party |
|
|
|
|
|
|
|
|
|
|
35 |
|
|
|
|
|
|
|
|
|
|
|
35 |
|
Short-term intercompany notes and interest
payable |
|
|
34 |
|
|
|
403 |
|
|
|
3 |
|
|
|
197 |
|
|
|
(637 |
) |
|
|
|
|
Other intercompany payables |
|
|
|
|
|
|
14 |
|
|
|
168 |
|
|
|
|
|
|
|
(182 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
425 |
|
|
|
422 |
|
|
|
3,508 |
|
|
|
367 |
|
|
|
(819 |
) |
|
|
3,903 |
|
Intercompany notes |
|
|
1,310 |
|
|
|
|
|
|
|
2 |
|
|
|
2,343 |
|
|
|
(3,655 |
) |
|
|
|
|
Long-term debt |
|
|
4,383 |
|
|
|
132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,515 |
|
Deferred income taxes, net |
|
|
|
|
|
|
2 |
|
|
|
643 |
|
|
|
563 |
|
|
|
(24 |
) |
|
|
1,184 |
|
Long-term retirement benefits (less current
portion) |
|
|
44 |
|
|
|
18 |
|
|
|
1,046 |
|
|
|
59 |
|
|
|
|
|
|
|
1,167 |
|
Other noncurrent liabilities |
|
|
36 |
|
|
|
92 |
|
|
|
262 |
|
|
|
4 |
|
|
|
|
|
|
|
394 |
|
Shareholders equity |
|
|
7,466 |
|
|
|
8,970 |
|
|
|
9,240 |
|
|
|
1,968 |
|
|
|
(20,178 |
) |
|
|
7,466 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
13,664 |
|
|
$ |
9,636 |
|
|
$ |
14,701 |
|
|
$ |
5,304 |
|
|
$ |
(24,676 |
) |
|
$ |
18,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
The following is a discussion and analysis of RAIs business, initiatives, critical accounting
policies and its consolidated results of operations and financial condition. Following the
overview and discussion of business initiatives, the critical accounting policies disclose certain
accounting policies that are material to RAIs results of operations and financial condition for
the periods presented in this report. The discussion and analysis of RAIs results of operations
compares the third quarter of 2008 with the third quarter of 2007 and the first nine months of 2008
with the first nine months of 2007. Disclosures related to liquidity and financial condition
complete managements discussion and analysis. You should read this discussion and analysis of
RAIs consolidated financial condition and results of operations in conjunction with the financial
information included in the condensed consolidated financial statements (unaudited).
Overview and Initiatives
RAIs reportable operating segments are RJR Tobacco and Conwood. RJR Tobacco consists of the
primary operations of R. J. Reynolds Tobacco Company. Conwood consists of the Conwood companies
and Lane. RAIs wholly owned operating subsidiaries Santa Fe and GPI, among others, are included
in All Other.
Santa Fe manufactures and markets cigarettes and other tobacco products under the NATURAL
AMERICAN SPIRIT brand. Beginning January 1, 2008, the management of super premium brands,
including DUNHILL and STATE EXPRESS 555 cigarette brands, was transferred to Santa Fe from RJR
Tobacco. GPI manufactures and exports tobacco products to U.S. territories, U.S. duty-free shops
and U.S. overseas military bases and manages the international businesses of Conwood and Santa Fe.
RJR Tobacco
RAIs largest reportable operating segment, RJR Tobacco, is the second largest cigarette
manufacturer in the United States. RJR Tobaccos largest selling cigarette brands, CAMEL, KOOL,
PALL MALL, DORAL and WINSTON, are five of the ten best-selling brands of cigarettes in the United
States as of September 30, 2008. Those brands, and its other brands, including SALEM, MISTY and
CAPRI, are manufactured in a variety of styles and marketed in the United States to meet a range of
adult smoker preferences. RJR Tobacco also manages contract manufacturing of cigarettes and
tobacco products through arrangements with BAT affiliates. On January 1, 2008, the contract
manufacturing business of GPI transferred to RJR Tobacco.
RJR Tobacco primarily conducts business in the highly competitive U.S. cigarette market with a
few large manufacturers and many smaller participants. The international rights to substantially
all of RJR Tobaccos brands were sold in 1999 to JTI. In addition, in connection with the B&W
business combination in 2004, RAI entered into a non-competition agreement with BAT under which
RAIs operating subsidiaries generally are prohibited, subject to certain exceptions, from
manufacturing and marketing certain tobacco products outside the United States until July 2009.
The U.S. cigarette market is a mature market in which overall consumer demand has declined
since 1981 and is expected to continue to decline. Trade inventory adjustments may result in
short-term changes in demand for RJR Tobaccos products when wholesale and retail tobacco
distributors adjust the timing of their purchases of product to manage their inventory levels. RJR
Tobacco believes it is not appropriate for it to speculate on other external factors that may
impact the purchasing decisions of the wholesale and retail tobacco distributors.
RJR Tobaccos brand portfolio strategy is based upon three categories: growth, support and
non-support. The growth brands consist of the premium brand CAMEL, and a value brand, PALL MALL.
The support brands include four premium brands, KOOL, WINSTON, SALEM and CAPRI, and two value
brands, DORAL and MISTY, all of which receive limited marketing support. During the third quarter
of 2008, RJR Tobacco announced that it was changing its brand portfolio strategy and reclassifying
KOOL to a support brand from a growth brand. The key objectives of the portfolio strategy are to
ensure the long-term market share growth of the growth brands while managing the support brands for
long-term sustainability and profitability. All remaining brands are non-support brands, and are
managed to maximize near-term profitability.
In addition to its brand portfolio strategy, RJR Tobacco remains focused on the following
items in response to the continuing challenges of an intensely regulated and competitive
environment:
63
|
|
|
its efforts to broaden its business with new types of tobacco products; |
|
|
|
|
its focus on continuous productivity improvement and complexity reduction; and |
|
|
|
|
its commitment to keep its cost structure in line with the companys
performance. |
RJR Tobacco is committed to building and maintaining a portfolio of profitable brands. RJR
Tobaccos marketing programs are designed to strengthen brand image, build brand awareness and
loyalty, and switch adult smokers of competing brands to RJR Tobacco brands. In addition to
building strong brand equity, RJR Tobaccos marketing approach utilizes a retail pricing strategy,
including discounting at retail, to defend certain brands shares of market against competitive
pricing pressure. RJR Tobaccos competitive pricing methods include list price changes,
discounting programs, such as retail buydowns, free product promotions and consumer coupons.
Retail buydowns refer to payments made to the retailer to reduce the price that consumers pay at
retail. Consumer coupons are distributed by a variety of methods, including in, or on, the
cigarette pack and by direct mail. Free product promotions include offers such as Buy 2 packs,
Get 1 pack free. The need for competitive pricing has increased significantly over time as a
result of, among other things, higher state excise taxes and the strength of deep-discount brands.
Deep-discount brands are brands marketed by manufacturers that are not original participants in the
MSA, and accordingly, do not have cost structures burdened with MSA payments to the same extent as
the original participating manufacturers.
Competition is based primarily on brand positioning, including price, product attributes and
packaging, consumer loyalty, promotions, advertising and retail presence. Cigarette brands produced
by the major manufacturers generally require competitive pricing, substantial marketing support,
retail programs and other incentives to maintain or improve market position or to introduce a new
brand style. RJR Tobacco, other cigarette manufacturers and smokeless tobacco manufacturers also
are introducing products in a new smokeless, spitless category, known as snus. CAMEL Snus is
pasteurized tobacco that is currently sold in a small pouch that provides discreet and convenient
tobacco consumption. RJR Tobacco expanded the sale of CAMEL Snus into a total of 17 markets in the first
half of 2008 and is planning to expand nationally in 2009.
In September 2008, RJR Tobacco completed a comprehensive business analysis to evaluate the
best way to continue to improve performance, efficiency and competitive position. As a result, RJR
Tobacco announced changes to its organizational structure to streamline non-core business processes
and programs in order to allocate additional resources to strategic growth initiatives. RJR
Tobacco has determined to evolve its operations to a total tobacco business model that includes
both cigarettes and innovative smokeless tobacco products. In October 2008, RJR Tobacco announced
its intent to introduce a new line of modern, smoke-free tobacco products called CAMEL Dissolvables
that include CAMEL Orbs, Sticks and Strips. CAMEL Dissolvables are made of finely milled tobacco,
and dissolve completely in the mouth. They are designed to provide current adult smokers and
smokeless tobacco users with additional, convenient alternative ways to enjoy tobacco products.
CAMEL Dissolvables will be launched in lead markets in the first half of 2009.
Conwood
RAIs other reportable segment, Conwood, is the second largest smokeless tobacco products
manufacturer in the United States. Conwoods primary brands include its largest selling moist
snuff brands, GRIZZLY and KODIAK, two of the seven best-selling brands of moist snuff in the United
States, and LEVI GARRETT, a loose leaf brand. Conwoods other products include dry snuff, plug and
twist tobacco products. Conwood also distributes a variety of other tobacco products including
WINCHESTER and CAPTAIN BLACK little cigars, and BUGLER roll-your-own tobacco.
The moist snuff category is divided into premium and price-value brands. The moist snuff
category has developed many of the characteristics of the larger cigarette market, including
pricing tiers with intense competition, focused marketing programs and significant product
innovation. GRIZZLY, the nations largest price-value brand, has led to Conwoods increased share
of the smokeless market. KODIAK is Conwoods leading premium brand.
In contrast to the declining U.S. cigarette market, U.S. moist snuff volumes grew at over 7%
for the first nine months of 2008 compared with the first nine months of 2007, driven by the
accelerated growth of price-value brands.
Profit margins on moist snuff products are generally higher than on cigarette products. Moist
snuffs growth is partially
64
attributable to cigarette smokers switching from cigarettes to
smokeless tobacco products or using both. Within the moist snuff category, premium brands have
lost market share to price-value brands, led by GRIZZLY, in recent years.
Conwood faces significant competition in the smokeless tobacco categories. Similar to the
cigarette market, competition is based primarily on brand positioning and price, as well as product
attributes and packaging, consumer loyalty, promotions, advertising and retail presence. Recently,
Altria Group Inc., parent company of Philip Morris USA Inc., announced it expected to complete its
acquisition of UST Inc., the largest smokeless tobacco products manufacturer in the United States,
in January 2009. RAI believes the acquisition of UST by Altria
could have a negative impact on the businesses of Conwood and RJR Tobacco.
Critical Accounting Policies
GAAP requires estimates and assumptions to be made that affect the reported amounts in RAIs
condensed consolidated financial statements (unaudited) and accompanying notes. Some of these
estimates require difficult, subjective and/or complex judgments about matters that are inherently
uncertain, and as a result, actual results could differ from those estimates. Due to the
estimation processes involved, the following summarized accounting policies and their application
are considered to be critical to understanding the business operations, financial condition and
results of operations of RAI and its subsidiaries.
Litigation
RAI discloses information concerning litigation for which an unfavorable outcome is more than
remote. RAI and its subsidiaries record their legal expenses and other litigation costs and
related administrative costs as selling, general and administrative expenses as those costs are
incurred. RAI and its subsidiaries will record any loss related to litigation at such time as an
unfavorable outcome becomes probable and the amount can be reasonably estimated. When the
reasonable estimate is a range, the recorded loss will be the best estimate within the range. If
no amount in the range is a better estimate than any other amount, the minimum amount of the range
will be recorded.
As discussed in note 12 to condensed consolidated financial statements (unaudited), RJR
Tobacco, the Conwood companies and their affiliates, including RAI, and indemnitees, have been
named in a number of tobacco-related legal actions, proceedings or claims seeking damages in
amounts ranging into the hundreds of millions or even billions of dollars. Unfavorable judgments
have been returned in a number of tobacco-related cases and state enforcement actions. As of
October 10, 2008, RJR Tobacco had paid approximately $12 million since January 1, 2006, related to
such unfavorable judgments.
RAI and its subsidiaries believe that they have valid bases for appeal of adverse verdicts
against them and have valid defenses to all actions, and they intend to defend all actions
vigorously. RAIs management continues to conclude that the loss of any particular smoking and
health tobacco litigation claim against RJR Tobacco or its affiliates or indemnitees, including
B&W, or the loss of any particular claim concerning the use of smokeless tobacco against the
Conwood companies, when viewed on an individual basis, is not probable or estimable. RJR has
liabilities totaling $94 million that were recorded in 1999 in connection with certain
indemnification claims, unrelated to smoking and health. These claims were asserted by JTI against
RJR and RJR Tobacco, concerning the activities of Northern Brands and related litigation.
Litigation is subject to many uncertainties, and it is possible that some of the
tobacco-related legal actions, proceedings or claims could ultimately be decided against RJR
Tobacco, the Conwood companies or their affiliates, including RAI, and indemnitees. Any
unfavorable outcome of such actions could have a material adverse effect on the consolidated
results of operations, financial position or cash flows of RAI or its subsidiaries.
Settlement Agreements
RJR Tobacco, Santa Fe and Lane are participants in the Master Settlement Agreement, and RJR
Tobacco is a participant in other state settlement agreements related to governmental health-care
cost recovery actions. Their obligations and the related expense charges under the MSA are subject
to adjustments based upon, among other things, the volume of cigarettes sold by the operating
subsidiaries, their relative market share and inflation. Since relative market share is based on
cigarette shipments, the best estimate of the allocation of charges
to RJR Tobacco under these agreements is
recorded in cost of products sold as the products are shipped. Adjustments to these estimates are
recorded in the period
that the change becomes probable and the amount can be reasonably estimated. The Conwood
companies are not
65
participants in the MSA. For more information related to historical and expected
settlement expenses and payments under the MSA, see -Litigation Affecting the Cigarette
Industry-Health-Care Cost Recovery Cases-MSA and -MSA-Enforcement and Validity in note 12 to
condensed consolidated financial statements (unaudited).
Income Taxes
Tax law requires certain items to be included in taxable income at different times than is
required for book reporting purposes under SFAS No. 109, Accounting for Income Taxes. These
differences may be permanent or temporary in nature. FIN No. 48, Accounting for Uncertainty in
Income Taxes, clarifies SFAS No. 109 by providing guidance for consistent reporting of uncertain
income tax positions recognized in a companys financial statements.
RAI determines its annual effective income tax rate based on forecasted pre-tax book income
and forecasted permanent book and tax differences. The rate is established at the beginning of the
year and is evaluated on a quarterly basis. Any changes to the forecasted information may cause
the effective rate to be adjusted. Additional tax, interest, and penalties associated with
uncertain tax positions are recognized in tax expense on a quarterly basis.
To the extent that any book and tax differences are temporary in nature, that is, the book
realization will occur in a different period than the tax realization, a deferred tax asset or
liability is established as required under SFAS No. 109. To the extent that a deferred tax asset
is created, management evaluates RAIs ability to realize this asset. Management currently
believes it is more likely than not that the deferred tax assets recorded in RAIs condensed
consolidated balance sheet (unaudited) will be realized. To the extent a deferred tax liability is
established under SFAS No. 109, it is recorded, tracked and, once it becomes currently due and
payable, paid to the taxing authorities.
The condensed consolidated financial statements (unaudited) reflect managements best estimate
of RAIs current and deferred tax liabilities and assets. Future events, including but not limited
to, additional resolutions with taxing authorities could have an impact on RAIs current estimate
of tax liabilities, realization of tax assets and upon RAIs effective income tax rate.
Restructuring Charge
During the third quarter of 2008, RAI and certain of its operating subsidiaries recorded
charges related to workforce reductions in accordance with the provisions of SFAS No. 112,
Employers Accounting for Postemployment Benefits, and SFAS No. 88, Employers Accounting for
Settlements and Curtailments of Defined Benefit Pension Plans and for Termination Benefits. The
calculation of severance pay requires management to estimate the population of employees to be
terminated and the timing of their severance from employment. The calculation of benefits charges
requires actuarial assumptions including determination of discount rates. These restructuring
charges were based on managements best estimate at the time of the restructuring. The status of
the restructuring activities is reviewed on a quarterly basis and any adjustments to the reserve,
which could differ from previous estimates, would be recorded as an adjustment to operating income.
See note 3 to condensed consolidated financial statements (unaudited) for more information related
to restructuring charges.
Trademark Impairment
During the third quarter of 2008, RJR Tobacco recorded a trademark impairment charge related
to its KOOL brand in accordance with the provisions of SFAS No. 142, Goodwill and Other Intangible
Assets. RAI generally engages an independent appraisal firm to assist it in determining the fair
value of its reporting units trademarks with indefinite lives annually in the fourth quarter or
more frequently if events indicate that the asset might be impaired. The determination of fair
value involves considerable estimates and judgment, including, among other things, developing
forecasts of future cash flows and determining an appropriate discount rate. Although RAI believes
it has based its impairment testing and impairment charges on reasonable estimates and assumptions,
the use of different estimates and assumptions could result in materially different results.
Generally, if the current competitive environment worsens or RAIs operating companies strategic
initiatives adversely affect their financial performance, the fair value of goodwill, trademarks
and other intangibles could be impaired in future periods. See note 2 to condensed consolidated
financial statements (unaudited) for more information related to RJR Tobaccos trademark
impairment.
66
Recently Adopted Accounting Pronouncements
Effective January 1, 2008, RAI adopted SFAS No. 157, Fair Value Measurements, for financial
assets and financial liabilities. SFAS No. 157 does not require any new fair value measurements
but provides a definition of fair value, establishes a framework for measuring fair value and
expands disclosure about fair value measurements. RAI will adopt SFAS No. 157 for nonfinancial
assets and nonfinancial liabilities on January 1, 2009. The adoption of SFAS No. 157 on financial
assets and financial liabilities did not have a material impact on RAIs consolidated results of
operations, financial position or cash flows. RAI is currently assessing the impact of SFAS No.
157 for nonfinancial assets and nonfinancial liabilities on its consolidated results of operations,
financial position and cash flows.
On October 10, 2008, the FASB issued FSP No. FAS 157-3, Determining the Fair Value of a
Financial Asset When the Market for That Asset Is Not Active. FSP FAS 157-3 clarifies the
application of SFAS No. 157, Fair Value Measurements, in a market that is not active
and provides an example to illustrate key considerations in determining the fair value of a
financial asset when the market for that financial asset is not active. FSP FAS 157-3 is effective
immediately, including prior periods for which financial statements have not been issued. RAI has
adopted FSP FAS 157-3 effective with the financial statements ended September 30, 2008. The
adoption of FSP FAS 157-3 had no impact on RAIs consolidated results of operations, financial
position or cash flows.
Recently Issued Accounting Pronouncements
In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and
Hedging Activities-an amendment of FASB Statement No. 133. SFAS No. 161 seeks qualitative
disclosures about the objectives and strategies for using derivatives, quantitative data about the
fair value of and gains and losses on derivative contracts, and details of credit-risk-related
contingent features in hedged positions. SFAS No. 161 also seeks enhanced disclosure around
derivative instruments in financial statements, accounting under SFAS No. 133, Accounting for
Derivative Instruments and Hedging Activities, and how hedges affect an entitys financial
position, financial performance and cash flows. SFAS No. 161 is effective for RAI as of January 1,
2009. RAI does not expect the adoption of SFAS No. 161 to have a material impact on its
consolidated results of operations, financial position or cash flows.
In April 2008, the FASB issued FSP No. FAS 142-3, Determination of the Useful Life of
Intangible Assets. FSP FAS 142-3 amends the factors that should be considered in developing
renewal or extension assumptions used to determine the useful life of a recognized intangible asset
under SFAS No. 142, Goodwill and Other Intangible Assets. The objective of FSP FAS 142-3 is to
improve the consistency between the useful life of a recognized intangible asset under SFAS No. 142
and the period of expected cash flows used to measure the fair value of the asset under SFAS No.
141(R) and GAAP. FSP FAS 142-3 is effective for financial statements issued for years beginning
after December 15, 2008, and interim periods within those years and is applied prospectively to
intangible assets acquired after the effective date. RAI does not expect the adoption of FSP FAS
142-3 to have a material impact on its financial position, results of operations or cash flows.
67
Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
2008 |
|
|
2007 |
|
|
Change |
|
|
2008 |
|
|
2007 |
|
|
Change |
|
Net sales:1
|
RJR Tobacco |
|
$ |
1,977 |
|
|
$ |
2,019 |
|
|
|
(2.1 |
)% |
|
$ |
5,798 |
|
|
$ |
5,995 |
|
|
|
(3.3 |
)% |
Conwood |
|
|
181 |
|
|
|
166 |
|
|
|
9.0 |
% |
|
|
536 |
|
|
|
495 |
|
|
|
8.3 |
% |
All Other |
|
|
114 |
|
|
|
112 |
|
|
|
1.8 |
% |
|
|
334 |
|
|
|
303 |
|
|
|
10.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
2,272 |
|
|
|
2,297 |
|
|
|
(1.1 |
)% |
|
|
6,668 |
|
|
|
6,793 |
|
|
|
(1.8 |
)% |
Cost of products sold1, 2 |
|
|
1,229 |
|
|
|
1,250 |
|
|
|
(1.7 |
)% |
|
|
3,698 |
|
|
|
3,768 |
|
|
|
(1.9 |
)% |
Selling, general and administrative expenses |
|
|
375 |
|
|
|
440 |
|
|
|
(14.8 |
)% |
|
|
1,148 |
|
|
|
1,237 |
|
|
|
(7.2 |
)% |
Amortization expense |
|
|
5 |
|
|
|
5 |
|
|
|
|
|
|
|
16 |
|
|
|
17 |
|
|
|
(5.9 |
)% |
Restructuring charge |
|
|
91 |
|
|
|
|
|
|
NM3 |
|
|
91 |
|
|
|
|
|
|
NM3 |
Trademark impairment charge |
|
|
173 |
|
|
|
|
|
|
NM3 |
|
|
173 |
|
|
|
|
|
|
NM3 |
Operating income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RJR Tobacco |
|
|
293 |
|
|
|
499 |
|
|
|
(41.3 |
)% |
|
|
1,231 |
|
|
|
1,483 |
|
|
|
(17.0 |
)% |
Conwood |
|
|
98 |
|
|
|
90 |
|
|
|
10.2 |
% |
|
|
275 |
|
|
|
260 |
|
|
|
6.0 |
% |
All Other |
|
|
35 |
|
|
|
37 |
|
|
|
(5.4 |
)% |
|
|
112 |
|
|
|
107 |
|
|
|
4.7 |
% |
Corporate expense |
|
|
(27 |
) |
|
|
(24 |
) |
|
|
12.5 |
% |
|
|
(76 |
) |
|
|
(79 |
) |
|
|
(3.8 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
$ |
399 |
|
|
$ |
602 |
|
|
|
(33.7 |
)% |
|
$ |
1,542 |
|
|
$ |
1,771 |
|
|
|
(12.9 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
Excludes excise taxes of:
|
|
RJR Tobacco |
|
$ |
438 |
|
|
$ |
474 |
|
|
|
|
|
|
$ |
1,276 |
|
|
$ |
1,413 |
|
|
|
|
|
Conwood |
|
|
5 |
|
|
|
5 |
|
|
|
|
|
|
|
15 |
|
|
|
14 |
|
|
|
|
|
All Other |
|
|
49 |
|
|
|
42 |
|
|
|
|
|
|
|
138 |
|
|
|
117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
492 |
|
|
$ |
521 |
|
|
|
|
|
|
$ |
1,429 |
|
|
$ |
1,544 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
See below for further information related to MSA settlement and federal tobacco buyout
expense included in cost of products sold. |
|
3 |
|
Percentage change not meaningful. |
In the third quarter of 2008, RAI and RJR Tobacco announced changes in their organizational
structures to streamline non-core business processes and programs in order to allocate additional
resources to strategic growth initiatives. The reorganizations will result in the elimination of
approximately 600 full-time jobs, expected to be substantially completed by December 31, 2009.
Under existing benefit plans, $84 million of severance-related cash benefits and $7 million of
non-cash pension-related benefits comprised a restructuring charge of $91 million. Of this charge,
$81 million was recorded in the RJR Tobacco segment. None of the cash portion of the charge was
paid as of September 30, 2008. The cash benefits are expected to be substantially paid by December
31, 2010. Cost savings related to the restructuring are expected to be $42 million in 2009, $53
million in 2010 and $55 million on an annualized basis thereafter.
RJR Tobacco
Net Sales
Domestic cigarette shipment volume, in billions of units for RJR Tobacco and the industry, was
as follows1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
% Change |
|
2008 |
|
2007 |
|
% Change |
Growth brands: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CAMEL excluding non-filter |
|
|
6.3 |
|
|
|
6.2 |
|
|
|
0.6 |
% |
|
|
17.7 |
|
|
|
18.5 |
|
|
|
(4.3 |
)% |
PALL MALL |
|
|
2.4 |
|
|
|
1.8 |
|
|
|
33.9 |
% |
|
|
6.2 |
|
|
|
5.3 |
|
|
|
17.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
68
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2008 |
|
2007 |
|
% Change |
|
2008 |
|
2007 |
|
% Change |
Total growth brands |
|
|
8.7 |
|
|
|
8.1 |
|
|
|
8.1 |
% |
|
|
23.9 |
|
|
|
23.8 |
|
|
|
0.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Support brands2 |
|
|
11.6 |
|
|
|
13.3 |
|
|
|
(12.7 |
)% |
|
|
35.5 |
|
|
|
39.7 |
|
|
|
(10.5 |
)% |
Non-support brands |
|
|
2.8 |
|
|
|
3.6 |
|
|
|
(23.2 |
)% |
|
|
8.4 |
|
|
|
11.1 |
|
|
|
(24.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic |
|
|
23.1 |
|
|
|
25.0 |
|
|
|
(7.5 |
)% |
|
|
67.8 |
|
|
|
74.6 |
|
|
|
(9.0 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total premium |
|
|
14.4 |
|
|
|
15.6 |
|
|
|
(8.0 |
)% |
|
|
42.5 |
|
|
|
46.5 |
|
|
|
(8.6 |
)% |
Total value |
|
|
8.7 |
|
|
|
9.4 |
|
|
|
(6.7 |
)% |
|
|
25.3 |
|
|
|
28.0 |
|
|
|
(9.7 |
)% |
Premium/Total mix |
|
|
62.2 |
% |
|
|
62.6 |
% |
|
|
|
|
|
|
62.7 |
% |
|
|
62.4 |
% |
|
|
|
|
|
Industry3: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium |
|
|
66.1 |
|
|
|
69.1 |
|
|
|
(4.4 |
)% |
|
|
190.2 |
|
|
|
198.2 |
|
|
|
(4.0 |
)% |
Value |
|
|
25.5 |
|
|
|
25.8 |
|
|
|
(1.0 |
)% |
|
|
71.5 |
|
|
|
72.6 |
|
|
|
(1.4 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic |
|
|
91.6 |
|
|
|
94.9 |
|
|
|
(3.4 |
)% |
|
|
261.7 |
|
|
|
270.7 |
|
|
|
(3.3 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium/Total mix |
|
|
72.2 |
% |
|
|
72.9 |
% |
|
|
|
|
|
|
72.7 |
% |
|
|
73.2 |
% |
|
|
|
|
|
|
|
1 |
|
Amounts presented in this table are rounded on an individual basis and, accordingly,
may not sum on an aggregate basis. Percentages are calculated on unrounded numbers. |
|
2 |
|
During the third quarter of 2008, the KOOL brand was reclassified from a growth
brand to a support brand.
|
|
3 |
|
Based on information from Management Science Associates, Inc., referred to as MSAi.
Prior year amounts have been restated to reflect current methodology.
|
RJR Tobaccos net sales are dependent upon its shipment volume in a declining market, premium
versus value-brand mix and list pricing, offset by promotional spending, trade incentives and
federal excise taxes. RJR Tobaccos net sales for the third quarter of 2008 decreased $42 million,
or 2.1%, from the comparable prior-year quarter, including $161 million attributable to lower
volume, partially offset by higher pricing, net of promotional spending. RJR Tobaccos domestic
shipment volume decreased 7.5% in the third quarter of 2008 compared with the prior-year quarter.
RJR Tobaccos decreases in net sales and shipment volume reflect a decrease in consumption,
wholesale inventory reductions and the impact of RJR Tobaccos discontinuation of certain
lower-priced, low-margin brands as well as several non-core styles of other brands, including
CAMEL. In addition, RJR Tobaccos consumers are believed to be more price-sensitive than consumers
of competing brands and, therefore, are more negatively affected by the current adverse economic
pressures. Industry shipment volume for the third quarter of 2008 was down 3.4% from the
comparable quarter in the prior year.
RJR Tobaccos net sales for the first nine months of 2008 decreased $197 million, or 3.3%,
from the first nine months of 2007. Lower volume of $575 million, partially offset by higher
pricing, net of promotional spending, account for the difference. Total domestic shipment volume
decreased 9.0% in the first nine months of 2008 compared with the first nine months of 2007.
Industry shipment volume for the first nine months of 2008 was down 3.3% compared with the first
nine months of 2007.
RJR Tobaccos full-year shipment volume decline in 2008 compared with 2007 is expected to be
approximately 8%, inclusive of the impact of the KOOL repositioning.
The shares of RJR Tobacco as a percentage of total share of U.S. retail cigarette sales
according to data1 from Information Resources, Inc./Capstone Research Inc., collectively
referred to as IRI, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended2 |
|
|
September 30, |
|
June 30, |
|
Share Point |
|
September 30, |
|
Share Point |
|
|
2008 |
|
2008 |
|
Change |
|
2007 |
|
Change |
Growth brands: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CAMEL excluding
non-filter |
|
|
8.1 |
% |
|
|
8.0 |
% |
|
|
0.2 |
|
|
|
8.0 |
% |
|
|
0.1 |
|
PALL MALL |
|
|
2.7 |
% |
|
|
2.6 |
% |
|
|
0.1 |
|
|
|
2.1 |
% |
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total growth brands |
|
|
10.8 |
% |
|
|
10.5 |
% |
|
|
0.3 |
|
|
|
10.1 |
% |
|
|
0.7 |
|
69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended2 |
|
|
September 30, |
|
June 30, |
|
Share Point |
|
September 30, |
|
Share Point |
|
|
2008 |
|
2008 |
|
Change |
|
2007 |
|
Change |
Support brands3 |
|
|
13.8 |
% |
|
|
13.9 |
% |
|
|
(0.1 |
) |
|
|
14.5 |
% |
|
|
(0.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-support brands |
|
|
3.5 |
% |
|
|
3.6 |
% |
|
|
(0.1 |
) |
|
|
4.3 |
% |
|
|
(0.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total domestic |
|
|
28.2 |
% |
|
|
28.1 |
% |
|
|
0.1 |
|
|
|
29.0 |
% |
|
|
(0.8 |
) |
|
|
|
1 |
|
Retail share of U.S. cigarette sales data is included in this document because it is
used by RJR Tobacco primarily as an indicator of the relative performance of industry participants,
and brands and market trends. You should not rely on the market share data reported by IRI as
being a precise measurement of actual market share because IRI is not able to effectively track all
volume. Moreover, you should be aware that in a product market experiencing overall declining
consumption, a particular product can experience increasing market share relative to competing
products, yet still be subject to declining consumption volumes. |
|
2 |
|
Amounts presented in this table are rounded on an individual basis and, accordingly,
may not sum on an aggregate basis. |
|
3 |
|
During the third quarter of 2008, the KOOL brand was reclassified from a growth
brand to a support brand. |
The retail share of market of CAMELs filtered styles increased slightly in the third quarter
of 2008 compared with the prior quarter and the third quarter of 2007. During the first half of
2008, CAMEL launched updated packaging and smoother blends for its core styles. CAMEL also
introduced CAMEL Crush in test markets during the first quarter of 2008. CAMEL Crush is an
innovative cigarette that uses RJR Tobaccos technology to provide adult smokers the option of
changing each cigarette from regular to menthol by crushing a capsule in the filter. CAMEL Crush
was expanded nationally during the third quarter of 2008. Continuing its planned expansion in
2008, CAMEL Snus is currently in 17 markets and is planned to be expanded nationally in 2009.
Additionally, in October 2008, RJR Tobacco introduced a new line of modern, smoke-free tobacco
products called CAMEL Dissolvables that include CAMEL Orbs, Sticks and Strips. CAMEL Dissolvables
are made of finely milled tobacco, and dissolve completely in the mouth. They are designed to
provide current adult smokers and smokeless tobacco users with additional, convenient alternative
ways to enjoy tobacco products. CAMEL Dissolvables will be launched in lead markets in the first
half of 2009.
PALL MALLs market share increased 0.1 share points in the third quarter of 2008 compared with
the previous quarter and increased 0.5 share points from the comparable quarter of 2007. PALL
MALLs growth is believed to be the result of the brands position as a product that offers a
longer-lasting cigarette at a value price. PALL MALL introduced more stylish, round-corner packs
in the second quarter of 2008.
The combined share of market of RJR Tobaccos growth brands during the first nine months of
2008 showed improvement over the comparative prior-year period. However, as expected, the decline
in share of support and non-support brands more than offset the gains on the growth brands.
Operating Income
RJR Tobaccos operating income for the third quarter of 2008 decreased $206 million to $293
million, or 14.8% of net sales, from $499 million, or 24.7% of net sales, in the comparable
prior-year quarter. For the nine months ended September 30, 2008, RJR Tobaccos operating income
decreased $252 million to $1,231 million, or 21.2% of net sales, from $1,483 million, or 24.7% of
net sales, for the first nine months of 2007. The change in brand
portfolio strategy and reclassification of the
KOOL brand to a support brand from a growth brand in the third quarter of 2008 triggered a non-cash
trademark impairment of $173 million. This charge was based on the excess of KOOLs carrying value
over its fair value using the present value of estimated future cash flows assuming a discount rate
of 10.5%. The discount rate was determined by adjusting the enterprise discount rate by an
appropriate risk premium to reflect an asset group risk. In addition, RJR Tobacco incurred
a restructuring charge of $81 million in the third quarter of 2008 as a result of streamlining
non-core business processes and programs and eliminating approximately 540 full-time positions.
The trademark impairment charge and restructuring charge were partially offset by higher pricing,
improvements in productivity and higher levels of undiscounted wholesale inventory. Additionally,
RJR Tobaccos volume and operating income were negatively impacted by the discontinuation of
certain lower-priced, low-margin brands as well as several non-core styles of other brands,
including CAMEL.
70
RJR Tobaccos MSA settlement and federal tobacco buyout expenses, included in cost of products
sold, are detailed in the schedule below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For The Three Months |
|
|
For The Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
|
|
2008 |
|
|
2007 |
|
|
2008 |
|
|
2007 |
|
Settlements |
|
$ |
686 |
|
|
$ |
712 |
|
|
$ |
2,050 |
|
|
$ |
2,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal tobacco quota buyout. |
|
$ |
57 |
|
|
$ |
59 |
|
|
$ |
180 |
|
|
$ |
197 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MSA expenses are expected to be approximately $2.7 billion in 2008, subject to adjustment for
changes in volume and other factors, and the federal tobacco quota buyout is expected to be
approximately $250 million in 2008. For additional information,
see Litigation Affecting the
Cigarette Industry-Health-Care Cost Recovery Cases MSA and Tobacco Buyout Legislation and
Related Litigation in note 12 to condensed consolidated financial statements (unaudited).
Selling, general and administrative expenses include the costs of litigating and administering
product liability claims, as well as other legal expenses. RJR Tobaccos product liability defense
costs were $21 million and $16 million for the three months, and $72 million and $67 million for the
nine months, ended September 30, 2008 and 2007, respectively.
Product liability cases generally include the following types of smoking and health related
cases:
|
|
|
Individual Smoking and Health; |
|
|
|
|
Engle Progeny; |
|
|
|
|
Broin II; |
|
|
|
|
Class Actions; and |
|
|
|
|
Health-Care Cost Recovery Cases. |
Product liability defense costs include the following items:
|
|
|
direct and indirect compensation, fees and related costs and expenses for
internal legal and related administrative staff administering product liability
claims; |
|
|
|
|
fees and cost reimbursements paid to outside attorneys; |
|
|
|
|
direct and indirect payments to third party vendors for litigation support
activities; |
|
|
|
|
expert witness costs and fees; and |
|
|
|
|
payments to fund legal defense costs for the now dissolved Council for Tobacco
Research-U.S.A. |
Numerous factors affect the amount of product liability defense costs. The most important
factors are the number of cases pending and the number of cases in trial or in preparation for
trial (that is, with active discovery and motions practice). See Litigation Affecting the
Cigarette IndustryOverview for detailed information regarding the number and type of cases
pending, and Litigation Affecting the Cigarette IndustryScheduled Trials for detailed
information regarding the number and nature of cases in trial and scheduled for trial through
September 30, 2009, in note 12 to condensed consolidated financial statements (unaudited).
RJR Tobacco expects that the factors described above will continue to have the primary impact
on its product liability defense costs in the future. Given the level of activity in cases in
preparation for trial, in trial and on appeal, and the amount of product liability defense costs
incurred by RJR Tobacco in the past, RJR Tobaccos recent
71
experiences in defending its product liability cases, and the reasonably anticipated level of
activity in RJR Tobaccos pending cases and possible new cases, RJR Tobacco does not expect that
the variances in its product liability defense costs will be significantly different than they have
been historically, aside from the assumption of certain B&W litigation and the increased individual
case filings in Florida due to the Engle decision. See Litigation Affecting the Cigarette
IndustryEngle Progeny Cases and Litigation Affecting the Cigarette IndustryClass Action
SuitsEngle Case in note 12 to condensed consolidated financial statements (unaudited) for
additional information. However, it is possible that adverse developments in the factors discussed
above, as well as other circumstances beyond the control of RJR Tobacco, could have a material
adverse effect on the financial condition, results of operations or cash flows of RAI or its
subsidiaries. Those other circumstances beyond the control of RJR Tobacco include the results of
present and future trials and appeals, and the development of possible new theories of liability by
plaintiffs and their counsel.
Conwood
The moist snuff shipment volume, in millions of cans, for Conwood was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30,1 |
|
For the Nine Months Ended September 30,1 |
|
|
2008 |
|
2007 |
|
% Change |
|
2008 |
|
2007 |
|
% Change |
Premium: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
KODIAK |
|
|
13.6 |
|
|
|
12.9 |
|
|
|
5.5 |
% |
|
|
39.5 |
|
|
|
39.9 |
|
|
|
(1.0 |
)% |
Other |
|
|
0.7 |
|
|
|
0.8 |
|
|
|
(6.5 |
)% |
|
|
2.1 |
|
|
|
2.4 |
|
|
|
(11.1 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Premium |
|
|
14.3 |
|
|
|
13.6 |
|
|
|
4.8 |
% |
|
|
41.6 |
|
|
|
42.2 |
|
|
|
(1.6 |
)% |
Price-value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GRIZZLY |
|
|
69.8 |
|
|
|
61.4 |
|
|
|
13.6 |
% |
|
|
205.9 |
|
|
|
174.9 |
|
|
|
17.7 |
% |
Other |
|
|
0.4 |
|
|
|
0.7 |
|
|
|
(42.1 |
)% |
|
|
1.3 |
|
|
|
1.8 |
|
|
|
(24.3 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Price-value |
|
|
70.2 |
|
|
|
62.1 |
|
|
|
12.9 |
% |
|
|
207.2 |
|
|
|
176.7 |
|
|
|
17.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total moist snuff |
|
|
84.5 |
|
|
|
75.8 |
|
|
|
11.5 |
% |
|
|
248.8 |
|
|
|
218.9 |
|
|
|
13.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate
basis. Percentages are calculated on unrounded numbers. |
The Conwood shares of the moist snuff category as a percentage of total share of
U.S. shipments of moist
snuff, according to distributor reported data1 processed by MSAi, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended2 |
|
|
September 30, |
|
June 30, |
|
Share Point |
|
September 30, |
|
Share Point |
|
|
2008 |
|
2008 |
|
Change |
|
2007 |
|
Change |
Premium: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
KODIAK |
|
|
4.2 |
% |
|
|
3.9 |
% |
|
|
0.3 |
|
|
|
4.3 |
% |
|
|
(0.1 |
) |
Other |
|
|
0.3 |
% |
|
|
0.2 |
% |
|
|
0.1 |
|
|
|
0.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Premium |
|
|
4.5 |
% |
|
|
4.2 |
% |
|
|
0.3 |
|
|
|
4.6 |
% |
|
|
(0.1 |
) |
Price-value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GRIZZLY |
|
|
23.4 |
% |
|
|
23.4 |
% |
|
|
|
|
|
|
21.2 |
% |
|
|
2.1 |
|
Other |
|
|
0.1 |
% |
|
|
0.2 |
% |
|
|
(0.1 |
) |
|
|
0.2 |
% |
|
|
(0.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Price-value |
|
|
23.5 |
% |
|
|
23.6 |
% |
|
|
(0.1 |
) |
|
|
21.4 |
% |
|
|
2.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total moist snuff |
|
|
28.0 |
% |
|
|
27.8 |
% |
|
|
0.2 |
|
|
|
26.0 |
% |
|
|
2.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Distributor shipments-to-retail share of U.S. moist snuff is included in this document because it is used by Conwood primarily as an indicator of the relative
performance of industry participants, and brands and market trends. You should not rely on the market share data reported by distributors and processed by MSAi as being a
precise measurement of actual market share because this distributor data set is not able to effectively track all volume. |
|
2 |
|
Amounts presented in this table are rounded on an individual basis and, accordingly, may not sum on an aggregate basis. |
72
Net Sales
Conwoods net sales for the third quarter of 2008 were $181 million compared with $166 million
in the third quarter of 2007. Net sales for the first nine months of 2008 were $536 million
compared with $495 million for the first nine months of 2007. Moist snuff sales generated the
increases over prior-year periods led by GRIZZLY, Conwoods leading price-value moist snuff brand.
GRIZZLY had a share position of 23.4% of moist snuff shipments in the third quarter of 2008,
stable with the previous quarter and an increase of 2.1 points from the third quarter of 2007. In
2008, Conwood expanded nationally the launch of two new GRIZZLY styles, GRIZZLY Wintergreen Pouches
and GRIZZLY Snuff, to build on the brands momentum and aid in its share growth. The shipment
share of KODIAK, Conwoods leading premium moist snuff brand, increased compared with the prior
quarter due to increased promotions, but declined slightly compared with prior-year quarter due to
competitive promotional activity and core markets being burdened by high tobacco taxes and tough
economies.
Operating Income
Conwoods operating income for the third quarter of 2008 increased to $98 million, or 54.1% of
net sales, from $90 million, or 53.5% of net sales, in the comparable prior-year quarter.
Operating income for the first nine months of 2008 increased to $275 million, or 51.3% of net
sales, from $260 million, or 52.4% of net sales, for the first nine months of 2007. These changes
are due to increased price-value volume and higher pricing offset by increased promotional
spending.
RAI Consolidated
Gain on termination of joint venture of $328 million in 2008 related to the termination of the
Reynolds-Gallaher International Sarl joint venture. See note 4 to condensed consolidated financial
statements (unaudited) for additional information related to the joint venture termination.
Other
(income) expense, net was $13 million expense in the
third quarter of 2008 compared with $7 million of income in the third quarter of 2007. For the nine months ended September 30, 2008,
other (income) expense, net was $3 million expense, which consisted primarily of $3 million of foreign
exchange losses and a $2 million realized loss on investments and higher bank fees, offset by a
gain of $5 million related to the sale of a non-consolidated equity investment. Other (income)
expense, net of $8 million expense for the first nine months of 2007 included the expensing of the
unamortized debt fees associated with a term loan that RAI prepaid in full in June 2007, which more
than offset foreign exchange gain and equity income.
Provision for income taxes was $123 million, or an effective rate of 36.8%, in the third
quarter of 2008 compared with $203 million, or an effective rate of 36.2%, in the third quarter of
2007. The provision for income taxes for the first nine months of 2008 was $630 million, or an
effective rate of 36.8%, compared with $590 million, or an effective rate of 36.9%, in the first
nine months of 2007. The effective rate for the first nine months of 2008 was favorably impacted
by a lower tax rate related to the gain on the termination of the Reynolds-Gallaher International
Sarl joint venture. The effective tax rates exceeded the federal statutory rate of 35% primarily
due to the impact of state taxes and certain non-deductible items, offset by the domestic
production activities deduction of the American Jobs Creation Act, enacted on October 22, 2004.
Liquidity and Financial Condition
Liquidity
At present, the principal sources of liquidity for RAIs operating subsidiaries businesses
and operating needs are internally generated funds from their operations and intercompany loans and
advances, mainly from RAI and RJR. The principal capital resources and sources of liquidity for
RAI and RJR, in turn, are proceeds from issuances of debt securities by RAI and RJR and the RAI
Credit Facility described below under Borrowing Arrangements. Cash flows from operating
activities are believed to be sufficient for the foreseeable future to enable the operating
subsidiaries to meet their obligations under the MSA, to fund their capital expenditures and to
make payments to RAI
73
and RJR that, when combined with RAIs and RJRs cash balances, will enable RAI and RJR to make
their required debt-service payments, and enable RAI to pay dividends to its shareholders.
The negative impact, if any, on the sources of liquidity that could result from a decrease in
demand for products due to short-term inventory adjustments by wholesale and retail distributors,
changes in competitive pricing or accelerated declines in consumption, cannot be predicted. RAI
cannot predict its cash requirements or those of its subsidiaries related to any future settlements
or judgments, including cash required to be held in escrow or to bond any appeals, if necessary,
and RAI makes no assurance that it or its subsidiaries will be able to meet all of those
requirements.
As of September 30, 2008, RAI held investments primarily in money market funds, commercial
paper, auction rate notes and mortgage-backed securities. In September 2008, certain money market
funds were reclassified to short-term investments from cash equivalents due to liquidity
restrictions by the fund managers. Given such restrictions, these funds will not be available until the
underlying investments mature or are sold. Adverse changes in financial markets during 2007 caused
certain auction rate notes and mortgage-backed securities to revalue
lower than their carrying value
and become less liquid. Auction rate notes and mortgage-backed securities will not become liquid
until a successful auction occurs or a buyer is found. RAI intends, and has the ability, to hold
these money market funds, auction rate notes and mortgage-backed securities for a period of time
sufficient to allow for sale, redemption or anticipated recovery in fair value. RAI considers the
auction rate notes and mortgage-backed securities to be temporarily impaired as of September 30,
2008.
Cash Flows
Net
cash flows from operating activities were $828 million in the first nine months of 2008,
compared with $1,288 million in the first nine months of 2007. This change was driven primarily by
higher MSA and tax payments, partially offset by lower pension funding in 2008.
Net
cash flows from investing activities were $264 million in the first nine months of 2008,
compared with $401 million in the prior-year period. This change was primarily driven by proceeds
received as a result of the termination of the joint venture in 2008 compared with higher
short-term investing net proceeds in the prior-year period.
Net cash flows used in financing activities were $955 million in the first nine months of
2008, compared with $1,063 million in the prior-year period. This change was due to prior-year
repayment of long-term debt, offset by higher stock repurchases and higher dividends per share in
the current-year period.
Borrowing Arrangements
As of September 30, 2008, RAIs total consolidated debt consisted of RAI Notes in the
aggregate principal amount of $4.3 billion, with maturity dates ranging from 2009 to 2037, and RJR
notes in the aggregate principal amount of $129 million, with maturity dates ranging from 2009 to
2015.
RAI and RJR use interest rate swaps to manage interest rate risk on a portion of their debt
obligations. Under certain conditions, any fair value that results in a liability position of
certain interest rate swaps may require full collateralization with cash or securities.
At their option, RAI and RJR, as applicable, may redeem any or all of their outstanding fixed
rate notes, in whole or in part at any time, subject to the payment of a make-whole premium. RAIs
floating rate notes are redeemable at par on any interest payment date after December 15, 2008.
On June 28, 2007, RAI entered into the Credit Facility. The Credit Facility provides for a
five-year, $550 million revolving credit facility, which may be increased to $900 million at the
discretion of the lenders upon the request of RAI. The Credit Facilitys maturity date of June 28,
2012, may be extended, at the discretion of the lenders upon RAIs request, in two separate
one-year increments.
74
Lenders and their respective commitments in the Credit Facility, which are several, not joint,
commitments, are listed below:
|
|
|
|
|
Lender |
|
Commitment |
|
JP Morgan Chase Bank, N.A. |
|
$ |
52.89 |
|
Citibank N.A. |
|
|
52.89 |
|
Morgan Stanley Bank |
|
|
52.00 |
|
Lehman Commercial Paper Inc. |
|
|
52.00 |
|
Mizuho Corporate Bank, Ltd. |
|
|
52.00 |
|
General Electric Capital Corporation |
|
|
52.00 |
|
AG First Farm Credit Bank |
|
|
52.00 |
|
Goldman Sachs Bank USA |
|
|
35.00 |
|
Wachovia Bank, National Association |
|
|
35.00 |
|
The Bank of Nova Scotia |
|
|
35.00 |
|
The Bank of New York |
|
|
35.00 |
|
Farm Credit Services of Minnesota Valley, PCA DBA FCS Commercial Finance Group |
|
|
20.00 |
|
City National Bank of New Jersey |
|
|
14.22 |
|
Farm Credit Bank of Texas |
|
|
10.00 |
|
|
|
|
|
|
|
$ |
550.00 |
|
|
|
|
|
On October 9, 2008, Wells Fargo & Company reaffirmed that it is proceeding with its merger
with Wachovia Corporation, the parent company of Wachovia Bank, National Association, pursuant to
which Wells Fargo will acquire all of Wachovia Corporation and all its business and its
obligations.
At September 30, 2008, RAI had $12 million in letters of credit outstanding under the Credit
Facility. At such date, no borrowings were outstanding, and the remaining $538 million of the
Credit Facility was available for borrowing.
On October 5, 2008, LCPI filed for protection under Chapter 11 of the federal Bankruptcy Code.
RAI has never borrowed under the Credit Facility, but given LCPIs bankruptcy filing, there can be
no assurance that LCPI would loan to RAI LCPIs pro rata share of any borrowing requests made by
RAI. Subject to the terms and conditions in the Credit Facility, RAI has the right to replace a
lender in certain circumstances, including upon a lender defaulting in its obligation to make
loans. If any lender were to default in its obligation to make loans, there can be no assurance as
to when or whether RAI could find an acceptable replacement lender.
The Guarantors
have guaranteed RAIs obligations under the Credit Facility and under the
Notes. During the second quarter of 2008, the collateral securing the Credit Facility, Notes and
related guarantees was released as a result of certain corporate credit ratings actions by S&P and
Moodys. The collateral for the Credit Facility, Notes and related guarantees will be reinstated
if RAIs corporate credit rating issued by each of S&P and Moodys is lowered to at least one level
below the lowest rating level established as investment grade, or if RAIs corporate credit rating
issued by either S&P or Moodys is lowered to at least two levels below the lowest rating level
established as investment grade. For more information on the release of collateral, see note 10 to
condensed consolidated financial statements (unaudited).
Prior to the credit ratings actions described above, RAI had pledged substantially all of its
assets, including the stock of its direct subsidiaries, to secure its obligations under the Credit
Facility, and the Guarantors had pledged substantially all of their assets to secure their
guarantees of RAIs obligations under the Credit Facility. Also prior to such credit ratings
actions, the Notes and related guarantees had been secured by any Principal Property, as such term
is defined in the indenture governing the Notes, of RAI and certain of the Guarantors, and the
stock, indebtedness or other obligations of RJR Tobacco.
Concerns about, or lowering of, RAIs ratings by S&P or Moodys could have an adverse impact
on RAIs ability to access the debt markets and could increase borrowing costs. However, given the
cash balances and operating performance of RAI and its subsidiaries, RAIs management believes that
such concerns about, or lowering of, such ratings would not have a material adverse impact on RAIs
cash flows.
RAI, RJR and their affiliates were in compliance with all covenants and restrictions imposed
by their indebtedness at September 30, 2008.
75
Dividends
On July 18, 2008, the board of directors of RAI declared a quarterly cash dividend of $0.85
per common share. The dividend was paid on October 1, 2008, to shareholders of record as of
September 10, 2008.
On an annualized basis, the dividend rate is $3.40 per common share. The dividend reflects
RAIs dividend policy of paying dividends to the holders of RAIs common stock in an aggregate
amount that is approximately 75% of RAIs annual consolidated net income.
Share Repurchases
On April 29, 2008, RAIs board of directors authorized RAIs repurchase, from time to time on
or before April 30, 2009, of up to $350 million of outstanding shares of RAI common stock in open
market or privately negotiated transactions. The repurchases are subject to prevailing market and
business conditions, and the program may be terminated or suspended at any time. In connection
with the share repurchase program, RAI and B&W entered into an agreement, pursuant to which B&W has
agreed to participate in the repurchase program on a basis approximately proportionate with B&Ws
42% ownership of RAIs equity. This repurchase program supersedes the $30 million repurchase
program authorized by RAIs board of directors on February 5, 2008, to offset the dilution from
shares issued under certain equity-based benefit plans.
Due to RAIs incorporation in North Carolina, which does not recognize treasury shares, the
shares repurchased are cancelled at the time of repurchase. As of September 30, 2008, RAI had
repurchased and cancelled 3,817,095 shares of RAI common stock for $207 million under the above
share repurchase programs.
Capital Expenditures
RAIs operating subsidiaries cash capital expenditures were $95 million for each of the first
nine months of 2008 and 2007. RAIs operating subsidiaries plan to spend an additional $40
million to $50 million for capital expenditures in the fourth quarter of 2008, funded primarily by
cash flows from operations. Most of the capital spending will be done in the RJR Tobacco segment.
RAIs operating subsidiaries capital expenditure programs are expected to continue at a level
sufficient to support their strategic and operating needs. There were no material long-term
commitments for capital expenditures as of September 30, 2008.
Retirement Benefits
Due to the adverse changes in the financial markets, RAIs pension assets have been negatively
impacted. Through September 30, 2008, the overall year-to-date rate of return on the investments
for the pension assets was approximately negative 16.3%. RAI is assessing the asset allocation and
investment strategy to determine if any adjustments may be appropriate in light of changes in the
accounting for and regulation of pension plans, such as the adoption of the Pension Protection Act
of 2006. Depending on the results of any new asset allocation and investment strategy, RAI may
lower the expected long-term return on pension assets, referred to as the ELTRA. The ELTRA,
current asset performance and the discount rate may impact the funded status of RAIs pension
plans, and possibly increase the funding requirements and pension expense in 2009.
Governmental Activity
The marketing, sale, taxation and use of tobacco products have been subject to substantial
regulation by government and health officials for many years. Various state governments have
adopted or are considering, among other things, legislation and regulations that would:
|
|
|
significantly increase their taxes on tobacco products; |
|
|
|
|
restrict displays, advertising and sampling of tobacco products; |
|
|
|
|
establish fire standards compliance for cigarettes; |
|
|
|
|
raise the minimum age to possess or purchase tobacco products; |
76
|
|
|
restrict or ban the use of certain flavorings, including menthol, in tobacco
products, or the use of certain flavor descriptors in the marketing of tobacco
products; |
|
|
|
|
require the disclosure of ingredients used in the manufacture of tobacco
products; |
|
|
|
|
require the disclosure of nicotine yield information for cigarettes based on a
machine test method different from that required by the U.S. Federal Trade Commission,
referred to as the FTC; |
|
|
|
|
impose restrictions on smoking in public and private areas; and |
|
|
|
|
restrict the sale of tobacco products directly to consumers or other unlicensed
recipients, including over the Internet. |
In addition, during 2009, the U.S. Congress likely will reconsider legislation regarding the
regulation of tobacco products by the U.S. Food and Drug Administration, referred to as the FDA, as
well as a further increase in the federal excise tax on cigarettes and other tobacco products. The
U.S. Congress also may consider legislation regarding:
|
|
|
regulation of environmental tobacco smoke; |
|
|
|
|
implementation of national fire standards compliance for cigarettes; |
|
|
|
|
the FTCs cigarette test method; |
|
|
|
|
regulation of the retail sale of tobacco products over the Internet and in
other non-face-to-face retail transactions, such as by mail order and telephone; and |
|
|
|
|
banning of the delivery of tobacco products by the U.S. Postal Service. |
Together with manufacturers price increases in recent years and substantial increases in
state and federal taxes on tobacco products, these developments have had and will likely continue
to have an adverse effect on the sale of tobacco products.
In February 2007, legislation was introduced in the U.S. House of Representatives and the U.S.
Senate that would have given the FDA broad regulatory authority over tobacco products. The
proposals would have granted the FDA authority to impose product standards, including standards
relating to, among other things, nicotine yields and smoke constituents, and would have reinstated
the FDAs 1996 proposed legislation that would have restricted marketing. The proposed legislation
also would have governed modified risk products, including tobacco products using the descriptors
light, mild, low or similar descriptors, and would have imposed new and larger warning labels
on tobacco products. The U.S. Senate Health, Education, Labor and Pensions Committee approved the
FDA regulation bill on August 1, 2007. The Health Subcommittee of the Energy and Commerce
Committee of the U.S. House of Representatives held a hearing on the bill on October 3, 2007, and
passed H.R. 1108, the Family Smoking Prevention and Tobacco Control Act, on March 11, 2008. The
full House Energy and Commerce Committee passed the bill on April 2, 2008. During the Committees
consideration of the bill, changes were made granting small manufacturers additional time to comply with certain portions of the proposed regulatory scheme. Retailers received some clarification on
enforcement penalties, but none of the changes could be classified as substantially changing the
scope of the bill. On July 30, 2008, the U.S. House of Representatives passed the bill by a vote
of 326-102. Congress recently adjourned without any further action on the bill. In 2009, it is
likely that Congress will again take up the issue of FDA regulation of tobacco products.
Cigarettes are subject to substantial excise taxes in the United States. The federal excise
tax per pack of 20 cigarettes is $0.39. In 2007, the U.S. Senate and U.S. House of Representatives
approved an increase of $0.61 in the excise tax per pack of cigarettes, and significant tax
increases on other tobacco products, to fund expansion of the State Childrens Health Insurance
Program, referred to as SCHIP. The President vetoed the bill on October 3, 2007. On October 18,
2007, the U.S. House of Representatives failed to override the Presidents veto of the bill.
Subsequently, the U.S. Congress passed a slightly revised version of the SCHIP bill, and the
President vetoed the bill on December 12, 2007. In January 2008, by a vote of 152-260, the U.S.
House of Representatives failed to override the veto. In between the passage of the revised
legislation and the override vote, the U.S. Congress passed an extension of SCHIP through
77
March of 2009 without a tax increase. At this time, RAI does not know whether any excise tax
bill will be approved to fund SCHIP or any other federal program. The adoption of any such increase
could have a material adverse effect on the business and results of operations of RJR Tobacco.
All states and the District of Columbia currently impose excise taxes at levels ranging from
$0.07 per pack in South Carolina to $2.75 per pack in New York. As of September 30, 2008, the
weighted average state cigarette excise tax per pack, calculated on a 12-month rolling average
basis, was approximately $1.019, an increase compared to the 12-month rolling average of $0.914 as
of December 31, 2007. As of September 30, 2008, three states had passed excise tax per pack
increases in 2008: New York, a $1.25 increase, from $1.50 to $2.75 per pack, effective June 3,
2008; Massachusetts, a $1.00 increase, from $1.51 to $2.51 per pack, effective July 1, 2008; and
New Hampshire, which approved a $0.25 increase, from $1.08 to $1.33 per pack, effective October 15,
2008. In addition, on January 1, 2008, the cigarette excise tax increased by $1.00 per pack in two
states as a result of legislation passed in 2007: Maryland, from
$1.00 to $2.00, and Wisconsin, from $0.77 to $1.77. On July 1, 2008, Vermont increased its cigarette excise tax rate by $0.20,
to $1.99 per pack, the result of an increase passed in 2006 and implemented in 2006 and 2008.
Hawaii increased its cigarette excise tax on September 30, 2008, as a result of a $1.20 tax passed
in 2006, which is being implemented in $0.20 increments until 2011. Certain city and county
governments, such as New York and Chicago, also impose substantial excise taxes on cigarettes sold
in those jurisdictions. The District of Columbia passed a $1.00 per pack increase, from $1.00 to
$2.00, effective October 1, 2008.
Cigars are generally taxed by states on an ad valorem basis, ranging from 5% in South Carolina
to 75% in Alaska and Washington. Other states have unit-based tax schemes for cigars or tax little
cigars the same as cigarettes.
The federal excise tax on smokeless tobacco products currently is $0.195 per pound for chewing
tobacco, and $0.585 per pound for snuff. The federal tax on small cigars, defined as those weighing
three pounds or less per thousand, is $1.828 per thousand. Large cigars are taxed at a rate of
20.719% of the manufacturers price, with a cap of $48.75 per thousand.
Forty-nine states also subject smokeless tobacco to excise taxes and the Commonwealth of
Pennsylvania, which currently levies no tax on other tobacco products, may consider one during its
current legislative session. As of September 30, 2008, 35 states taxed moist snuff, and 46 states
taxed chewing tobacco, on an ad valorem basis at rates that range from 5% in South Carolina to 90%
in Massachusetts. Other states have a unit tax or a weight-based tax. In 2008, two states passed
legislation that changed their tax on moist snuff from an ad valorem tax to a weight-based tax:
Utahs tax changed from 35% to $0.75 per ounce, and New Yorks tax changed from 37% to $0.96 per
ounce, both effective July 1, 2008. Legislation to convert from an ad valorem to a weight-based
tax also has been introduced in approximately 14 other states since January 1, 2008.
On October 25, 2006, the Alcohol and Tobacco Tax and Trade Bureau of the U.S. Department of
Treasury, referred to as the TTB, issued a Notice of Proposed Rulemaking, proposing changes to the
regulations that govern the classification and labeling of cigars and cigarettes for federal excise
tax purposes. The TTB now is considering written comments that were received prior to the March 26,
2007, deadline. Both the CAPTAIN BLACK and WINCHESTER little cigar brands manufactured by Lane,
which are classified and sold as little cigars, would be re-classified as cigarettes under
these proposed regulations. Although it is not possible to fully assess and quantify the negative
impact of the proposed regulations, if adopted, on the little cigar products of Lane, the immediate
impact would be to increase the federal excise tax on such products by more than tenfold. In
addition, if little cigars are classified as cigarettes for federal
excise tax purposes, it is possible
that the states would take the position that MSA obligations also apply to these products.
On July 8, 2008, the FTC published a notice in the Federal Register, stating its proposal to
rescind its guidance, issued in 1966, indicating that factual statements of tar and nicotine yields
based on the Cambridge Filter Method generally will not violate the FTC Act. Specifically, the FTC
sought public comments, which were due on September 12, 2008, to address the following two
questions: (1) Should the Commission rescind its guidance that generally permits factual
statements about tar and nicotine yields when such statements are based on a single test method the
Cambridge Filter Method?; and (2) What effect, if any, would the Commissions proposal likely
have on consumers purchases of cigarettes and/or their smoking behavior? Will these changes be
likely to affect smoking intensity, brand choice, and/or the decision whether to quit smoking, and
if so, how? How else would the proposal likely affect consumers? If it withdraws its guidance, the
FTC has stated in its notice that advertisers should not use terms such as per FTC method or
other phrases that state or imply FTC endorsement or approval of the Cambridge Filter Method or
other machine-based test methods. The FTC has not indicated when it will publish final guidance on
this issue. RJR Tobacco is currently unable to assess whether the proposed action by the FTC, if
implemented, would have a material effect on RAIs results of operations, financial position or
cash flows.
78
In 2003, the New York Office of Fire Prevention and Control issued a final standard with
accompanying regulations that requires all cigarettes offered for sale in New York State after June
28, 2004, to achieve specified test results when placed on ten layers of filter paper in controlled
laboratory conditions. The cigarettes that RAIs operating companies sell in New York State comply
with this standard. As of September 30, 2008, 36 states in addition to New York, as well as
Washington, D.C., had enacted fire standards compliance legislation of their own, adopting the same
testing standard set forth in the OFPC regulations described above. Similar legislation is being
considered in a number of other states. Consistent with these state legislative trends and its
effort to increase productivity and reduce complexity, on October 25, 2007, RJR Tobacco announced
its plans to voluntarily convert all its brands to fire standards compliant paper by the end of
2009. Varying standards from state to state could have an adverse effect on the business or results
of operations of RJR Tobacco.
On July 28, 2008, the San Francisco Board of Supervisors passed a ban on the sale of tobacco
products in some pharmacies. The ban is effective October 1, 2008. A similar ban is also under
consideration by the Boston Public Health Commission.
It is not possible to determine what additional federal, state or local legislation or
regulations relating to smoking or cigarettes will be enacted or to predict the effect of new
legislation or regulations on RJR Tobacco or the cigarette industry in general, but any new
legislation or regulations could have an adverse effect on RJR Tobacco or the cigarette industry in
general. Similarly, it is not possible to determine what additional federal, state or local
legislation or regulations relating to smokeless tobacco products will be enacted or to predict the
effect of new regulation on Conwood or smokeless tobacco products in general, but any new
legislation or regulations could have an adverse effect on Conwood.
Tobacco Buyout Legislation
For information relating to tobacco buyout legislation, see Tobacco Buyout Legislation and
Related Litigation in note 12 to condensed consolidated financial statements (unaudited).
Other Contingencies
For
information relating to other contingencies of RAI, RJR, RJR Tobacco
and Conwood, see Other
Contingencies in note 12 to condensed consolidated financial statements (unaudited).
Off-Balance Sheet Arrangements
RAI has no off-balance sheet arrangements that have or are reasonably likely to have a current
or future material effect on its financial position, results of operations, liquidity, capital
expenditures or capital resources.
Cautionary Information Regarding Forward-Looking Statements
Statements included in this report that are not historical in nature are forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. These statements regarding future events or the future performance or results of RAI
and its subsidiaries inherently are subject to a variety of risks and uncertainties that could
cause actual results to differ materially from those described in the forward-looking statements.
These risks and uncertainties include:
|
|
|
the substantial and increasing regulation and taxation of tobacco products,
including the possible regulation of tobacco products by the FDA and a possible
increase in the federal excise tax on tobacco products; |
|
|
|
|
the possibility of further restrictions or bans on the use of certain
flavorings, including menthol, in tobacco products, or the use of certain flavor
descriptors in the marketing of tobacco products; |
|
|
|
|
various legal actions, proceedings and claims relating to the sale,
distribution, manufacture, development, advertising, marketing and claimed health
effects of tobacco products that are pending or may be instituted against RAI or its
subsidiaries; |
79
|
|
|
the potential difficulty of obtaining bonds as a result of litigation outcomes; |
|
|
|
|
the substantial payment obligations and limitations on the advertising and
marketing of cigarettes under the MSA; |
|
|
|
|
the continuing decline in volume in the domestic cigarette industry and RAIs
dependence on the U.S. cigarette industry; |
|
|
|
|
concentration of a material amount of sales with a single customer or
distributor; |
|
|
|
|
competition from other manufacturers, including any new entrants in the
marketplace; |
|
|
|
|
increased promotional activities by competitors, including deep-discount
cigarette brands; |
|
|
|
|
the success or failure of new product innovations and acquisitions; |
|
|
|
|
the responsiveness of both the trade and consumers to new products, marketing
strategies and promotional programs; |
|
|
|
|
the ability to achieve efficiencies in the businesses of RAIs operating
companies, including outsourcing functions, without negatively affecting sales; |
|
|
|
|
the reliance on a limited number of suppliers for certain raw materials; |
|
|
|
|
the cost of tobacco leaf and other raw materials and other commodities used in
products; |
|
|
|
|
the effect of market conditions on foreign currency exchange rate risk,
interest rate risk and the return on corporate cash; |
|
|
|
|
declining liquidity in the financial markets, including bankruptcy of lenders
participating in the Credit Facility and decreased availability of money market funds; |
|
|
|
|
the impairment of goodwill and other intangible assets, including trademarks; |
|
|
|
|
the effect of market conditions on the performance of pension assets or any
adverse effects of any new legislation or regulations changing pension expense
accounting or required pension funding levels; |
|
|
|
|
the substantial amount of RAI debt; |
|
|
|
|
the rating of RAIs securities; |
|
|
|
|
any restrictive covenants imposed under RAIs debt agreements; |
|
|
|
|
the possibility of fire, violent weather and other disasters that may adversely
affect manufacturing and other facilities; |
|
|
|
|
the significant ownership interest of B&W, RAIs largest shareholder, in RAI
and the rights of B&W under the governance agreement between the companies; |
|
|
|
|
the expiration of the standstill provisions of the governance agreement; and |
|
|
|
|
the potential existence of significant deficiencies or material weaknesses in
internal control over financial reporting that may be identified during the performance
of testing required under Section 404 of the Sarbanes-Oxley Act of 2002. |
Due to these uncertainties and risks, you are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this report. Except as provided by
federal securities laws, RAI is not
80
required to publicly update or revise any forward-looking statement, whether as a result of
new information, future events or otherwise.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk represents the risk of loss that may impact the consolidated financial position,
results of operations and cash flows due to adverse changes in financial market prices and rates.
RAI and its subsidiaries are exposed to interest rate risk directly related to their normal
investing and funding activities. In addition, RAI and its subsidiaries have exposure to foreign
currency exchange rate risk concerning obligations for, and service agreements related to, foreign
operations denominated in euros, British pounds, Swiss francs, Chinese renminbi and Japanese yen.
RAI and its subsidiaries have established policies and procedures to manage their exposure to
market risks and use major institutions, that are believed to be creditworthy at the time the
contracts are entered, as counterparties to minimize their investment and credit risk. Frequently,
these institutions are also members of the bank group that provide RAI credit, and management
believes this further minimizes the risk of nonperformance. Derivative financial instruments are
not used for trading or speculative purposes.
The table below provides information about RAIs financial instruments, as of September 30,
2008, that are sensitive to changes in interest rates. The table presents notional amounts and
weighted average interest rates by contractual maturity dates for the years ending December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair |
|
|
2008 |
|
2009 |
|
2010 |
|
2011 |
|
2012 |
|
Thereafter |
|
Total |
|
Value1 |
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variable Rate |
|
$ |
2,339 |
|
|
|
|
|
|
|
|
|
|
$ |
27 |
|
|
|
|
|
|
$ |
108 |
|
|
$ |
2,474 |
|
|
$ |
2,474 |
|
Average Interest Rate |
|
|
0.9 |
% |
|
|
|
|
|
|
|
|
|
|
4.1 |
% |
|
|
|
|
|
|
4.2 |
% |
|
|
1.1 |
% |
|
|
|
|
Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Rate |
|
|
|
|
|
$ |
200 |
|
|
$ |
300 |
|
|
|
|
|
|
$ |
450 |
|
|
$ |
3,060 |
|
|
$ |
4,010 |
|
|
$ |
3,919 |
|
Average Interest Rate 2 |
|
|
|
|
|
|
7.9 |
% |
|
|
6.5 |
% |
|
|
|
|
|
|
7.3 |
% |
|
|
7.3 |
% |
|
|
7.3 |
% |
|
|
|
|
Variable Rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
400 |
|
|
|
|
|
|
|
|
|
|
$ |
400 |
|
|
$ |
382 |
|
Average Interest Rate 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.7 |
% |
|
|
|
|
|
|
|
|
|
|
3.7 |
% |
|
|
|
|
Swaps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional Amount 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
450 |
|
|
$ |
1,150 |
|
|
$ |
1,600 |
|
|
$ |
106 |
|
Average Variable Interest Pay
Rate2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.6 |
% |
|
|
4.1 |
% |
|
|
4.2 |
% |
|
|
|
|
Average Fixed Interest Receive
Rate2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.3 |
% |
|
|
7.1 |
% |
|
|
7.1 |
% |
|
|
|
|
|
|
|
1 |
|
Fair values are based on current market rates available or on rates available for
instruments with similar terms and maturities and quoted market values. |
|
2 |
|
Based upon contractual interest rates for fixed rate indebtedness or current market
rates for LIBOR plus negotiated spreads for variable rate indebtedness. |
|
3 |
|
RAI has swapped $1.6 billion of fixed rate debt to variable rate debt. |
RAIs exposure to foreign currency transactions was not material to its results of operations
for the nine months ended September 30, 2008, but may be in future periods in relation to activity
associated with international operations of RAIs subsidiaries. RAI currently has no hedges for
its exposure to foreign currency. See Liquidity and Financial Condition in Item 2 for
additional information.
Item 4. Controls and Procedures
|
(a) |
|
RAIs chief executive officer and chief financial officer have concluded that RAIs
disclosure controls and procedures were effective as of the end of the period covered by
this report, based on their evaluation of these controls and procedures. |
|
|
(b) |
|
There have been no changes in RAIs internal controls over financial reporting that
occurred during the third quarter of 2008 that have materially affected, or are reasonably
likely to materially affect, RAIs internal controls over financial reporting. |
81
PART II Other Information
Item 1. Legal Proceedings
For a discussion of the litigation and legal proceedings pending against RJR Tobacco, Conwood
or their affiliates, including RAI and RJR, or indemnitees, including B&W, see note 12 to condensed
consolidated financial statements (unaudited) and Managements Discussion and Analysis of
Financial Condition and Results of Operations Critical Accounting Policies Litigation included
in Part I, Item 2.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
RAI conducts its business through its subsidiaries and is dependent on the earnings and cash
flows of its subsidiaries to satisfy its obligations and other cash needs. For more information,
see Managements Discussion and Analysis of Financial Condition and Results of
OperationsLiquidity and Financial Condition in Part I, Item 2. RAI believes that the provisions
of the Credit Facility and the guarantees of the Credit Facility, interest rate swaps and Notes
will not impair its payment of quarterly dividends.
The following table summarizes RAIs purchases of its common stock during the third quarter of
2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Number of |
|
Approximate Dollar |
|
|
|
|
|
|
|
|
|
|
Shares Purchased |
|
Value that May Yet |
|
|
Total Number |
|
Average Price |
|
as Part of Publicly |
|
Be Purchased Under |
|
|
of Shares |
|
Paid per |
|
Announced Plans or |
|
the Plans or |
|
|
Purchased 1 |
|
Share |
|
Programs |
|
Programs 2 |
July 1, 2008 to July 31, 2008 |
|
|
4,809 |
|
|
$ |
55.06 |
|
|
|
|
|
|
$ |
232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
August 1, 2008 to August 31, 2008 |
|
|
1,251,275 |
|
|
$ |
55.93 |
|
|
|
1,248,855 |
|
|
$ |
162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 1, 2008 to
September 30, 2008 |
|
|
369,136 |
|
|
$ |
53.49 |
|
|
|
365,175 |
|
|
$ |
143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Quarter Total |
|
|
1,625,220 |
|
|
$ |
55.37 |
|
|
|
1,614,030 |
|
|
$ |
143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
RAI repurchases and cancels shares of its common stock
forfeited with respect to the tax liability associated with
certain option exercises and vesting of restricted stock
grants under the LTIP. |
|
2 |
|
On April 29, 2008, the board of directors of RAI authorized
the repurchase, on or before April 30, 2009, of up to $350
million of outstanding shares of RAI common stock.
Concurrent with this authorization, the board of directors
rescinded the $30 million repurchase authorized on February
5, 2008. |
82
Item 6. Exhibits
(a) Exhibits
|
|
|
Exhibit Number |
|
Description |
|
|
|
31.1
|
|
Certification of Chief Executive Officer relating to
RAIs Quarterly Report on Form 10-Q for the quarter
ended September 30, 2008. |
|
|
|
31.2
|
|
Certification of Chief Financial Officer relating to
RAIs Quarterly Report on Form 10-Q for the quarter
ended September 30, 2008. |
|
|
|
32.1
|
|
Certification of Chief Executive Officer and Chief
Financial Officer relating to RAIs Quarterly Report on
Form 10-Q for the quarter ended September 30, 2008,
pursuant to Section 18 U.S.C. §1350, adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
83
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
REYNOLDS AMERICAN INC.
(Registrant) |
|
|
|
|
|
|
|
|
|
/s/ Thomas R. Adams
Thomas R. Adams
|
|
|
|
|
Executive Vice President and |
|
|
|
|
Chief Financial Officer |
|
|
Date: October 24, 2008
84